baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,gene_id,direction,SWISS_Description,SWISS_Length,SWISS_.Hits,SWISS_e.Value,SWISS_sim.mean,SWISS_.GO,SWISS_GO.IDs,SWISS_GO.Names,SWISS_Enzyme.Codes,SWISS_Enzyme.Names,TREMBL_Description,TREMBL_Length,TREMBL_.Hits,TREMBL_e.Value,TREMBL_sim.mean,TREMBL_.GO,TREMBL_GO.IDs,TREMBL_GO.Names,TREMBL_Enzyme.Codes,TREMBL_Enzyme.Names,INTERPRO_Length,InterPro.IDs,InterPro.GO.IDs,InterPro.GO.Names,BLAST_Description,BLAST_Length,BLAST_.Hits,BLAST_e.Value,BLAST_sim.mean,BLAST_.GO,BLAST_GO.IDs,BLAST_GO.Names,BLAST_Enzyme.Codes,BLAST_Enzyme.Names
685.661774208878,-0.264916152454256,0.0578739348034412,-4.57746917250396,4.70635118771252e-6,0.00325400607304509,Pver_g130,Downregulated,FBXW7_BOVINF-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3,367,5,2.64e-15,56.67,37,P:GO:0001570; P:GO:0006974; P:GO:0007062; P:GO:0007219; P:GO:0010629; P:GO:0030324; P:GO:0031146; P:GO:0031648; P:GO:0034644; P:GO:0042752; P:GO:0045741; P:GO:0048193; P:GO:0050821; P:GO:0051443; P:GO:0070374; P:GO:0090049; P:GO:1901800; P:GO:1903026; P:GO:1903146; P:GO:1903378; P:GO:1903955; P:GO:2000060; P:GO:2001205; F:GO:0030332; F:GO:0030674; F:GO:0031625; F:GO:0042802; F:GO:0050816; F:GO:0097027; C:GO:0005654; C:GO:0005730; C:GO:0005739; C:GO:0005783; C:GO:0005794; C:GO:0019005; C:GO:0048471; C:GO:1990452,P:vasculogenesis; P:cellular response to DNA damage stimulus; P:sister chromatid cohesion; P:Notch signaling pathway; P:negative regulation of gene expression; P:lung development; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; P:protein destabilization; P:cellular response to UV; P:regulation of circadian rhythm; P:positive regulation of epidermal growth factor-activated receptor activity; P:Golgi vesicle transport; P:protein stabilization; P:positive regulation of ubiquitin-protein transferase activity; P:positive regulation of ERK1 and ERK2 cascade; P:regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of proteasomal protein catabolic process; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:regulation of autophagy of mitochondrion; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; P:positive regulation of protein targeting to mitochondrion; P:positive regulation of ubiquitin-dependent protein catabolic process; P:negative regulation of osteoclast development; F:cyclin binding; F:protein-macromolecule adaptor activity; F:ubiquitin protein ligase binding; F:identical protein binding; F:phosphothreonine residue binding; F:ubiquitin-protein transferase activator activity; C:nucleoplasm; C:nucleolus; C:mitochondrion; C:endoplasmic reticulum; C:Golgi apparatus; C:SCF ubiquitin ligase complex; C:perinuclear region of cytoplasm; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,366,IPR020472 (PRINTS); IPR001680 (SMART); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); PTHR44129 (PANTHER); IPR001680 (PROSITE_PROFILES); PS50294 (PROSITE_PROFILES); PS50294 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR036322 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_027043597.1,367,1,5.4e-190,98.63,NA,NA,NA,NA,NA
422.119980969208,0.65857398008065,0.19279553120445,3.41591932119144,6.3567077239696e-4,0.048634024504535,Pver_g7878,Upregulated,UAFA_STAS1Uro-adherence factor A OS=Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41) OX=342451 GN=uafA PE=1 SV=1,685,1,1.85e-7,47.1,3,P:GO:0007155; C:GO:0005576; C:GO:0005618,P:cell adhesion; C:extracellular region; C:cell wall,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,684,Coil (COILS); PR01217 (PRINTS); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR48134 (PANTHER),NA,NA,XP_027044563.1,685,1,1.1e-207,94.88,NA,NA,NA,NA,NA
269.072966314843,0.636483232528983,0.153242234448306,4.15344526148692,3.27506583453431e-5,0.00970459190461692,Pver_g1842,Upregulated,"SQOR_HUMANSulfide:quinone oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=SQOR PE=1 SV=1",794,4,1.8e-59,69.52,8,P:GO:0006750; P:GO:0070219; P:GO:0070221; P:GO:0070813; P:GO:0098849; F:GO:0070224; F:GO:0071949; C:GO:0005743,"P:glutathione biosynthetic process; P:cellular sulfide ion homeostasis; P:sulfide oxidation, using sulfide:quinone oxidoreductase; P:hydrogen sulfide metabolic process; P:cellular detoxification of cadmium ion; F:sulfide:quinone oxidoreductase activity; F:FAD binding; C:mitochondrial inner membrane",EC:1.8.5,Acting on a sulfur group of donors,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,793,Coil (COILS); IPR036188 (G3DSA:3.50.50.GENE3D); IPR021109 (G3DSA:2.40.70.GENE3D); IPR036188 (G3DSA:3.50.50.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR015904 (PANTHER); cd05481 (CDD); IPR012337 (SUPERFAMILY); IPR036188 (SUPERFAMILY),NA,NA,PFX18608.1,794,1,2.9999999999999996e-145,76.6,4,P:GO:0006259; F:GO:0004518; F:GO:0005488; F:GO:0016779,P:DNA metabolic process; F:nuclease activity; F:binding; F:nucleotidyltransferase activity,EC:3.1; EC:2.7.7,Acting on ester bonds; Transferring phosphorus-containing groups
244.654040598579,1.46377366520026,0.331325997602992,4.41792577639565,9.96526280642408e-6,0.00516754239084235,Pver_g23161,Upregulated,NA,882,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6V3N2_POCDAPNPLA domain-containing protein OS=Pocillopora damicornis OX=46731 GN=pdam_00021544 PE=4 SV=1,882,5,0,81.1,2,P:GO:0006629; C:GO:0016021,P:lipid metabolic process; C:integral component of membrane,NA,NA,881,G3DSA:3.40.1090.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR10728:SF40 (PANTHER); PTHR10728 (PANTHER); IPR016035 (SUPERFAMILY),NA,NA,XP_027040289.1,882,1,0,85.04,NA,NA,NA,NA,NA
2085.50631730157,2.08140060058646,0.40677860004051,5.11678982222559,3.10779596509025e-7,4.2341703931316e-4,Pver_g26469,Upregulated,ZN363_HUMANRING finger and CHY zinc finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RCHY1 PE=1 SV=1,857,5,9.400000000000001e-30,49.98,7,P:GO:0016567; P:GO:0032270; F:GO:0004842; F:GO:0005515; F:GO:0046872; C:GO:0005654; C:GO:0005737,P:protein ubiquitination; P:positive regulation of cellular protein metabolic process; F:ubiquitin-protein transferase activity; F:protein binding; F:metal ion binding; C:nucleoplasm; C:cytoplasm,EC:2,Transferases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,856,Coil (COILS); IPR001841 (SMART); IPR008913 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001841 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR21319 (PANTHER); PTHR21319:SF20 (PANTHER); IPR008913 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR017921 (PROSITE_PROFILES); SSF57850 (SUPERFAMILY); IPR037274 (SUPERFAMILY); IPR037275 (SUPERFAMILY),F:GO:0008270,F:zinc ion binding,XP_027054728.1,857,1,3.1e-289,79.43,NA,NA,NA,NA,NA
734.971658997499,0.641537562169333,0.181633306225899,3.53204803402877,4.123544462621e-4,0.0403027895435653,Pver_g7972,Upregulated,KNDC1_HUMANKinase non-catalytic C-lobe domain-containing protein 1 OS=Homo sapiens OX=9606 GN=KNDC1 PE=2 SV=2,3856,5,1.9599999999999996e-101,47.81,6,P:GO:0009966; P:GO:0048522; P:GO:0050773; F:GO:0030695; C:GO:0042995; C:GO:0043025,P:regulation of signal transduction; P:positive regulation of cellular process; P:regulation of dendrite development; F:GTPase regulator activity; C:cell projection; C:neuronal cell body,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3855,Coil (COILS); IPR001895 (SMART); IPR011019 (SMART); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.20.870.10 (GENE3D); IPR036964 (G3DSA:1.10.840.GENE3D); IPR001895 (PFAM); IPR000651 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR029899 (PANTHER); IPR001895 (PROSITE_PROFILES); IPR011019 (PROSITE_PROFILES); IPR000651 (PROSITE_PROFILES); IPR000651 (CDD); IPR023578 (SUPERFAMILY),P:GO:0007264; F:GO:0005085,P:small GTPase mediated signal transduction; F:guanyl-nucleotide exchange factor activity,RMX61505.1,3856,1,0,94.54,3,P:GO:0007264; P:GO:0050790; F:GO:0005085,P:small GTPase mediated signal transduction; P:regulation of catalytic activity; F:guanyl-nucleotide exchange factor activity,NA,NA
291.700528900783,-0.636954885275785,0.174237021857049,-3.65568051202327,2.5650064337469e-4,0.0319223600701248,Pver_g25888,Downregulated,FBL4_ARATHF-box/LRR-repeat protein 4 OS=Arabidopsis thaliana OX=3702 GN=FBL4 PE=2 SV=1,488,5,7.35e-13,44.28,5,P:GO:0044267; P:GO:0050896; F:GO:0005515; C:GO:0005622; C:GO:0043226,P:cellular protein metabolic process; P:response to stimulus; F:protein binding; C:intracellular anatomical structure; C:organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,487,IPR006553 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR13382 (PANTHER); PTHR13382:SF7 (PANTHER); PTHR13382 (PANTHER); SSF52047 (SUPERFAMILY),NA,NA,XP_027057250.1,488,1,2.8e-255,97.54,NA,NA,NA,NA,NA
1084.6305492416,0.244311240248396,0.0629747032108225,3.87951396024063,1.0466539440972e-4,0.0189698406101036,Pver_g26149,Upregulated,P5CS_PONABDelta-1-pyrroline-5-carboxylate synthase OS=Pongo abelii OX=9601 GN=ALDH18A1 PE=2 SV=1,799,5,0,73.69,9,P:GO:0006536; P:GO:0006561; P:GO:0006592; P:GO:0019240; F:GO:0000166; F:GO:0004349; F:GO:0004350; F:GO:0042802; C:GO:0005743,P:glutamate metabolic process; P:proline biosynthetic process; P:ornithine biosynthetic process; P:citrulline biosynthetic process; F:nucleotide binding; F:glutamate 5-kinase activity; F:glutamate-5-semialdehyde dehydrogenase activity; F:identical protein binding; C:mitochondrial inner membrane,EC:1.2.1.41; EC:2.7.2.11,Glutamate-5-semialdehyde dehydrogenase; Glutamate 5-kinase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,798,IPR001057 (PRINTS); IPR016162 (G3DSA:3.40.605.GENE3D); IPR001048 (PFAM); IPR005766 (TIGRFAM); IPR000965 (TIGRFAM); IPR036393 (G3DSA:3.40.1160.GENE3D); IPR005715 (TIGRFAM); IPR016163 (G3DSA:3.40.309.GENE3D); IPR015590 (PFAM); IPR005766 (PIRSF); PIRSR016496-1 (PIRSR); mobidb-lite (MOBIDB_LITE); PTHR11063:SF8 (PANTHER); PTHR11063 (PANTHER); IPR020593 (PROSITE_PATTERNS); IPR019797 (PROSITE_PATTERNS); IPR000965 (HAMAP); IPR005715 (HAMAP); IPR000965 (CDD); IPR041744 (CDD); IPR016161 (SUPERFAMILY); IPR036393 (SUPERFAMILY),P:GO:0006561; F:GO:0003824; F:GO:0004349; F:GO:0004350; F:GO:0016491; F:GO:0016620; C:GO:0005737,"P:proline biosynthetic process; F:catalytic activity; F:glutamate 5-kinase activity; F:glutamate-5-semialdehyde dehydrogenase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; C:cytoplasm",XP_027036271.1,799,1,0,99.87,NA,NA,NA,NA,NA
2575.68947348989,1.75460456288471,0.471722954026547,3.71956579154713,1.9956556052759e-4,0.0269963035067333,Pver_g6161,Upregulated,TRPA1_HUMANTransient receptor potential cation channel subfamily A member 1 OS=Homo sapiens OX=9606 GN=TRPA1 PE=1 SV=3,1217,5,2.6099999999999997e-125,47.47,20,P:GO:0006950; P:GO:0007165; P:GO:0009266; P:GO:0009416; P:GO:0009581; P:GO:0009582; P:GO:0010033; P:GO:0010646; P:GO:0023051; P:GO:0032879; P:GO:0044057; P:GO:0048518; P:GO:0050951; P:GO:0062149; P:GO:0065008; P:GO:0070588; F:GO:0005262; F:GO:0022836; C:GO:0005886; C:GO:0016021,P:response to stress; P:signal transduction; P:response to temperature stimulus; P:response to light stimulus; P:detection of external stimulus; P:detection of abiotic stimulus; P:response to organic substance; P:regulation of cell communication; P:regulation of signaling; P:regulation of localization; P:regulation of system process; P:positive regulation of biological process; P:sensory perception of temperature stimulus; P:detection of stimulus involved in sensory perception of pain; P:regulation of biological quality; P:calcium ion transmembrane transport; F:calcium channel activity; F:gated channel activity; C:plasma membrane; C:integral component of membrane,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1216,Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); PF13637 (PFAM); IPR005821 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); G3DSA:1.10.287.70 (GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR24121 (PANTHER); PTHR24121 (PANTHER); PTHR24121:SF2 (PANTHER); PTHR24121 (PANTHER); PTHR24121:SF2 (PANTHER); PTHR24121:SF2 (PANTHER); PS50297 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY),P:GO:0006811; P:GO:0055085; F:GO:0005216; F:GO:0005515; C:GO:0016020,P:ion transport; P:transmembrane transport; F:ion channel activity; F:protein binding; C:membrane,XP_027043914.1,1217,1,0,98.36,NA,NA,NA,NA,NA
3400.94881039311,0.877388873292257,0.2081847577492,4.21447219661128,2.50362990927994e-5,0.00805823502524793,Pver_g1594,Upregulated,PLD3B_CRIGRPRELI domain containing protein 3B OS=Cricetulus griseus OX=10029 GN=PRELID3B PE=2 SV=1,227,5,1.2699999999999999e-60,70.17,3,P:GO:0015914; F:GO:1990050; C:GO:0005758,P:phospholipid transport; F:phosphatidic acid transfer activity; C:mitochondrial intermembrane space,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,226,Coil (COILS); IPR006797 (PFAM); IPR037365 (PANTHER); PTHR11158:SF22 (PANTHER); IPR006797 (PROSITE_PROFILES),C:GO:0005758,C:mitochondrial intermembrane space,XP_022790046.1,227,1,3.499999999999999e-107,95.58,NA,NA,NA,NA,NA
172.932360897315,0.644125615966311,0.180654316813358,3.56551466540257,3.6314285355262e-4,0.0375963621919611,Pver_g82,Upregulated,PK1L2_MOUSEPolycystic kidney disease protein 1-like 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,5518,5,2.78e-64,48.54,22,P:GO:0003002; P:GO:0003143; P:GO:0003170; P:GO:0007166; P:GO:0009628; P:GO:0030001; P:GO:0042221; P:GO:0048793; P:GO:0050909; P:GO:0051262; P:GO:0051282; P:GO:0051606; P:GO:0061371; P:GO:0098662; F:GO:0005267; F:GO:0008092; F:GO:0022836; C:GO:0005783; C:GO:0005929; C:GO:0016021; C:GO:0032991; C:GO:0098590,P:regionalization; P:embryonic heart tube morphogenesis; P:heart valve development; P:cell surface receptor signaling pathway; P:response to abiotic stimulus; P:metal ion transport; P:response to chemical; P:pronephros development; P:sensory perception of taste; P:protein tetramerization; P:regulation of sequestering of calcium ion; P:detection of stimulus; P:determination of heart left/right asymmetry; P:inorganic cation transmembrane transport; F:potassium channel activity; F:cytoskeletal protein binding; F:gated channel activity; C:endoplasmic reticulum; C:cilium; C:integral component of membrane; C:protein-containing complex; C:plasma membrane region,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5517,IPR001024 (SMART); IPR000203 (SMART); IPR000742 (SMART); IPR001881 (SMART); G3DSA:2.60.120.260 (GENE3D); IPR000203 (PFAM); IPR001881 (PFAM); IPR000421 (PFAM); G3DSA:2.60.220.50 (GENE3D); G3DSA:2.60.60.20 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001024 (PFAM); G3DSA:2.60.60.20 (GENE3D); IPR031751 (PFAM); IPR002859 (PFAM); G3DSA:1.10.287.70 (GENE3D); IPR013122 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR10877 (PANTHER); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000421 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000203 (PROSITE_PROFILES); IPR014010 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000203 (PROSITE_PROFILES); IPR000421 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR014010 (PROSITE_PROFILES); cd00054 (CDD); cd00054 (CDD); SSF57196 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR036392 (SUPERFAMILY); SSF57196 (SUPERFAMILY),F:GO:0005509; F:GO:0005515,F:calcium ion binding; F:protein binding,XP_027057616.1,5518,1,0,93.09,NA,NA,NA,NA,NA
1301.95650593358,1.55603202817178,0.35320505600682,4.40546363000458,1.05557862645262e-5,0.005185668894373,Pver_g25926,Upregulated,S38A2_DANRESodium-coupled neutral amino acid transporter 2 OS=Danio rerio OX=7955 GN=slc38a2 PE=3 SV=1,494,5,8.880000000000001e-29,46.19,2,P:GO:0006810; C:GO:0016020,P:transport; C:membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,493,IPR013057 (PFAM); PTHR22950 (PANTHER); PTHR22950:SF660 (PANTHER),NA,NA,XP_027057416.1,494,1,2.2e-271,98.17,NA,NA,NA,NA,NA
778.03903223173,2.52761699949727,0.174859111269964,14.4551632519445,2.32577702318452e-47,2.1708802734404296e-43,Pver_g5715,Upregulated,HLF_HUMANHepatic leukemia factor OS=Homo sapiens OX=9606 GN=HLF PE=1 SV=1,238,5,2.22e-14,64.92,7,P:GO:0035914; P:GO:0045944; F:GO:0000978; F:GO:0001228; F:GO:0042802; F:GO:0044877; C:GO:0005654,"P:skeletal muscle cell differentiation; P:positive regulation of transcription by RNA polymerase II; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:identical protein binding; F:protein-containing complex binding; C:nucleoplasm",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,237,Coil (COILS); IPR004827 (SMART); IPR004827 (PFAM); G3DSA:1.20.5.170 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR040223 (PANTHER); IPR004827 (PROSITE_PROFILES); cd14695 (CDD); SSF57959 (SUPERFAMILY),P:GO:0006355; P:GO:0006357; F:GO:0003700,"P:regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; F:DNA-binding transcription factor activity",XP_027042675.1,238,1,1.0999999999999999e-108,100,NA,NA,NA,NA,NA
88.0229380498426,1.14139955459314,0.230732562438975,4.94685077185421,7.54237526000805e-7,7.8222811863239e-4,Pver_g5714,Upregulated,NA,190,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TZY7_POCDAUncharacterized protein OS=Pocillopora damicornis OX=46731 GN=pdam_00011925 PE=4 SV=1,190,2,3.89e-122,85.24,NA,NA,NA,NA,NA,189,mobidb-lite (MOBIDB_LITE),NA,NA,XP_027042659.1,190,1,5.199999999999999e-88,94.62,NA,NA,NA,NA,NA
195.383023548261,0.990702861194765,0.19251904685664,5.14599920044532,2.66100554635687e-7,4.2341703931316e-4,Pver_g5713,Upregulated,NA,116,NA,NA,NA,NA,NA,NA,NA,NA,A7RFQ4_NEMVEPredicted protein OS=Nematostella vectensis OX=45351 GN=v1g231731 PE=4 SV=1,116,5,2.3199999999999997e-74,67.71,NA,NA,NA,NA,NA,115,IPR027932 (PFAM); PTHR35256 (PANTHER),NA,NA,XP_027042659.1,116,1,8.5e-57,98.26,NA,NA,NA,NA,NA
4616.85273760278,-0.251172406092956,0.0603219561381255,-4.16386374337431,3.12906891772409e-5,0.00957597681247104,Pver_g4609,Downregulated,GNA13_HUMANGuanine nucleotide-binding protein subunit alpha-13 OS=Homo sapiens OX=9606 GN=GNA13 PE=1 SV=2,359,5,7.709999999999999e-169,78.64,28,P:GO:0001569; P:GO:0001701; P:GO:0007189; P:GO:0007204; P:GO:0007266; P:GO:0008360; P:GO:0010762; P:GO:0030154; P:GO:0030168; P:GO:0031584; P:GO:0032006; P:GO:0032434; P:GO:0042733; P:GO:0051056; P:GO:1904706; P:GO:1904753; F:GO:0003924; F:GO:0005085; F:GO:0005525; F:GO:0031683; F:GO:0031752; F:GO:0046872; C:GO:0005634; C:GO:0005829; C:GO:0005834; C:GO:0016328; C:GO:0031526; C:GO:0031982,P:branching involved in blood vessel morphogenesis; P:in utero embryonic development; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; P:Rho protein signal transduction; P:regulation of cell shape; P:regulation of fibroblast migration; P:cell differentiation; P:platelet activation; P:activation of phospholipase D activity; P:regulation of TOR signaling; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; P:embryonic digit morphogenesis; P:regulation of small GTPase mediated signal transduction; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of vascular associated smooth muscle cell migration; F:GTPase activity; F:guanyl-nucleotide exchange factor activity; F:GTP binding; F:G-protein beta/gamma-subunit complex binding; F:D5 dopamine receptor binding; F:metal ion binding; C:nucleus; C:cytosol; C:heterotrimeric G-protein complex; C:lateral plasma membrane; C:brush border membrane; C:vesicle,EC:3.6.1,Acting on acid anhydrides,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,358,IPR001019 (PRINTS); IPR000469 (PRINTS); IPR001019 (SMART); IPR011025 (G3DSA:1.10.400.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001019 (PFAM); IPR001019 (PANTHER); PTHR10218:SF205 (PANTHER); IPR001019 (PROSITE_PROFILES); IPR001019 (CDD); IPR027417 (SUPERFAMILY); IPR011025 (SUPERFAMILY),P:GO:0007165; P:GO:0007186; P:GO:0007266; F:GO:0001664; F:GO:0003924; F:GO:0019001; F:GO:0031683,P:signal transduction; P:G protein-coupled receptor signaling pathway; P:Rho protein signal transduction; F:G protein-coupled receptor binding; F:GTPase activity; F:guanyl nucleotide binding; F:G-protein beta/gamma-subunit complex binding,XP_027053171.1,359,1,2.8e-199,100,NA,NA,NA,NA,NA
208.881737174741,2.46770280710113,0.471625296855666,5.23233767050525,1.67379625472926e-7,3.1246428483285e-4,Pver_g20439,Upregulated,PTPRF_DANREReceptor-type tyrosine-protein phosphatase F OS=Danio rerio OX=7955 GN=ptprf PE=2 SV=1,641,5,1.9199999999999999e-53,49.02,20,P:GO:0007155; P:GO:0010646; P:GO:0010977; P:GO:0016311; P:GO:0021537; P:GO:0022603; P:GO:0023051; P:GO:0048585; P:GO:0050767; P:GO:0051093; P:GO:0051241; P:GO:0051963; F:GO:0004721; F:GO:0005515; F:GO:0097367; F:GO:1901681; C:GO:0005887; C:GO:0031410; C:GO:0098793; C:GO:0098984,P:cell adhesion; P:regulation of cell communication; P:negative regulation of neuron projection development; P:dephosphorylation; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:regulation of signaling; P:negative regulation of response to stimulus; P:regulation of neurogenesis; P:negative regulation of developmental process; P:negative regulation of multicellular organismal process; P:regulation of synapse assembly; F:phosphoprotein phosphatase activity; F:protein binding; F:carbohydrate derivative binding; F:sulfur compound binding; C:integral component of plasma membrane; C:cytoplasmic vesicle; C:presynapse; C:neuron to neuron synapse,EC:3.1.3,Acting on ester bonds,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,640,IPR003961 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR003961 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR008454 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR13817:SF55 (PANTHER); PTHR13817:SF55 (PANTHER); PTHR13817 (PANTHER); PTHR13817:SF55 (PANTHER); PTHR13817 (PANTHER); PTHR13817 (PANTHER); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (CDD); IPR003961 (CDD); IPR003961 (CDD); IPR003961 (CDD); IPR003961 (CDD); IPR036116 (SUPERFAMILY); IPR036116 (SUPERFAMILY); IPR036116 (SUPERFAMILY),F:GO:0005515,F:protein binding,RMX58477.1,641,1,7.399999999999998e-102,56.34,NA,NA,NA,NA,NA
9088.46893441608,1.46519961125272,0.369027193637255,3.97043805040822,7.17406084978959e-5,0.0163323619443746,Pver_g13706,Upregulated,DMBT1_HUMANDeleted in malignant brain tumors 1 protein OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,2006,5,1.54e-157,49.98,10,P:GO:0006897; P:GO:0019730; P:GO:0042742; P:GO:0048856; F:GO:0005515; F:GO:0097367; C:GO:0005615; C:GO:0030659; C:GO:0071944; C:GO:0098588,P:endocytosis; P:antimicrobial humoral response; P:defense response to bacterium; P:anatomical structure development; F:protein binding; F:carbohydrate derivative binding; C:extracellular space; C:cytoplasmic vesicle membrane; C:cell periphery; C:bounding membrane of organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2005,IPR001314 (PRINTS); IPR001190 (PRINTS); IPR000998 (SMART); IPR003598 (SMART); IPR017448 (SMART); IPR003599 (SMART); IPR001254 (SMART); IPR036772 (G3DSA:3.10.250.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.60.120.200 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000998 (PFAM); IPR043504 (G3DSA:2.40.10.GENE3D); IPR001254 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR036772 (G3DSA:3.10.250.GENE3D); PF13927 (PFAM); IPR001190 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR19331:SF462 (PANTHER); PTHR19331:SF462 (PANTHER); PTHR19331:SF462 (PANTHER); PTHR19331 (PANTHER); PTHR19331 (PANTHER); IPR018114 (PROSITE_PATTERNS); IPR033116 (PROSITE_PATTERNS); IPR001190 (PROSITE_PATTERNS); IPR001190 (PROSITE_PATTERNS); IPR001190 (PROSITE_PATTERNS); IPR001190 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001254 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000998 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000998 (CDD); cd00096 (CDD); IPR001254 (CDD); cd00096 (CDD); IPR009003 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036772 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036772 (SUPERFAMILY); IPR036772 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR013320 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036772 (SUPERFAMILY); IPR036772 (SUPERFAMILY); IPR036772 (SUPERFAMILY),P:GO:0006508; F:GO:0004252; F:GO:0005044; C:GO:0016020,P:proteolysis; F:serine-type endopeptidase activity; F:scavenger receptor activity; C:membrane,XP_027049239.1,2006,1,0,98.75,NA,NA,NA,NA,NA
391.912978067511,-0.367410497823268,0.105320773390792,-3.48849031387183,4.8575642093312e-4,0.0428328316587693,Pver_g916,Downregulated,"MGT4C_CHICKAlpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Gallus gallus OX=9031 GN=MGAT4C PE=1 SV=1",480,5,2.1e-66,52.88,2,F:GO:0008375; C:GO:0016020,F:acetylglucosaminyltransferase activity; C:membrane,EC:2.4.1,Glycosyltransferases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,479,PF04666 (PFAM); G3DSA:2.60.120.260 (GENE3D); IPR006759 (PANTHER),NA,NA,XP_027054904.1,480,1,7.800000000000001e-274,98.12,NA,NA,NA,NA,NA
5344.91966620123,0.310246975111033,0.0725177923830704,4.27821869524343,1.88394880072297e-5,0.00676337619459548,Pver_g7459,Upregulated,FZD8_RATFrizzled-8 OS=Rattus norvegicus OX=10116 GN=Fzd8 PE=2 SV=1,336,4,3.26e-6,50.16,28,P:GO:0001525; P:GO:0001934; P:GO:0007165; P:GO:0007166; P:GO:0007186; P:GO:0008150; P:GO:0016055; P:GO:0030182; P:GO:0033077; P:GO:0043507; P:GO:0051091; P:GO:0060070; F:GO:0003674; F:GO:0004888; F:GO:0004930; F:GO:0005102; F:GO:0005515; F:GO:0017147; F:GO:0030165; F:GO:0031625; F:GO:0042813; C:GO:0005575; C:GO:0005576; C:GO:0005794; C:GO:0005886; C:GO:0016020; C:GO:0016021; C:GO:1990851,P:angiogenesis; P:positive regulation of protein phosphorylation; P:signal transduction; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:biological_process; P:Wnt signaling pathway; P:neuron differentiation; P:T cell differentiation in thymus; P:positive regulation of JUN kinase activity; P:positive regulation of DNA-binding transcription factor activity; P:canonical Wnt signaling pathway; F:molecular_function; F:transmembrane signaling receptor activity; F:G protein-coupled receptor activity; F:signaling receptor binding; F:protein binding; F:Wnt-protein binding; F:PDZ domain binding; F:ubiquitin protein ligase binding; F:Wnt-activated receptor activity; C:cellular_component; C:extracellular region; C:Golgi apparatus; C:plasma membrane; C:membrane; C:integral component of membrane; C:Wnt-Frizzled-LRP5/6 complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,335,IPR020067 (SMART); IPR020067 (PFAM); IPR036790 (G3DSA:1.10.2000.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR11309:SF47 (PANTHER); PTHR11309:SF47 (PANTHER); IPR015526 (PANTHER); IPR015526 (PANTHER); IPR020067 (PROSITE_PROFILES); cd07066 (CDD); IPR036790 (SUPERFAMILY); IPR036790 (SUPERFAMILY),F:GO:0005515,F:protein binding,RMX42093.1,336,1,1.1999999999999999e-196,98.8,1,C:GO:0016021,C:integral component of membrane,NA,NA
83.1985074509286,-2.42326035896717,0.515948821116531,-4.69670684337091,2.64389485271101e-6,0.00201301469244063,Pver_g19051,Downregulated,WDFY3_HUMANWD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2,1655,5,1.4e-94,48.76,8,P:GO:0006914; F:GO:0008289; C:GO:0005635; C:GO:0005654; C:GO:0005776; C:GO:0019898; C:GO:0031090; C:GO:0043232,P:autophagy; F:lipid binding; C:nuclear envelope; C:nucleoplasm; C:autophagosome; C:extrinsic component of membrane; C:organelle membrane; C:intracellular non-membrane-bounded organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1654,Coil (COILS); IPR000477 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR46108:SF1 (PANTHER); PTHR46108 (PANTHER); IPR043502 (SUPERFAMILY); IPR016024 (SUPERFAMILY),NA,NA,XP_027041277.1,1655,1,0,77.96,NA,NA,NA,NA,NA
100.742546386368,0.980175851536043,0.288142140176299,3.40170948593748,6.6965783031459e-4,0.0497878480783014,Pver_g9266,Upregulated,PKD2_ORYLAPolycystin-2 OS=Oryzias latipes OX=8090 GN=pkd2 PE=1 SV=2,812,5,6.14e-35,45.72,19,P:GO:0001822; P:GO:0003143; P:GO:0007166; P:GO:0009628; P:GO:0030001; P:GO:0032879; P:GO:0042221; P:GO:0051606; P:GO:0061371; P:GO:0065003; P:GO:0098662; F:GO:0005261; F:GO:0005515; F:GO:0022836; F:GO:0046873; C:GO:0005783; C:GO:0005929; C:GO:0016021; C:GO:0098590,P:kidney development; P:embryonic heart tube morphogenesis; P:cell surface receptor signaling pathway; P:response to abiotic stimulus; P:metal ion transport; P:regulation of localization; P:response to chemical; P:detection of stimulus; P:determination of heart left/right asymmetry; P:protein-containing complex assembly; P:inorganic cation transmembrane transport; F:cation channel activity; F:protein binding; F:gated channel activity; F:metal ion transmembrane transporter activity; C:endoplasmic reticulum; C:cilium; C:integral component of membrane; C:plasma membrane region,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,811,Coil (COILS); Coil (COILS); G3DSA:1.10.287.70 (GENE3D); IPR013122 (PFAM); PTHR10877 (PANTHER),NA,NA,XP_027041643.1,812,1,0,79.73,NA,NA,NA,NA,NA
2955.65814268683,1.56928128625065,0.399713105525945,3.92601909858768,8.63633012883419e-5,0.0181149450387727,Pver_g19527,Upregulated,HMCN1_HUMANHemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,426,5,9.05e-59,58.17,7,P:GO:0007155; F:GO:0005515; F:GO:0016787; C:GO:0005576; C:GO:0005604; C:GO:0005938; C:GO:0030054,P:cell adhesion; F:protein binding; F:hydrolase activity; C:extracellular region; C:basement membrane; C:cell cortex; C:cell junction,EC:3,Hydrolases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,425,PR01705 (PRINTS); IPR000884 (SMART); IPR036383 (G3DSA:2.20.100.GENE3D); IPR000884 (PFAM); PTHR22906 (PANTHER); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR036383 (SUPERFAMILY); IPR036383 (SUPERFAMILY); IPR036383 (SUPERFAMILY); IPR036383 (SUPERFAMILY),NA,NA,XP_022803080.1,426,1,1.1999999999999998e-241,90.24,NA,NA,NA,NA,NA
857.94320675556,-0.218612334727347,0.0641451911464499,-3.40808610622475,6.5420247455703e-4,0.0490467943575527,Pver_g15382,Downregulated,DHYS_MOUSEDeoxyhypusine synthase OS=Mus musculus OX=10090 GN=Dhps PE=1 SV=2,362,5,0,85.21,8,P:GO:0006412; P:GO:0008612; P:GO:0042102; P:GO:0042593; P:GO:0046203; F:GO:0034038; F:GO:0042802; C:GO:0005829,P:translation; P:peptidyl-lysine modification to peptidyl-hypusine; P:positive regulation of T cell proliferation; P:glucose homeostasis; P:spermidine catabolic process; F:deoxyhypusine synthase activity; F:identical protein binding; C:cytosol,EC:2.5.1.46,Deoxyhypusine synthase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,361,IPR002773 (PFAM); IPR036982 (G3DSA:3.40.910.GENE3D); IPR002773 (TIGRFAM); IPR002773 (PANTHER); IPR029035 (SUPERFAMILY),P:GO:0008612,P:peptidyl-lysine modification to peptidyl-hypusine,XP_027049519.1,362,1,1.1e-211,99.45,NA,NA,NA,NA,NA
181.996360179467,-1.68235144241169,0.43756268179959,-3.84482386727446,1.2063905827398e-4,0.0204735449078066,Pver_g16771,Downregulated,NA,160,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6UR14_POCDAML domain-containing protein OS=Pocillopora damicornis OX=46731 GN=pdam_00019584 PE=4 SV=1,160,5,6.6099999999999996e-111,82.25,NA,NA,NA,NA,NA,159,IPR014756 (SUPERFAMILY),NA,NA,XP_027059561.1,160,1,9.499999999999999e-83,98.74,NA,NA,NA,NA,NA
2591.69922861709,1.8349701522757,0.537978210955541,3.41086333035028,6.475754207906e-4,0.0489464152905021,Pver_g11517,Upregulated,CRYAB_LITCTAlpha-crystallin B chain OS=Lithobates catesbeianus OX=8400 GN=CRYAB PE=2 SV=1,674,5,3.26e-13,64.85,4,P:GO:0009408; P:GO:0050829; F:GO:0005515; C:GO:0005737,P:response to heat; P:defense response to Gram-negative bacterium; F:protein binding; C:cytoplasm,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,673,IPR001436 (PRINTS); IPR002068 (PFAM); IPR008978 (G3DSA:2.60.40.GENE3D); IPR008978 (G3DSA:2.60.40.GENE3D); IPR008978 (G3DSA:2.60.40.GENE3D); IPR008978 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR001436 (PANTHER); IPR002068 (PROSITE_PROFILES); IPR002068 (PROSITE_PROFILES); IPR002068 (PROSITE_PROFILES); cd06526 (CDD); cd06526 (CDD); cd06526 (CDD); cd06526 (CDD); cd06526 (CDD); cd06464 (CDD); IPR008978 (SUPERFAMILY); IPR008978 (SUPERFAMILY); IPR008978 (SUPERFAMILY); IPR008978 (SUPERFAMILY); IPR008978 (SUPERFAMILY); IPR008978 (SUPERFAMILY),NA,NA,RMX48166.1,674,1,9.3e-265,68.89,NA,NA,NA,NA,NA
1819.55592404974,-0.637008845518526,0.187315912580612,-3.40071933421239,6.7208794277544e-4,0.0497878480783014,Pver_g8523,Downregulated,TIMP4_BOVINMetalloproteinase inhibitor 4 OS=Bos taurus OX=9913 GN=TIMP4 PE=2 SV=2,234,5,8.14e-19,47.12,3,P:GO:0010033; P:GO:0048523; C:GO:0110165,P:response to organic substance; P:negative regulation of cellular process; C:cellular anatomical entity,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,233,IPR001820 (SMART); IPR008993 (G3DSA:2.40.50.GENE3D); IPR027465 (G3DSA:3.90.370.GENE3D); IPR001820 (PFAM); IPR001820 (PANTHER); IPR001134 (PROSITE_PROFILES); cd03577 (CDD); IPR008993 (SUPERFAMILY),F:GO:0005515; F:GO:0008191,F:protein binding; F:metalloendopeptidase inhibitor activity,XP_027060658.1,234,1,4.2e-132,99.14,NA,NA,NA,NA,NA
1591.07867636478,1.44391722354153,0.402687101230286,3.58570517687329,3.3616857674393e-4,0.0360983956490794,Pver_g26232,Upregulated,DNJB4_PONABDnaJ homolog subfamily B member 4 OS=Pongo abelii OX=9601 GN=DNAJB4 PE=2 SV=1,360,5,4.29e-111,66.78,10,P:GO:0000122; P:GO:0006457; P:GO:0006986; P:GO:0009408; F:GO:0001671; F:GO:0051082; F:GO:0051087; C:GO:0005654; C:GO:0005829; C:GO:0005886,P:negative regulation of transcription by RNA polymerase II; P:protein folding; P:response to unfolded protein; P:response to heat; F:ATPase activator activity; F:unfolded protein binding; F:chaperone binding; C:nucleoplasm; C:cytosol; C:plasma membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,359,IPR001623 (PRINTS); IPR001623 (SMART); G3DSA:2.60.260.20 (GENE3D); IPR002939 (PFAM); IPR036869 (G3DSA:1.10.287.GENE3D); IPR001623 (PFAM); G3DSA:2.60.260.20 (GENE3D); PTHR24078:SF525 (PANTHER); PTHR24078 (PANTHER); IPR018253 (PROSITE_PATTERNS); IPR001623 (PROSITE_PROFILES); IPR001623 (CDD); cd10747 (CDD); IPR008971 (SUPERFAMILY); IPR036869 (SUPERFAMILY); IPR008971 (SUPERFAMILY),P:GO:0006457; F:GO:0051082,P:protein folding; F:unfolded protein binding,XP_027048703.1,360,1,6.4e-204,100,NA,NA,NA,NA,NA
1202.37021557935,0.302719576645701,0.0568951577124503,5.3206562529566,1.03393601738888e-7,2.1446130636239e-4,Pver_g12577,Upregulated,"SYMC_HUMANMethionine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=MARS1 PE=1 SV=2",744,5,0,72.08,12,P:GO:0006431; P:GO:0009267; P:GO:0032869; P:GO:0036120; P:GO:0071364; P:GO:1901838; F:GO:0000166; F:GO:0003723; F:GO:0004825; C:GO:0005730; C:GO:0005829; C:GO:0017101,P:methionyl-tRNA aminoacylation; P:cellular response to starvation; P:cellular response to insulin stimulus; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to epidermal growth factor stimulus; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; F:nucleotide binding; F:RNA binding; F:methionine-tRNA ligase activity; C:nucleolus; C:cytosol; C:aminoacyl-tRNA synthetase multienzyme complex,EC:6.1.1.10,Methionine--tRNA ligase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,743,Coil (COILS); Coil (COILS); IPR033911 (PRINTS); IPR000738 (SMART); IPR000738 (PFAM); IPR014729 (G3DSA:3.40.50.GENE3D); IPR013155 (PFAM); G3DSA:1.10.287.10 (GENE3D); IPR015413 (PFAM); G3DSA:1.10.730.10 (GENE3D); IPR014758 (TIGRFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR45765 (PANTHER); IPR000738 (PROSITE_PATTERNS); IPR001412 (PROSITE_PATTERNS); IPR000738 (PROSITE_PROFILES); cd00939 (CDD); IPR033911 (CDD); IPR041872 (CDD); IPR009068 (SUPERFAMILY); IPR009080 (SUPERFAMILY); SSF52374 (SUPERFAMILY),P:GO:0006418; P:GO:0006431; F:GO:0000166; F:GO:0004812; F:GO:0004825; F:GO:0005524,P:tRNA aminoacylation for protein translation; P:methionyl-tRNA aminoacylation; F:nucleotide binding; F:aminoacyl-tRNA ligase activity; F:methionine-tRNA ligase activity; F:ATP binding,XP_027055794.1,744,1,0,84.11,NA,NA,NA,NA,NA
1844.07055462398,-1.37028017124568,0.146989892933933,-9.32227477614105,1.1387226116774e-20,4.25153474295873e-17,Pver_g6289,Downregulated,LONF3_MOUSELON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,648,5,6.43e-77,51.16,1,F:GO:0005515,F:protein binding,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,647,IPR001841 (SMART); IPR003111 (SMART); IPR003111 (PFAM); PF15227 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); G3DSA:2.30.130.40 (GENE3D); PF13923 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR23327 (PANTHER); IPR017907 (PROSITE_PATTERNS); IPR017907 (PROSITE_PATTERNS); IPR001841 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR003111 (PROSITE_PROFILES); cd16449 (CDD); SSF57850 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR015947 (SUPERFAMILY); SSF57850 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_027041360.1,648,1,0,98.45,NA,NA,NA,NA,NA
5006.67367820406,0.417867986969732,0.120697441548243,3.46211138868847,5.3595528894515e-4,0.0454782424274007,Pver_g23053,Upregulated,SURF4_DROMESurfeit locus protein 4 homolog OS=Drosophila melanogaster OX=7227 GN=Surf4 PE=2 SV=1,279,5,5.4799999999999995e-129,78.42,6,C:GO:0005789; C:GO:0005793; C:GO:0005794; C:GO:0016021; C:GO:0045169; C:GO:0098588,C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:integral component of membrane; C:fusome; C:bounding membrane of organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,278,IPR002995 (PFAM); PTHR23427 (PANTHER); PTHR23427:SF1 (PANTHER); IPR002995 (PROSITE_PATTERNS),C:GO:0016021,C:integral component of membrane,XP_027052133.1,279,1,3e-148,99.64,NA,NA,NA,NA,NA
2557.97284188282,-0.245047625376668,0.0717146624457877,-3.41698081005276,6.3319742758195e-4,0.048634024504535,Pver_g71,Downregulated,RAB23_HUMANRas-related protein Rab-23 OS=Homo sapiens OX=9606 GN=RAB23 PE=1 SV=1,243,5,1.29e-109,65.36,25,P:GO:0000045; P:GO:0001843; P:GO:0006887; P:GO:0006968; P:GO:0008589; P:GO:0021513; P:GO:0021904; P:GO:0036010; P:GO:0042308; P:GO:0042733; P:GO:0045861; P:GO:0046039; P:GO:0060271; P:GO:0097094; P:GO:1990090; F:GO:0003924; F:GO:0005515; F:GO:0005525; C:GO:0005776; C:GO:0005813; C:GO:0005829; C:GO:0005886; C:GO:0010008; C:GO:0045335; C:GO:0098993,P:autophagosome assembly; P:neural tube closure; P:exocytosis; P:cellular defense response; P:regulation of smoothened signaling pathway; P:spinal cord dorsal/ventral patterning; P:dorsal/ventral neural tube patterning; P:protein localization to endosome; P:negative regulation of protein import into nucleus; P:embryonic digit morphogenesis; P:negative regulation of proteolysis; P:GTP metabolic process; P:cilium assembly; P:craniofacial suture morphogenesis; P:cellular response to nerve growth factor stimulus; F:GTPase activity; F:protein binding; F:GTP binding; C:autophagosome; C:centrosome; C:cytosol; C:plasma membrane; C:endosome membrane; C:phagocytic vesicle; C:anchored component of synaptic vesicle membrane,EC:3.6.1,Acting on acid anhydrides,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,242,Coil (COILS); PR00449 (PRINTS); SM00175 (SMART); SM00176 (SMART); SM00173 (SMART); IPR001806 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); IPR005225 (TIGRFAM); PTHR24073 (PANTHER); PTHR24073:SF209 (PANTHER); IPR001806 (PROSITE_PROFILES); PS51420 (PROSITE_PROFILES); PS51419 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY),F:GO:0003924; F:GO:0005525,F:GTPase activity; F:GTP binding,XP_027048089.1,243,1,4.6e-129,99.59,NA,NA,NA,NA,NA
2416.92934062609,-0.335449383525152,0.0970987268296468,-3.45472484014827,5.5085469720462e-4,0.045820560129863,Pver_g11124,Downregulated,PACN2_CHICKProtein kinase C and casein kinase substrate in neurons protein 2 OS=Gallus gallus OX=9031 GN=PACSIN2 PE=1 SV=1,444,5,1.9099999999999997e-110,58.83,12,P:GO:0006897; P:GO:0007010; P:GO:0051128; P:GO:0051641; P:GO:0060088; P:GO:0060271; F:GO:0005515; F:GO:0008289; C:GO:0005768; C:GO:0005886; C:GO:0045202; C:GO:0120025,P:endocytosis; P:cytoskeleton organization; P:regulation of cellular component organization; P:cellular localization; P:auditory receptor cell stereocilium organization; P:cilium assembly; F:protein binding; F:lipid binding; C:endosome; C:plasma membrane; C:synapse; C:plasma membrane bounded cell projection,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,443,Coil (COILS); IPR001452 (PRINTS); IPR001060 (SMART); IPR001452 (SMART); IPR027267 (G3DSA:1.20.1270.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR001060 (PFAM); IPR001452 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR23065:SF11 (PANTHER); PTHR23065 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR031160 (PROSITE_PROFILES); cd07655 (CDD); IPR027267 (SUPERFAMILY); IPR036028 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_027042284.1,444,1,2.3e-256,98.87,NA,NA,NA,NA,NA
195.6933659955,1.23976683069494,0.352420064531807,3.51786676034459,4.3503073151559e-4,0.0413749963472268,Pver_g11126,Upregulated,TNAA_SALRDTryptophanase OS=Salinibacter ruber (strain DSM 13855 / M31) OX=309807 GN=tnaA PE=3 SV=1,941,5,1.0099999999999999e-166,68.84,2,P:GO:0009072; F:GO:0016829,P:aromatic amino acid family metabolic process; F:lyase activity,EC:4,Lyases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,940,IPR015421 (G3DSA:3.40.640.GENE3D); IPR001597 (PFAM); IPR015422 (G3DSA:3.90.1150.GENE3D); IPR015422 (G3DSA:3.90.1150.GENE3D); PTHR32325 (PANTHER); IPR018176 (PROSITE_PATTERNS); IPR015424 (SUPERFAMILY); IPR015424 (SUPERFAMILY),P:GO:0006520; F:GO:0003824; F:GO:0016829,P:cellular amino acid metabolic process; F:catalytic activity; F:lyase activity,RMX60100.1,941,1,0,92.47,2,P:GO:0006520; F:GO:0016829,P:cellular amino acid metabolic process; F:lyase activity,EC:4,Lyases
516.113763409963,-0.309440212386625,0.0801064196472566,-3.86286409690041,1.1206535910952e-4,0.0196507082295297,Pver_g3620,Downregulated,GPN2_RATGPN-loop GTPase 2 OS=Rattus norvegicus OX=10116 GN=Gpn2 PE=3 SV=1,300,5,1.1799999999999999e-148,81.95,2,F:GO:0003924; F:GO:0005525,F:GTPase activity; F:GTP binding,EC:3.6.1,Acting on acid anhydrides,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,299,Coil (COILS); IPR027417 (G3DSA:3.40.50.GENE3D); IPR004130 (PFAM); IPR004130 (PANTHER); IPR030231 (PTHR21231:PANTHER); cd17871 (CDD); IPR027417 (SUPERFAMILY),NA,NA,XP_027040431.1,300,1,1.4999999999999997e-169,100,NA,NA,NA,NA,NA
363.285707948528,-0.62190267788773,0.15149363907228,-4.10514053062658,4.04069165046904e-5,0.0109321205407183,Pver_g4013,Downregulated,HEY1_XENLAHairy/enhancer-of-split related with YRPW motif protein 1 OS=Xenopus laevis OX=8355 GN=hey1 PE=1 SV=1,301,5,4.7900000000000005e-27,59.61,17,P:GO:0001525; P:GO:0003179; P:GO:0003206; P:GO:0033504; P:GO:0045595; P:GO:0045746; P:GO:0072013; P:GO:0072082; P:GO:0072196; P:GO:2000678; P:GO:2000820; F:GO:0000981; F:GO:0042803; F:GO:0043425; F:GO:0046982; F:GO:1990837; C:GO:0005634,"P:angiogenesis; P:heart valve morphogenesis; P:cardiac chamber morphogenesis; P:floor plate development; P:regulation of cell differentiation; P:negative regulation of Notch signaling pathway; P:glomus development; P:specification of proximal tubule identity; P:proximal/distal pattern formation involved in pronephric nephron development; P:negative regulation of transcription regulatory region DNA binding; P:negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein homodimerization activity; F:bHLH transcription factor binding; F:protein heterodimerization activity; F:sequence-specific double-stranded DNA binding; C:nucleus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,300,IPR011598 (SMART); IPR036638 (G3DSA:4.10.280.GENE3D); IPR011598 (PFAM); mobidb-lite (MOBIDB_LITE); PTHR10985 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR036638 (SUPERFAMILY),F:GO:0046983,F:protein dimerization activity,XP_027048342.1,301,1,6.599999999999999e-146,99.63,NA,NA,NA,NA,NA
8385.02234931279,0.987199029906065,0.250590757182573,3.9394869986638,8.16560268376836e-5,0.0179015744321941,Pver_g4016,Upregulated,LOX5_HUMANPolyunsaturated fatty acid 5-lipoxygenase OS=Homo sapiens OX=9606 GN=ALOX5 PE=1 SV=2,667,5,3.349999999999999e-119,52.15,23,P:GO:0001676; P:GO:0002523; P:GO:0003008; P:GO:0006633; P:GO:0016525; P:GO:0019370; P:GO:0031323; P:GO:0042221; P:GO:0048522; P:GO:0048523; P:GO:0050727; P:GO:0051049; P:GO:0051240; P:GO:0061045; P:GO:0065008; P:GO:0080135; P:GO:1901570; F:GO:0016702; F:GO:0046872; C:GO:0005635; C:GO:0005737; C:GO:0016020; C:GO:0031981,"P:long-chain fatty acid metabolic process; P:leukocyte migration involved in inflammatory response; P:system process; P:fatty acid biosynthetic process; P:negative regulation of angiogenesis; P:leukotriene biosynthetic process; P:regulation of cellular metabolic process; P:response to chemical; P:positive regulation of cellular process; P:negative regulation of cellular process; P:regulation of inflammatory response; P:regulation of transport; P:positive regulation of multicellular organismal process; P:negative regulation of wound healing; P:regulation of biological quality; P:regulation of cellular response to stress; P:fatty acid derivative biosynthetic process; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:metal ion binding; C:nuclear envelope; C:cytoplasm; C:membrane; C:nuclear lumen",EC:1.13.11,Acting on single donors with incorporation of molecular oxygen (oxygenases). The oxygen incorporated need not be derived from O(2),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,666,IPR013819 (PRINTS); IPR001024 (SMART); G3DSA:3.10.450.60 (GENE3D); IPR001024 (PFAM); G3DSA:2.60.60.20 (GENE3D); G3DSA:1.20.245.10 (GENE3D); IPR013819 (PFAM); PTHR11771:SF153 (PANTHER); IPR000907 (PANTHER); IPR020834 (PROSITE_PATTERNS); IPR013819 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR036226 (SUPERFAMILY); IPR036392 (SUPERFAMILY),F:GO:0005515; F:GO:0016702; F:GO:0046872,"F:protein binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:metal ion binding",XP_027048285.1,667,1,0,99.55,NA,NA,NA,NA,NA
220.469206241628,0.604708195259564,0.1773734440242,3.40923749091245,6.5144740640823e-4,0.0490371781565683,Pver_g7920,Upregulated,HCN2_HUMANPotassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 OS=Homo sapiens OX=9606 GN=HCN2 PE=1 SV=3,784,5,8.729999999999999e-180,69.52,24,P:GO:0006954; P:GO:0007267; P:GO:0007420; P:GO:0007568; P:GO:0071320; P:GO:0071321; P:GO:0072718; P:GO:0086012; P:GO:0098719; P:GO:1904045; P:GO:1990573; F:GO:0005222; F:GO:0005248; F:GO:0005249; F:GO:0030165; F:GO:0042802; F:GO:0044877; F:GO:0060090; C:GO:0005737; C:GO:0032590; C:GO:0043025; C:GO:0043198; C:GO:0044316; C:GO:0098855,P:inflammatory response; P:cell-cell signaling; P:brain development; P:aging; P:cellular response to cAMP; P:cellular response to cGMP; P:response to cisplatin; P:membrane depolarization during cardiac muscle cell action potential; P:sodium ion import across plasma membrane; P:cellular response to aldosterone; P:potassium ion import across plasma membrane; F:intracellular cAMP-activated cation channel activity; F:voltage-gated sodium channel activity; F:voltage-gated potassium channel activity; F:PDZ domain binding; F:identical protein binding; F:protein-containing complex binding; F:molecular adaptor activity; C:cytoplasm; C:dendrite membrane; C:neuronal cell body; C:dendritic shaft; C:cone cell pedicle; C:HCN channel complex,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,783,IPR000595 (SMART); IPR005821 (PFAM); IPR013621 (PFAM); IPR000595 (PFAM); G3DSA:1.10.287.70 (GENE3D); G3DSA:1.10.287.630 (GENE3D); IPR014710 (G3DSA:2.60.120.GENE3D); PIRSR000548-1 (PIRSR); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR45689 (PANTHER); PTHR45689:SF4 (PANTHER); IPR018488 (PROSITE_PATTERNS); IPR000595 (PROSITE_PROFILES); IPR000595 (CDD); SSF81324 (SUPERFAMILY); IPR018490 (SUPERFAMILY),P:GO:0006811; P:GO:0055085; F:GO:0005216; C:GO:0016020,P:ion transport; P:transmembrane transport; F:ion channel activity; C:membrane,XP_027056637.1,784,1,0,99.11,NA,NA,NA,NA,NA
819.343130417733,-0.351708165224707,0.0838801117818151,-4.19298636772866,2.75305993433137e-5,0.00856568714234968,Pver_g7929,Downregulated,SRTD4_HUMANSERTA domain-containing protein 4 OS=Homo sapiens OX=9606 GN=SERTAD4 PE=1 SV=1,219,2,5.35e-7,72.25,1,F:GO:0005515,F:protein binding,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,218,IPR009263 (PFAM); IPR009263 (PROSITE_PROFILES),NA,NA,XP_027043785.1,219,1,8.899999999999999e-116,100,NA,NA,NA,NA,NA
763.023274095547,1.79112404650838,0.483114623121426,3.70745152555276,2.0935547402987e-4,0.0277180708453169,Pver_g12312,Upregulated,TYR3_CAEELPutative tyrosinase-like protein tyr-3 OS=Caenorhabditis elegans OX=6239 GN=tyr-3 PE=3 SV=5,467,3,1.64e-10,53.85,15,P:GO:0018401; F:GO:0004497; F:GO:0004656; F:GO:0005506; F:GO:0016491; F:GO:0016705; F:GO:0016740; F:GO:0016757; F:GO:0031418; F:GO:0046872; F:GO:0051213; C:GO:0005783; C:GO:0005789; C:GO:0016020; C:GO:0016021,"P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; F:monooxygenase activity; F:procollagen-proline 4-dioxygenase activity; F:iron ion binding; F:oxidoreductase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:transferase activity; F:glycosyltransferase activity; F:L-ascorbic acid binding; F:metal ion binding; F:dioxygenase activity; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:membrane; C:integral component of membrane",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,466,IPR003582 (SMART); IPR003582 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR003582 (PROSITE_PROFILES); IPR003582 (PROSITE_PROFILES),NA,NA,XP_027058679.1,467,1,1.4999999999999998e-229,99.54,NA,NA,NA,NA,NA
1249.9459173743,2.36149809032707,0.568496821908836,4.15393367090055,3.26807943789859e-5,0.00970459190461692,Pver_g16605,Upregulated,ORC6_BOVINOrigin recognition complex subunit 6 OS=Bos taurus OX=9913 GN=ORC6 PE=2 SV=1,227,3,4.08e-13,56.09,6,P:GO:0006261; P:GO:0051782; F:GO:0005515; C:GO:0000808; C:GO:0001650; C:GO:0005654,P:DNA-dependent DNA replication; P:negative regulation of cell division; F:protein binding; C:origin recognition complex; C:fibrillar center; C:nucleoplasm,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,226,G3DSA:1.10.472.10 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020529 (PANTHER); PTHR13394:SF0 (PANTHER),P:GO:0006260; C:GO:0005664,P:DNA replication; C:nuclear origin of replication recognition complex,XP_027052263.1,227,1,4.999999999999999e-69,97.22,NA,NA,NA,NA,NA
1396.57908648032,0.655931580524224,0.180897338712807,3.62598800618942,2.878587153699e-4,0.0333773074442569,Pver_g18735,Upregulated,AB22G_ARATHABC transporter G family member 22 OS=Arabidopsis thaliana OX=3702 GN=ABCG22 PE=1 SV=1,797,5,2.2499999999999999e-72,68.79,20,P:GO:0009408; P:GO:0009409; P:GO:0009414; P:GO:0009736; P:GO:0009738; P:GO:0010148; P:GO:0010184; P:GO:0010222; P:GO:0010496; P:GO:0010588; P:GO:0042542; P:GO:0042742; P:GO:0048581; P:GO:0080168; P:GO:0140115; F:GO:0000166; F:GO:0005515; F:GO:0015562; F:GO:0042626; C:GO:0005886,P:response to heat; P:response to cold; P:response to water deprivation; P:cytokinin-activated signaling pathway; P:abscisic acid-activated signaling pathway; P:transpiration; P:cytokinin transport; P:stem vascular tissue pattern formation; P:intercellular transport; P:cotyledon vascular tissue pattern formation; P:response to hydrogen peroxide; P:defense response to bacterium; P:negative regulation of post-embryonic development; P:abscisic acid transport; P:export across plasma membrane; F:nucleotide binding; F:protein binding; F:efflux transmembrane transporter activity; F:ATPase-coupled transmembrane transporter activity; C:plasma membrane,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,796,IPR003593 (SMART); IPR027417 (G3DSA:3.40.50.GENE3D); IPR013525 (PFAM); IPR043926 (PFAM); IPR003439 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR48041:SF63 (PANTHER); PTHR48041:SF63 (PANTHER); PTHR48041 (PANTHER); PTHR48041 (PANTHER); IPR017871 (PROSITE_PATTERNS); IPR003439 (PROSITE_PROFILES); cd03213 (CDD); IPR027417 (SUPERFAMILY),F:GO:0005524; F:GO:0140359; C:GO:0016020,F:ATP binding; F:ABC-type transporter activity; C:membrane,XP_022797461.1,797,1,0,87.44,NA,NA,NA,NA,NA
313.958460905909,0.607746509196977,0.159187771706396,3.81779644681438,1.3464894649114e-4,0.0215256940737864,Pver_g26142,Upregulated,"IVD_RATIsovaleryl-CoA dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Ivd PE=1 SV=2",1069,5,0,83.63,9,P:GO:0006552; P:GO:0033539; F:GO:0004085; F:GO:0008470; F:GO:0042802; F:GO:0050660; C:GO:0005654; C:GO:0005759; C:GO:0031966,P:leucine catabolic process; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; F:butyryl-CoA dehydrogenase activity; F:isovaleryl-CoA dehydrogenase activity; F:identical protein binding; F:flavin adenine dinucleotide binding; C:nucleoplasm; C:mitochondrial matrix; C:mitochondrial membrane,EC:1.3.8.4; EC:1.3.99.3; EC:1.3.8.1,Isovaleryl-CoA dehydrogenase; Acting on the CH-CH group of donors; Short-chain acyl-CoA dehydrogenase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1068,Coil (COILS); IPR024810 (SMART); G3DSA:1.20.140.10 (GENE3D); IPR037069 (G3DSA:1.10.540.GENE3D); IPR024810 (PFAM); IPR009075 (PFAM); IPR006091 (PFAM); G3DSA:2.40.110.10 (GENE3D); G3DSA:3.30.460.90 (GENE3D); G3DSA:1.10.1410.40 (GENE3D); IPR013786 (PFAM); PTHR43884:SF12 (PANTHER); PTHR43884 (PANTHER); IPR006089 (PROSITE_PATTERNS); IPR006089 (PROSITE_PATTERNS); IPR034183 (CDD); IPR009100 (SUPERFAMILY); IPR036250 (SUPERFAMILY),F:GO:0003995; F:GO:0016627; F:GO:0050660,"F:acyl-CoA dehydrogenase activity; F:oxidoreductase activity, acting on the CH-CH group of donors; F:flavin adenine dinucleotide binding",XP_027054810.1,1069,1,1.4999999999999998e-232,98.53,NA,NA,NA,NA,NA
1695.0461926649,0.770155190079359,0.181878873962466,4.23444006057732,2.29121885240022e-5,0.00770736156956022,Pver_g6070,Upregulated,CA050_HUMANUncharacterized protein C1orf50 OS=Homo sapiens OX=9606 GN=C1orf50 PE=1 SV=2,211,5,1.1e-66,75.76,1,F:GO:0042802,F:identical protein binding,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,210,Coil (COILS); IPR019534 (PFAM); IPR019534 (PANTHER),NA,NA,XP_027044262.1,211,1,2.7999999999999998e-114,99.52,NA,NA,NA,NA,NA
494.344802391104,-0.514832975796661,0.119924455231218,-4.29297739817993,1.76292958403517e-5,0.00676337619459548,Pver_g2043,Downregulated,SPSB4_HUMANSPRY domain-containing SOCS box protein 4 OS=Homo sapiens OX=9606 GN=SPSB4 PE=1 SV=1,219,5,1.37e-6,42.12,23,P:GO:0006511; P:GO:0007274; P:GO:0007399; P:GO:0010629; P:GO:0016567; P:GO:0035556; P:GO:0042752; P:GO:0043161; P:GO:0045732; P:GO:0045886; P:GO:0048511; P:GO:1902916; F:GO:0005515; F:GO:1990756; C:GO:0005634; C:GO:0005737; C:GO:0005829; C:GO:0005938; C:GO:0019005; C:GO:0030054; C:GO:0031594; C:GO:0045202; C:GO:0045495,P:ubiquitin-dependent protein catabolic process; P:neuromuscular synaptic transmission; P:nervous system development; P:negative regulation of gene expression; P:protein ubiquitination; P:intracellular signal transduction; P:regulation of circadian rhythm; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of protein catabolic process; P:negative regulation of synaptic assembly at neuromuscular junction; P:rhythmic process; P:positive regulation of protein polyubiquitination; F:protein binding; F:ubiquitin ligase-substrate adaptor activity; C:nucleus; C:cytoplasm; C:cytosol; C:cell cortex; C:SCF ubiquitin ligase complex; C:cell junction; C:neuromuscular junction; C:synapse; C:pole plasm,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,218,IPR043136 (G3DSA:2.60.120.GENE3D); G3DSA:1.10.750.20 (GENE3D); IPR003877 (PFAM); PTHR12245 (PANTHER); IPR001870 (PROSITE_PROFILES); IPR001496 (PROSITE_PROFILES); cd11709 (CDD); IPR013320 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_027055413.1,219,1,8.900000000000001e-124,99.54,NA,NA,NA,NA,NA
40.5433697598505,0.759530636014719,0.193051960512323,3.93433267395508,8.34281645382946e-5,0.0179015744321941,Pver_g12076,Upregulated,CFAD_DICDICounting factor associated protein D OS=Dictyostelium discoideum OX=44689 GN=cfaD PE=1 SV=1,621,5,1.66e-76,53.92,19,P:GO:0002376; P:GO:0016485; P:GO:0022617; P:GO:0030154; P:GO:0030163; P:GO:0032101; P:GO:0042221; P:GO:0044093; P:GO:0044265; P:GO:0048513; P:GO:0048522; P:GO:0048584; F:GO:0004175; F:GO:0005515; F:GO:0008234; C:GO:0005764; C:GO:0012505; C:GO:0016020; C:GO:0031410,P:immune system process; P:protein processing; P:extracellular matrix disassembly; P:cell differentiation; P:protein catabolic process; P:regulation of response to external stimulus; P:response to chemical; P:positive regulation of molecular function; P:cellular macromolecule catabolic process; P:animal organ development; P:positive regulation of cellular process; P:positive regulation of response to stimulus; F:endopeptidase activity; F:protein binding; F:cysteine-type peptidase activity; C:lysosome; C:endomembrane system; C:membrane; C:cytoplasmic vesicle,EC:3.4,Acting on peptide bonds (peptidases),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,620,IPR000668 (PRINTS); IPR000668 (SMART); IPR013201 (SMART); IPR013201 (PFAM); IPR000668 (PFAM); G3DSA:3.90.70.10 (GENE3D); PTHR12411 (PANTHER); PTHR12411:SF575 (PANTHER); IPR000169 (PROSITE_PATTERNS); IPR025661 (PROSITE_PATTERNS); IPR025660 (PROSITE_PATTERNS); IPR039417 (CDD); IPR038765 (SUPERFAMILY),P:GO:0006508; F:GO:0008234,P:proteolysis; F:cysteine-type peptidase activity,XP_027040999.1,621,1,0,98.71,NA,NA,NA,NA,NA
53.3656126849214,-1.92233264897057,0.550372269925219,-3.49278616313965,4.7800912291035e-4,0.0428328316587693,Pver_g3259,Downregulated,CTHR1_HUMANCollagen triple helix repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=CTHRC1 PE=1 SV=1,282,5,8.55e-40,53.1,13,P:GO:0016477; P:GO:0033690; P:GO:0043932; P:GO:0045669; P:GO:0060071; P:GO:0060122; P:GO:0090103; P:GO:0090177; F:GO:0005109; F:GO:0017147; C:GO:0005615; C:GO:0005737; C:GO:0031012,"P:cell migration; P:positive regulation of osteoblast proliferation; P:ossification involved in bone remodeling; P:positive regulation of osteoblast differentiation; P:Wnt signaling pathway, planar cell polarity pathway; P:inner ear receptor cell stereocilium organization; P:cochlea morphogenesis; P:establishment of planar polarity involved in neural tube closure; F:frizzled binding; F:Wnt-protein binding; C:extracellular space; C:cytoplasm; C:extracellular matrix",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,281,IPR008160 (PFAM); mobidb-lite (MOBIDB_LITE); PTHR11903:SF18 (PANTHER); PTHR11903 (PANTHER); PTHR11903:SF18 (PANTHER); PTHR11903 (PANTHER),NA,NA,XP_027060045.1,282,1,1.5e-75,85.77,NA,NA,NA,NA,NA
4178.98718236606,0.437983915885844,0.115047687119225,3.80697714880576,1.4067573800096e-4,0.0215256940737864,Pver_g19246,Upregulated,HTK7_HYDVUPutative insulin-like peptide receptor OS=Hydra vulgaris OX=6087 GN=HTK7 PE=2 SV=1,1392,5,0,55.65,92,P:GO:0000380; P:GO:0001666; P:GO:0001933; P:GO:0002092; P:GO:0003007; P:GO:0003008; P:GO:0006111; P:GO:0007186; P:GO:0008284; P:GO:0008286; P:GO:0008544; P:GO:0008584; P:GO:0009749; P:GO:0010042; P:GO:0010310; P:GO:0010560; P:GO:0010629; P:GO:0014823; P:GO:0019087; P:GO:0021549; P:GO:0021766; P:GO:0030238; P:GO:0030325; P:GO:0030335; P:GO:0031017; P:GO:0032094; P:GO:0032148; P:GO:0032355; P:GO:0032410; P:GO:0033280; P:GO:0033574; P:GO:0034612; P:GO:0038083; P:GO:0042593; P:GO:0042594; P:GO:0043243; P:GO:0043406; P:GO:0045429; P:GO:0045444; P:GO:0045471; P:GO:0045719; P:GO:0045725; P:GO:0045821; P:GO:0045840; P:GO:0045893; P:GO:0045995; P:GO:0046326; P:GO:0048639; P:GO:0051384; P:GO:0051446; P:GO:0051897; P:GO:0060267; P:GO:0071363; P:GO:0097062; P:GO:0097242; P:GO:0097421; P:GO:1902438; P:GO:1904638; P:GO:1990402; P:GO:1990535; P:GO:2000194; P:GO:2000252; F:GO:0001540; F:GO:0005009; F:GO:0005159; F:GO:0005198; F:GO:0005524; F:GO:0005525; F:GO:0019903; F:GO:0031405; F:GO:0031994; F:GO:0031995; F:GO:0038024; F:GO:0042169; F:GO:0042802; F:GO:0043423; F:GO:0043548; F:GO:0043559; F:GO:0043560; F:GO:0044877; F:GO:0051425; C:GO:0005635; C:GO:0005768; C:GO:0005829; C:GO:0005899; C:GO:0005901; C:GO:0009897; C:GO:0031981; C:GO:0032590; C:GO:0032809; C:GO:0045202; C:GO:0060417,"P:alternative mRNA splicing, via spliceosome; P:response to hypoxia; P:negative regulation of protein phosphorylation; P:positive regulation of receptor internalization; P:heart morphogenesis; P:system process; P:regulation of gluconeogenesis; P:G protein-coupled receptor signaling pathway; P:positive regulation of cell population proliferation; P:insulin receptor signaling pathway; P:epidermis development; P:male gonad development; P:response to glucose; P:response to manganese ion; P:regulation of hydrogen peroxide metabolic process; P:positive regulation of glycoprotein biosynthetic process; P:negative regulation of gene expression; P:response to activity; P:transformation of host cell by virus; P:cerebellum development; P:hippocampus development; P:male sex determination; P:adrenal gland development; P:positive regulation of cell migration; P:exocrine pancreas development; P:response to food; P:activation of protein kinase B activity; P:response to estradiol; P:negative regulation of transporter activity; P:response to vitamin D; P:response to testosterone; P:response to tumor necrosis factor; P:peptidyl-tyrosine autophosphorylation; P:glucose homeostasis; P:response to starvation; P:positive regulation of protein-containing complex disassembly; P:positive regulation of MAP kinase activity; P:positive regulation of nitric oxide biosynthetic process; P:fat cell differentiation; P:response to ethanol; P:negative regulation of glycogen biosynthetic process; P:positive regulation of glycogen biosynthetic process; P:positive regulation of glycolytic process; P:positive regulation of mitotic nuclear division; P:positive regulation of transcription, DNA-templated; P:regulation of embryonic development; P:positive regulation of glucose import; P:positive regulation of developmental growth; P:response to glucocorticoid; P:positive regulation of meiotic cell cycle; P:positive regulation of protein kinase B signaling; P:positive regulation of respiratory burst; P:cellular response to growth factor stimulus; P:dendritic spine maintenance; P:amyloid-beta clearance; P:liver regeneration; P:response to vanadate(3-); P:response to resveratrol; P:embryonic liver development; P:neuron projection maintenance; P:regulation of female gonad development; P:negative regulation of feeding behavior; F:amyloid-beta binding; F:insulin-activated receptor activity; F:insulin-like growth factor receptor binding; F:structural molecule activity; F:ATP binding; F:GTP binding; F:protein phosphatase binding; F:lipoic acid binding; F:insulin-like growth factor I binding; F:insulin-like growth factor II binding; F:cargo receptor activity; F:SH2 domain binding; F:identical protein binding; F:3-phosphoinositide-dependent protein kinase binding; F:phosphatidylinositol 3-kinase binding; F:insulin binding; F:insulin receptor substrate binding; F:protein-containing complex binding; F:PTB domain binding; C:nuclear envelope; C:endosome; C:cytosol; C:insulin receptor complex; C:caveola; C:external side of plasma membrane; C:nuclear lumen; C:dendrite membrane; C:neuronal cell body membrane; C:synapse; C:yolk",EC:2.7.10.1,Receptor protein-tyrosine kinase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1391,IPR001245 (PRINTS); IPR006212 (SMART); IPR020635 (SMART); IPR003961 (SMART); IPR000494 (PFAM); G3DSA:3.30.200.20 (GENE3D); IPR001245 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR036941 (G3DSA:3.80.20.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR006211 (PFAM); G3DSA:1.10.510.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR036941 (G3DSA:3.80.20.GENE3D); PIRSR038172-1 (PIRSR); PIRSR037921-1 (PIRSR); PIRSR037568-1 (PIRSR); mobidb-lite (MOBIDB_LITE); PTHR24416:SF525 (PANTHER); PTHR24416 (PANTHER); IPR017441 (PROSITE_PATTERNS); IPR002011 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); IPR003961 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR003961 (CDD); IPR006212 (CDD); cd05032 (CDD); IPR003961 (CDD); IPR009030 (SUPERFAMILY); SSF52058 (SUPERFAMILY); IPR011009 (SUPERFAMILY); IPR036116 (SUPERFAMILY); IPR036116 (SUPERFAMILY); SSF52058 (SUPERFAMILY),P:GO:0006468; P:GO:0007169; F:GO:0004672; F:GO:0004713; F:GO:0004714; F:GO:0005515; F:GO:0005524; C:GO:0016020,P:protein phosphorylation; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:protein kinase activity; F:protein tyrosine kinase activity; F:transmembrane receptor protein tyrosine kinase activity; F:protein binding; F:ATP binding; C:membrane,XP_027052611.1,1392,1,0,89.67,NA,NA,NA,NA,NA
88.0221965840374,-3.11746304778509,0.726682529655361,-4.28999311331124,1.78678658864163e-5,0.00676337619459548,Pver_g17354,Downregulated,NPHP3_DANRENephrocystin-3 OS=Danio rerio OX=7955 GN=nphp3 PE=3 SV=1,688,5,2.14e-38,47.39,11,P:GO:0001822; P:GO:0002009; P:GO:0007368; P:GO:0007507; P:GO:0009887; P:GO:0016043; P:GO:0030111; P:GO:0035295; P:GO:0048598; P:GO:0050793; C:GO:0005929,P:kidney development; P:morphogenesis of an epithelium; P:determination of left/right symmetry; P:heart development; P:animal organ morphogenesis; P:cellular component organization; P:regulation of Wnt signaling pathway; P:tube development; P:embryonic morphogenesis; P:regulation of developmental process; C:cilium,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,687,IPR019734 (SMART); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); PF13424 (PFAM); PF13374 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); IPR011990 (G3DSA:1.25.40.GENE3D); IPR019734 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR45641 (PANTHER); PTHR45641 (PANTHER); PTHR45641 (PANTHER); PTHR45641:SF1 (PANTHER); PTHR45641 (PANTHER); PTHR45641:SF1 (PANTHER); PTHR45641:SF1 (PANTHER); PTHR45641:SF1 (PANTHER); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011990 (SUPERFAMILY),F:GO:0005515,F:protein binding,PFX11951.1,688,1,4.3e-7,76.92,NA,NA,NA,NA,NA
631.694415671139,1.84420953843675,0.487586837091336,3.78232019026241,1.5537332331161e-4,0.0230199142823911,Pver_g11179,Upregulated,"CP17A_ICTPUSteroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1",513,5,1.73e-94,55.46,5,P:GO:0008202; P:GO:0009058; P:GO:0042445; F:GO:0004497; F:GO:0016705,"P:steroid metabolic process; P:biosynthetic process; P:hormone metabolic process; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",EC:1.14,"Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,512,IPR002401 (PRINTS); IPR001128 (PRINTS); IPR036396 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PIRSR000209-1 (PIRSR); PTHR24300 (PANTHER); PTHR24300:SF334 (PANTHER); IPR017972 (PROSITE_PATTERNS); IPR036396 (SUPERFAMILY),F:GO:0004497; F:GO:0005506; F:GO:0016705; F:GO:0020037,"F:monooxygenase activity; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:heme binding",XP_027053511.1,513,1,2.8999999999999997e-298,99.61,NA,NA,NA,NA,NA
32768.3524264738,0.465045610897974,0.122769603383225,3.78795400557201,1.5189295886623e-4,0.0226843020489194,Pver_g8105,Upregulated,"MYS_ARGIRMyosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",1963,5,0,71.16,20,P:GO:0002026; P:GO:0002027; P:GO:0007512; P:GO:0014728; P:GO:0014883; P:GO:0014898; P:GO:0030049; P:GO:0031449; P:GO:0046034; P:GO:0055010; P:GO:0060048; F:GO:0000146; F:GO:0003779; F:GO:0005524; F:GO:0042802; F:GO:0044877; C:GO:0001725; C:GO:0005859; C:GO:0030018; C:GO:0032982,P:regulation of the force of heart contraction; P:regulation of heart rate; P:adult heart development; P:regulation of the force of skeletal muscle contraction; P:transition between fast and slow fiber; P:cardiac muscle hypertrophy in response to stress; P:muscle filament sliding; P:regulation of slow-twitch skeletal muscle fiber contraction; P:ATP metabolic process; P:ventricular cardiac muscle tissue morphogenesis; P:cardiac muscle contraction; F:microfilament motor activity; F:actin binding; F:ATP binding; F:identical protein binding; F:protein-containing complex binding; C:stress fiber; C:muscle myosin complex; C:Z disc; C:myosin filament,EC:5.6.1.8,Myosin ATPase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1962,Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); IPR001609 (PRINTS); IPR000048 (SMART); IPR001609 (SMART); IPR001609 (PFAM); IPR036961 (G3DSA:3.40.850.GENE3D); IPR014751 (G3DSA:1.20.5.GENE3D); IPR008989 (G3DSA:2.30.30.GENE3D); IPR014751 (G3DSA:1.20.5.GENE3D); G3DSA:1.20.58.530 (GENE3D); G3DSA:1.10.10.820 (GENE3D); G3DSA:1.20.5.4820 (GENE3D); IPR014751 (G3DSA:1.20.5.GENE3D); IPR014751 (G3DSA:1.20.5.GENE3D); G3DSA:1.20.120.720 (GENE3D); IPR004009 (PFAM); G3DSA:1.20.5.340 (GENE3D); IPR002928 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR45615:SF26 (PANTHER); PTHR45615 (PANTHER); IPR000048 (PROSITE_PROFILES); IPR004009 (PROSITE_PROFILES); IPR001609 (PROSITE_PROFILES); cd01377 (CDD); SSF90257 (SUPERFAMILY); SSF90257 (SUPERFAMILY); SSF90257 (SUPERFAMILY); SSF90257 (SUPERFAMILY); SSF90257 (SUPERFAMILY); IPR027417 (SUPERFAMILY); SSF90257 (SUPERFAMILY),F:GO:0003774; F:GO:0005515; F:GO:0005524; F:GO:0051015; C:GO:0016459,F:cytoskeletal motor activity; F:protein binding; F:ATP binding; F:actin filament binding; C:myosin complex,RMX52688.1,1963,1,0,100,4,F:GO:0003774; F:GO:0005524; F:GO:0051015; C:GO:0016459,F:cytoskeletal motor activity; F:ATP binding; F:actin filament binding; C:myosin complex,NA,NA
4808.33490988295,0.61440994879524,0.143051011834471,4.29504091523795,1.74661120984202e-5,0.00676337619459548,Pver_g8101,Upregulated,"PROD_HUMANProline dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PRODH PE=1 SV=3",608,5,2.2599999999999994e-176,64.06,10,P:GO:0002118; P:GO:0006562; P:GO:0007626; P:GO:0010942; P:GO:0019470; P:GO:0042331; F:GO:0004657; F:GO:0071949; C:GO:0005654; C:GO:0005743,P:aggressive behavior; P:proline catabolic process; P:locomotory behavior; P:positive regulation of cell death; P:4-hydroxyproline catabolic process; P:phototaxis; F:proline dehydrogenase activity; F:FAD binding; C:nucleoplasm; C:mitochondrial inner membrane,EC:1.5.99.8,Acting on the CH-NH group of donors,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,607,IPR002872 (PFAM); G3DSA:3.20.20.220 (GENE3D); G3DSA:3.20.20.220 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR015659 (PANTHER); PTHR13914:SF22 (PANTHER); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR002048 (CDD); IPR029041 (SUPERFAMILY); IPR011992 (SUPERFAMILY),P:GO:0006562; F:GO:0004657; F:GO:0005509,P:proline catabolic process; F:proline dehydrogenase activity; F:calcium ion binding,XP_027051246.1,608,1,0,99.18,NA,NA,NA,NA,NA
960.579503663645,1.10844055910746,0.290573462052478,3.81466549380641,1.3636752498256e-4,0.0215256940737864,Pver_g7742,Upregulated,PLCL_MYTGAPerlucin-like protein OS=Mytilus galloprovincialis OX=29158 PE=1 SV=1,163,5,3.13e-18,44.74,7,P:GO:0010033; P:GO:0010604; P:GO:0048513; P:GO:0048522; P:GO:0051716; F:GO:0005515; C:GO:0005886,P:response to organic substance; P:positive regulation of macromolecule metabolic process; P:animal organ development; P:positive regulation of cellular process; P:cellular response to stimulus; F:protein binding; C:plasma membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,162,IPR001304 (SMART); IPR001304 (PFAM); IPR016186 (G3DSA:3.10.100.GENE3D); PTHR22803 (PANTHER); PTHR22803:SF110 (PANTHER); PS51257 (PROSITE_PROFILES); IPR001304 (PROSITE_PROFILES); cd00037 (CDD); IPR016187 (SUPERFAMILY),NA,NA,ACN53515.1,163,1,3.8999999999999998e-84,90.12,1,F:GO:0030246,F:carbohydrate binding,NA,NA
10567.2010507974,1.381067897493,0.28490392504539,4.84748638430647,1.25035611107521e-6,0.00122850778323958,Pver_novel_187_5de57afd,Upregulated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
440.049610855851,1.19121991159265,0.304197279738636,3.91594531225308,9.00506607703679e-5,0.0185330897897075,Pver_g16112,Upregulated,TX60A_ACTVLDELTA-thalatoxin-Avl2a OS=Actineria villosa OX=227975 PE=1 SV=1,297,3,9.480000000000001e-64,57.28,6,P:GO:0019835; P:GO:0035821; P:GO:0044179; F:GO:0090729; C:GO:0005576; C:GO:0042151,P:cytolysis; P:modulation of process of other organism; P:hemolysis in other organism; F:toxin activity; C:extracellular region; C:nematocyst,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,296,IPR020864 (PFAM); IPR020864 (PROSITE_PROFILES),NA,NA,XP_027053114.1,297,1,2.6999999999999996e-152,87.76,NA,NA,NA,NA,NA
363.135715200093,0.515653103845343,0.150579788115381,3.42445098574734,6.1604295897149e-4,0.0483205460423521,Pver_g25828,Upregulated,NA,743,NA,NA,NA,NA,NA,NA,NA,NA,A7RTA0_NEMVEPredicted protein OS=Nematostella vectensis OX=45351 GN=v1g240523 PE=4 SV=1,743,5,0,66.81,1,C:GO:0016021,C:integral component of membrane,NA,NA,742,mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,XP_027052707.1,743,1,0,97.84,NA,NA,NA,NA,NA
98.8109775975913,1.56908667668111,0.419803342478126,3.73767075654685,1.8573294520532e-4,0.0261581293064129,Pver_g10185,Upregulated,NA,369,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6UAQ8_POCDAUncharacterized protein OS=Pocillopora damicornis OX=46731 GN=pdam_00018282 PE=4 SV=1,369,5,0,68.7,1,C:GO:0016021,C:integral component of membrane,NA,NA,368,NA,NA,NA,XP_027038094.1,369,1,9.2e-190,83.53,NA,NA,NA,NA,NA
320.392443455005,2.71994676744273,0.631857313360409,4.30468510837871,1.67223419789499e-5,0.00676337619459548,Pver_g10186,Upregulated,NA,470,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6UAQ2_POCDAUncharacterized protein OS=Pocillopora damicornis OX=46731 GN=pdam_00018285 PE=4 SV=1,470,5,0,69.36,NA,NA,NA,NA,NA,469,NA,NA,NA,XP_027038096.1,470,1,5.399999999999999e-243,92.62,NA,NA,NA,NA,NA
221.981781626699,3.00788325852081,0.729530516342833,4.12303966885368,3.73905275605042e-5,0.010549592628446,Pver_g10188,Upregulated,NA,449,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TRA7_POCDAUncharacterized protein OS=Pocillopora damicornis OX=46731 GN=pdam_00017067 PE=4 SV=1,449,5,0,74.14,NA,NA,NA,NA,NA,448,NA,NA,NA,RMX43798.1,449,1,6.3999999999999985e-254,98.21,NA,NA,NA,NA,NA
83.5226171620537,2.21329751935978,0.534691695871591,4.13939011293588,3.48230351461095e-5,0.0101574440641808,Pver_g16932,Upregulated,NA,111,NA,NA,NA,NA,NA,NA,NA,NA,NA,111,NA,NA,NA,NA,NA,NA,NA,NA,110,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
134.026535439781,1.8401515236225,0.502491097866827,3.6620579577117,2.5019723477635e-4,0.0315598009191867,Pver_g9980,Upregulated,CLIC2_HUMANChloride intracellular channel protein 2 OS=Homo sapiens OX=9606 GN=CLIC2 PE=1 SV=3,240,5,1.04e-30,49.32,8,P:GO:0010880; P:GO:0048522; P:GO:0050877; P:GO:0051716; P:GO:0065009; C:GO:0005634; C:GO:0005737; C:GO:0005886,P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; P:positive regulation of cellular process; P:nervous system process; P:cellular response to stimulus; P:regulation of molecular function; C:nucleus; C:cytoplasm; C:plasma membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,239,IPR004045 (PFAM); G3DSA:1.20.1050.10 (GENE3D); G3DSA:3.40.30.10 (GENE3D); PTHR43920 (PANTHER); PTHR43920:SF5 (PANTHER); IPR004045 (PROSITE_PROFILES); IPR036282 (SUPERFAMILY); IPR036249 (SUPERFAMILY),P:GO:0006749; F:GO:0005515,P:glutathione metabolic process; F:protein binding,XP_027047769.1,240,1,4.4e-132,100,NA,NA,NA,NA,NA
1305.38248597175,-0.263375167523746,0.0664341479227191,-3.96445466313683,7.35639256603707e-5,0.0165456790870819,Pver_g1867,Downregulated,EAF6_XENTRChromatin modification-related protein MEAF6 OS=Xenopus tropicalis OX=8364 GN=meaf6 PE=2 SV=1,169,5,2.13e-54,70.13,13,P:GO:0006325; P:GO:0043968; P:GO:0043981; P:GO:0043982; P:GO:0043983; P:GO:0044154; F:GO:0005515; C:GO:0000776; C:GO:0005730; C:GO:0035267; C:GO:0070776; C:GO:1990467; C:GO:1990468,P:chromatin organization; P:histone H2A acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation; P:histone H4-K12 acetylation; P:histone H3-K14 acetylation; F:protein binding; C:kinetochore; C:nucleolus; C:NuA4 histone acetyltransferase complex; C:MOZ/MORF histone acetyltransferase complex; C:NuA3a histone acetyltransferase complex; C:NuA3b histone acetyltransferase complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,168,Coil (COILS); IPR015418 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR015418 (PANTHER),P:GO:0016573; C:GO:0000123,P:histone acetylation; C:histone acetyltransferase complex,XP_027043906.1,169,1,1.9000000000000002e-81,100,NA,NA,NA,NA,NA
510.575039141366,1.43029328266582,0.409611119924814,3.49183216248708,4.7971958195743e-4,0.0428328316587693,Pver_novel_715_5de57afd,Upregulated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
1884.44326453239,-0.594896684474433,0.17287157345081,-3.44126378096345,5.7900377977431e-4,0.046791526237346,Pver_g3838,Downregulated,DLX4A_DANREHomeobox protein Dlx4a OS=Danio rerio OX=7955 GN=dlx4a PE=2 SV=1,264,5,1.69e-38,70.92,28,P:GO:0000122; P:GO:0009954; P:GO:0021544; P:GO:0021766; P:GO:0021879; P:GO:0021893; P:GO:0030326; P:GO:0030514; P:GO:0030855; P:GO:0042472; P:GO:0042475; P:GO:0043524; P:GO:0045746; P:GO:0045944; P:GO:0046533; P:GO:0048646; P:GO:0048706; P:GO:0048715; P:GO:0050679; P:GO:0060021; P:GO:1902871; P:GO:1903845; F:GO:0000978; F:GO:0000981; F:GO:0003682; F:GO:0005515; C:GO:0000785; C:GO:0005634,"P:negative regulation of transcription by RNA polymerase II; P:proximal/distal pattern formation; P:subpallium development; P:hippocampus development; P:forebrain neuron differentiation; P:cerebral cortex GABAergic interneuron fate commitment; P:embryonic limb morphogenesis; P:negative regulation of BMP signaling pathway; P:epithelial cell differentiation; P:inner ear morphogenesis; P:odontogenesis of dentin-containing tooth; P:negative regulation of neuron apoptotic process; P:negative regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:negative regulation of photoreceptor cell differentiation; P:anatomical structure formation involved in morphogenesis; P:embryonic skeletal system development; P:negative regulation of oligodendrocyte differentiation; P:positive regulation of epithelial cell proliferation; P:roof of mouth development; P:positive regulation of amacrine cell differentiation; P:negative regulation of cellular response to transforming growth factor beta stimulus; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:chromatin binding; F:protein binding; C:chromatin; C:nucleus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,263,IPR020479 (PRINTS); IPR000047 (PRINTS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR24327 (PANTHER); PTHR24327:SF74 (PANTHER); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY),P:GO:0006355; F:GO:0000981; F:GO:0003677,"P:regulation of transcription, DNA-templated; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding",XP_027049030.1,264,1,4.7999999999999996e-148,100,NA,NA,NA,NA,NA
312.272601208231,-0.686624588696819,0.184141719982774,-3.72878339987838,1.9240644187533e-4,0.0266062478291025,Pver_g17946,Downregulated,NA,295,NA,NA,NA,NA,NA,NA,NA,NA,A0A2B4SIF4_STYPINeuronal pentraxin-1 OS=Stylophora pistillata OX=50429 GN=NPTX1 PE=4 SV=1,295,5,0,67.93,2,C:GO:0016020; C:GO:0016021,C:membrane; C:integral component of membrane,NA,NA,294,NA,NA,NA,XP_027052182.1,295,1,2.6e-155,97.82,NA,NA,NA,NA,NA
157.293568815487,1.39745727335272,0.397568548819481,3.51500961910154,4.3973806016116e-4,0.0413749963472268,Pver_g11103,Upregulated,NA,190,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TYP2_POCDAEGF-like domain-containing protein (Fragment) OS=Pocillopora damicornis OX=46731 GN=pdam_00023274 PE=4 SV=1,190,4,4.6e-27,67.45,5,P:GO:0007173; F:GO:0005154; F:GO:0048018; C:GO:0016020; C:GO:0016021,P:epidermal growth factor receptor signaling pathway; F:epidermal growth factor receptor binding; F:receptor ligand activity; C:membrane; C:integral component of membrane,NA,NA,189,G3DSA:2.10.25.10 (GENE3D); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); SSF57196 (SUPERFAMILY),NA,NA,XP_027043336.1,190,1,2.9e-38,82.61,NA,NA,NA,NA,NA
3464.61654629899,-0.415658803656908,0.114733191938126,-3.62282959826539,2.9139779770817e-4,0.0333874109621207,Pver_g18259,Downregulated,APCD1_XENLAProtein APCDD1 OS=Xenopus laevis OX=8355 GN=apcdd1 PE=2 SV=1,543,5,3.71e-80,51.84,3,P:GO:0048731; P:GO:0050794; C:GO:0016020,P:system development; P:regulation of cellular process; C:membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,542,IPR029405 (SMART); IPR029405 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR042425 (PANTHER),P:GO:0030178; F:GO:0017147; C:GO:0005886,P:negative regulation of Wnt signaling pathway; F:Wnt-protein binding; C:plasma membrane,XP_027051771.1,543,1,5.1000000000000003e-306,98.15,NA,NA,NA,NA,NA
2786.45125911064,0.52725033392517,0.152594417055678,3.45524000221311,5.4980317530483e-4,0.045820560129863,Pver_g23813,Upregulated,PTK7_HUMANInactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,621,5,2.86e-65,44.67,9,P:GO:0002009; P:GO:0007165; P:GO:0007507; P:GO:0035295; P:GO:0048598; F:GO:0005488; C:GO:0016020; C:GO:0070161; C:GO:0071944,P:morphogenesis of an epithelium; P:signal transduction; P:heart development; P:tube development; P:embryonic morphogenesis; F:binding; C:membrane; C:anchoring junction; C:cell periphery,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,620,IPR003598 (SMART); IPR003599 (SMART); IPR013106 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013151 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR45080:SF13 (PANTHER); PTHR45080 (PANTHER); PTHR45080:SF13 (PANTHER); PTHR45080:SF13 (PANTHER); PTHR45080 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); cd00096 (CDD); cd00096 (CDD); cd00096 (CDD); cd00096 (CDD); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY),NA,NA,PFX20561.1,621,1,1.8e-262,73.38,4,P:GO:0006468; F:GO:0000166; F:GO:0004672; C:GO:0016020,P:protein phosphorylation; F:nucleotide binding; F:protein kinase activity; C:membrane,EC:2.7.1,Transferring phosphorus-containing groups
424.645920717924,0.83016302949145,0.240950223639242,3.44537148359071,5.7027507231683e-4,0.0465729774508469,Pver_g7904,Upregulated,NPFF1_RATNeuropeptide FF receptor 1 OS=Rattus norvegicus OX=10116 GN=Npffr1 PE=1 SV=1,387,5,4.57e-44,50.51,5,P:GO:0007186; F:GO:0005515; F:GO:0008188; C:GO:0005886; C:GO:0043226,P:G protein-coupled receptor signaling pathway; F:protein binding; F:neuropeptide receptor activity; C:plasma membrane; C:organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,386,IPR000611 (PRINTS); IPR000276 (PRINTS); IPR000276 (SMART); G3DSA:1.20.1070.10 (GENE3D); IPR000276 (PFAM); mobidb-lite (MOBIDB_LITE); PTHR45695 (PANTHER); PTHR45695:SF9 (PANTHER); IPR000276 (PROSITE_PATTERNS); IPR017452 (PROSITE_PROFILES); SSF81321 (SUPERFAMILY),P:GO:0007186; F:GO:0004930; F:GO:0004983; C:GO:0016021,P:G protein-coupled receptor signaling pathway; F:G protein-coupled receptor activity; F:neuropeptide Y receptor activity; C:integral component of membrane,XP_027056509.1,387,1,8.7e-191,99.44,NA,NA,NA,NA,NA
207.804171270685,-2.37014865438984,0.550441404942557,-4.3059054662452,1.66304070817984e-5,0.00676337619459548,Pver_g1773,Downregulated,ANR52_MOUSESerine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Mus musculus OX=10090 GN=Ankrd52 PE=1 SV=1,839,5,9.65e-30,42.23,6,P:GO:0009987; P:GO:0051179; F:GO:0005515; C:GO:0005737; C:GO:0005886; C:GO:0043232,P:cellular process; P:localization; F:protein binding; C:cytoplasm; C:plasma membrane; C:intracellular non-membrane-bounded organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,838,IPR002110 (PRINTS); IPR002110 (SMART); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PFAM); IPR020683 (PFAM); PF13637 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR24134 (PANTHER); PTHR24134:SF9 (PANTHER); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_022785713.1,839,1,0,72.18,NA,NA,NA,NA,NA
794.971392679199,0.537762258648817,0.118263612238423,4.54714893677247,5.43775186583398e-6,0.00350041213211686,Pver_g1577,Upregulated,NA,95,NA,NA,NA,NA,NA,NA,NA,NA,NA,95,NA,NA,NA,NA,NA,NA,NA,NA,94,mobidb-lite (MOBIDB_LITE),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
715.056363919192,-0.265022085245998,0.0772176557921113,-3.43214362735256,5.9883032813078e-4,0.0473684939218028,Pver_g8190,Downregulated,NB5R5_MOUSENADH-cytochrome b5 reductase-like OS=Mus musculus OX=10090 GN=Cyb5rl PE=2 SV=1,322,5,4.52e-91,59.58,8,P:GO:0015701; P:GO:0044238; P:GO:0044249; P:GO:1901576; F:GO:0004128; C:GO:0005654; C:GO:0005789; C:GO:0005886,"P:bicarbonate transport; P:primary metabolic process; P:cellular biosynthetic process; P:organic substance biosynthetic process; F:cytochrome-b5 reductase activity, acting on NAD(P)H; C:nucleoplasm; C:endoplasmic reticulum membrane; C:plasma membrane",EC:1.6.2.2,Cytochrome-b5 reductase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,321,IPR001834 (PRINTS); IPR001709 (PRINTS); IPR019180 (PFAM); IPR008333 (PFAM); G3DSA:2.40.30.10 (GENE3D); IPR039261 (G3DSA:3.40.50.GENE3D); IPR001433 (PFAM); mobidb-lite (MOBIDB_LITE); PTHR19370 (PANTHER); PTHR19370:SF171 (PANTHER); IPR017927 (PROSITE_PROFILES); cd06183 (CDD); IPR039261 (SUPERFAMILY); IPR017938 (SUPERFAMILY),F:GO:0016491,F:oxidoreductase activity,XP_027054413.1,322,1,2.2999999999999998e-176,94.08,NA,NA,NA,NA,NA
1433.9115135077,2.46086974409554,0.616480743100762,3.99180310437258,6.55728073407708e-5,0.0156756995981179,Pver_novel_520_5de57afd,Upregulated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
1315.17204269832,-0.30623771234031,0.088175343396688,-3.47305381009508,5.145721761049e-4,0.0448880064650765,Pver_g9534,Downregulated,NEUL2_MOUSENeuralized-like protein 2 OS=Mus musculus OX=10090 GN=Neurl2 PE=1 SV=1,237,5,4.3e-41,45.78,2,P:GO:0030239; C:GO:0005737,P:myofibril assembly; C:cytoplasm,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,236,IPR006573 (SMART); IPR006573 (PFAM); IPR043136 (G3DSA:2.60.120.GENE3D); PTHR12429:SF8 (PANTHER); IPR037962 (PANTHER); IPR001496 (PROSITE_PROFILES); IPR006573 (PROSITE_PROFILES); cd12887 (CDD),NA,NA,XP_027037361.1,237,1,3.4999999999999993e-134,99.58,NA,NA,NA,NA,NA
6283.79034784409,0.497329343418016,0.139221245822981,3.57222305028334,3.5396373033159e-4,0.0371224433585966,Pver_g16873,Upregulated,ATF2_MOUSECyclic AMP-dependent transcription factor ATF-2 OS=Mus musculus OX=10090 GN=Atf2 PE=1 SV=2,456,5,3.81e-84,49.41,20,P:GO:0000165; P:GO:0006357; P:GO:0006915; P:GO:0006996; P:GO:0010604; P:GO:0018193; P:GO:0030154; P:GO:0030902; P:GO:0033554; P:GO:0048522; P:GO:0048523; P:GO:0048857; F:GO:0000977; F:GO:0000987; F:GO:0003700; F:GO:0004402; F:GO:0005515; C:GO:0005634; C:GO:0005694; C:GO:0005737,P:MAPK cascade; P:regulation of transcription by RNA polymerase II; P:apoptotic process; P:organelle organization; P:positive regulation of macromolecule metabolic process; P:peptidyl-amino acid modification; P:cell differentiation; P:hindbrain development; P:cellular response to stress; P:positive regulation of cellular process; P:negative regulation of cellular process; P:neural nucleus development; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity; F:histone acetyltransferase activity; F:protein binding; C:nucleus; C:chromosome; C:cytoplasm,EC:2.3.1.48,Histone acetyltransferase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,455,Coil (COILS); IPR004827 (SMART); IPR013087 (SMART); IPR004827 (PFAM); G3DSA:3.30.160.60 (GENE3D); G3DSA:1.20.5.170 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR19304 (PANTHER); IPR013087 (PROSITE_PATTERNS); IPR004827 (PROSITE_PATTERNS); IPR013087 (PROSITE_PROFILES); IPR004827 (PROSITE_PROFILES); cd14687 (CDD); IPR036236 (SUPERFAMILY); SSF57959 (SUPERFAMILY),P:GO:0006355; F:GO:0003700,"P:regulation of transcription, DNA-templated; F:DNA-binding transcription factor activity",XP_027040301.1,456,1,2.4e-240,100,NA,NA,NA,NA,NA
679.031065571613,2.12817455024805,0.426831999106082,4.98597704648458,6.16494638377631e-7,6.7698364171962e-4,Pver_g16877,Upregulated,SRFP1_ORYSJE3 ubiquitin-protein ligase SRFP1 OS=Oryza sativa subsp. japonica OX=39947 GN=SRFP1 PE=1 SV=1,1505,5,8.680000000000001e-29,48.63,7,P:GO:0016567; P:GO:0032270; F:GO:0004842; F:GO:0005515; F:GO:0046872; C:GO:0005654; C:GO:0005737,P:protein ubiquitination; P:positive regulation of cellular protein metabolic process; F:ubiquitin-protein transferase activity; F:protein binding; F:metal ion binding; C:nucleoplasm; C:cytoplasm,EC:2,Transferases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1504,Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); IPR008913 (PFAM); IPR045063 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR21319 (PANTHER); PTHR21319:SF20 (PANTHER); IPR008913 (PROSITE_PROFILES); IPR017921 (PROSITE_PROFILES); IPR037275 (SUPERFAMILY); IPR037274 (SUPERFAMILY); IPR027417 (SUPERFAMILY),F:GO:0008270,F:zinc ion binding,XP_027054728.1,1505,1,5.3e-276,79.06,NA,NA,NA,NA,NA
115.958486893812,1.5938082979012,0.372192841551493,4.28221104752412,1.85045345338946e-5,0.00676337619459548,Pver_g11858,Upregulated,GABR2_HUMANGamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,1392,5,1.91e-33,45.01,12,P:GO:0007267; P:GO:0050794; P:GO:0051046; F:GO:0004930; F:GO:0005515; C:GO:0005737; C:GO:0005887; C:GO:0043005; C:GO:0043235; C:GO:0097060; C:GO:0098793; C:GO:0098794,P:cell-cell signaling; P:regulation of cellular process; P:regulation of secretion; F:G protein-coupled receptor activity; F:protein binding; C:cytoplasm; C:integral component of plasma membrane; C:neuron projection; C:receptor complex; C:synaptic membrane; C:presynapse; C:postsynapse,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1391,Coil (COILS); G3DSA:3.40.50.2300 (GENE3D); IPR001828 (PFAM); G3DSA:3.40.50.2300 (GENE3D); IPR017978 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR10519:SF20 (PANTHER); PTHR10519:SF20 (PANTHER); IPR002455 (PANTHER); IPR017978 (PROSITE_PROFILES); IPR028082 (SUPERFAMILY),P:GO:0007186; F:GO:0004930; F:GO:0004965; C:GO:0016021,P:G protein-coupled receptor signaling pathway; F:G protein-coupled receptor activity; F:G protein-coupled GABA receptor activity; C:integral component of membrane,XP_027056393.1,1392,1,0,89.26,NA,NA,NA,NA,NA
582.991460308829,2.26687754790422,0.658036015815214,3.44491409804655,5.7124090080814e-4,0.0465729774508469,Pver_g11857,Upregulated,GRE1_ECOLIProbable dehydratase PflD OS=Escherichia coli (strain K12) OX=83333 GN=pflD PE=3 SV=1,2414,5,8.83e-38,40.65,1,F:GO:0003824,F:catalytic activity,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2413,Coil (COILS); IPR004184 (PFAM); IPR006314 (PFAM); G3DSA:3.20.70.20 (GENE3D); PTHR43641 (PANTHER); IPR006314 (PROSITE_PROFILES); IPR004184 (PROSITE_PROFILES); IPR006314 (PROSITE_PROFILES); IPR004184 (PROSITE_PROFILES); IPR001150 (PROSITE_PROFILES); SSF51998 (SUPERFAMILY); SSF51998 (SUPERFAMILY); IPR011008 (SUPERFAMILY); IPR011008 (SUPERFAMILY),F:GO:0003824; F:GO:0004601; F:GO:0020037,F:catalytic activity; F:peroxidase activity; F:heme binding,RMX58392.1,2414,1,0,67.39,4,P:GO:0098869; F:GO:0003824; F:GO:0004601; F:GO:0020037,P:cellular oxidant detoxification; F:catalytic activity; F:peroxidase activity; F:heme binding,NA,NA
1017.22567986987,1.22164026304245,0.320503011461783,3.81163427285962,1.380510310856e-4,0.0215256940737864,Pver_g18067,Upregulated,GSXL4_ARATHFlavin-containing monooxygenase FMO GS-OX-like 4 OS=Arabidopsis thaliana OX=3702 GN=At1g62600 PE=2 SV=1,429,5,8.709999999999999e-83,56.47,7,P:GO:0010033; P:GO:0019761; P:GO:1901700; F:GO:0004499; F:GO:0080103; F:GO:0080107; C:GO:0005773,"P:response to organic substance; P:glucosinolate biosynthetic process; P:response to oxygen-containing compound; F:N,N-dimethylaniline monooxygenase activity; F:4-methylthiopropyl glucosinolate S-oxygenase activity; F:8-methylthiopropyl glucosinolate S-oxygenase activity; C:vacuole",EC:1.14.13.8,Flavin-containing monooxygenase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,428,IPR000960 (PRINTS); IPR036188 (G3DSA:3.50.50.GENE3D); IPR020946 (PFAM); IPR000960 (PIRSF); IPR036188 (G3DSA:3.50.50.GENE3D); PTHR23023 (PANTHER); PTHR23023:SF208 (PANTHER); IPR036188 (SUPERFAMILY); IPR036188 (SUPERFAMILY),F:GO:0004499; F:GO:0050660; F:GO:0050661,"F:N,N-dimethylaniline monooxygenase activity; F:flavin adenine dinucleotide binding; F:NADP binding",XP_027037956.1,429,1,8.599999999999998e-248,98.36,NA,NA,NA,NA,NA
2333.37037036576,1.53626276174419,0.39854573304878,3.85467120671985,1.1588526430941e-4,0.019847212056221,Pver_g8581,Upregulated,KCNK9_HUMANPotassium channel subfamily K member 9 OS=Homo sapiens OX=9606 GN=KCNK9 PE=1 SV=1,535,5,9.82e-36,51.92,4,P:GO:0071805; F:GO:0005244; F:GO:0005267; C:GO:0005886,P:potassium ion transmembrane transport; F:voltage-gated ion channel activity; F:potassium channel activity; C:plasma membrane,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,534,IPR003280 (PRINTS); G3DSA:1.10.287.70 (GENE3D); IPR013099 (PFAM); IPR003280 (PANTHER); PTHR11003:SF304 (PANTHER); SSF81324 (SUPERFAMILY); SSF81324 (SUPERFAMILY),P:GO:0071805; F:GO:0005267; C:GO:0016020,P:potassium ion transmembrane transport; F:potassium channel activity; C:membrane,XP_027049177.1,535,1,5.899999999999998e-153,98.64,NA,NA,NA,NA,NA
1069.78205993693,-0.323254582175555,0.0919842428443316,-3.51423865849079,4.4101639048734e-4,0.0413749963472268,Pver_g5180,Downregulated,KLH12_DANREKelch-like protein 12 OS=Danio rerio OX=7955 GN=klhl12 PE=2 SV=2,1275,5,1.45e-53,45.58,6,P:GO:0007275; P:GO:0009888; P:GO:0009987; F:GO:0005515; C:GO:0005737; C:GO:0005856,P:multicellular organism development; P:tissue development; P:cellular process; F:protein binding; C:cytoplasm; C:cytoskeleton,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1274,IPR000210 (SMART); IPR006652 (SMART); IPR011705 (SMART); IPR011333 (G3DSA:3.30.710.GENE3D); IPR015915 (G3DSA:2.120.10.GENE3D); IPR011705 (PFAM); IPR011333 (G3DSA:3.30.710.GENE3D); IPR006652 (PFAM); G3DSA:1.25.40.420 (GENE3D); IPR000210 (PFAM); PF13964 (PFAM); G3DSA:1.25.40.420 (GENE3D); PTHR24412:SF210 (PANTHER); PTHR24412:SF210 (PANTHER); PTHR24412 (PANTHER); IPR000210 (PROSITE_PROFILES); IPR000210 (PROSITE_PROFILES); cd18186 (CDD); IPR011333 (SUPERFAMILY); IPR015915 (SUPERFAMILY); IPR015915 (SUPERFAMILY); IPR011333 (SUPERFAMILY),F:GO:0005515,F:protein binding,RMX50165.1,1275,1,1.9e-295,55.03,NA,NA,NA,NA,NA
140.63126094323,0.979323464452261,0.273737812329123,3.57759659186138,3.4676809104775e-4,0.0365732583258726,Pver_g5181,Upregulated,KLHL2_RATKelch-like protein 2 OS=Rattus norvegicus OX=10116 GN=Klhl2 PE=1 SV=3,582,5,4.58e-76,49.27,7,P:GO:0009987; F:GO:0003779; F:GO:0042802; C:GO:0005737; C:GO:0015629; C:GO:0030054; C:GO:0120025,P:cellular process; F:actin binding; F:identical protein binding; C:cytoplasm; C:actin cytoskeleton; C:cell junction; C:plasma membrane bounded cell projection,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,581,IPR011705 (SMART); IPR006652 (SMART); IPR000210 (SMART); IPR006652 (PFAM); IPR011333 (G3DSA:3.30.710.GENE3D); IPR015915 (G3DSA:2.120.10.GENE3D); IPR000210 (PFAM); IPR017096 (PIRSF); IPR011705 (PFAM); G3DSA:1.25.40.420 (GENE3D); mobidb-lite (MOBIDB_LITE); PTHR24412 (PANTHER); PTHR24412:SF210 (PANTHER); IPR000210 (PROSITE_PROFILES); cd18186 (CDD); IPR011333 (SUPERFAMILY); IPR015915 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_027038683.1,582,1,4.6e-220,95.5,NA,NA,NA,NA,NA
638.374531987168,2.29740117678933,0.584988066181083,3.92726161370644,8.59185098312883e-5,0.0181149450387727,Pver_g18899,Upregulated,KCD21_MOUSEBTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1,312,5,1.09e-22,60.29,8,P:GO:0006511; P:GO:0035024; P:GO:0050806; P:GO:0072359; F:GO:0019899; F:GO:0042802; C:GO:0005634; C:GO:0032991,P:ubiquitin-dependent protein catabolic process; P:negative regulation of Rho protein signal transduction; P:positive regulation of synaptic transmission; P:circulatory system development; F:enzyme binding; F:identical protein binding; C:nucleus; C:protein-containing complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,311,IPR000210 (SMART); IPR006571 (SMART); IPR003131 (PFAM); IPR011333 (G3DSA:3.30.710.GENE3D); IPR006571 (PFAM); PTHR14499 (PANTHER); IPR006571 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY),P:GO:0051260; F:GO:0005515,P:protein homooligomerization; F:protein binding,XP_022784367.1,312,1,1.7999999999999998e-138,85.11,NA,NA,NA,NA,NA
82.0033788735432,2.29623437979304,0.655145731158674,3.50492153208719,4.5674187939314e-4,0.0420022532241936,Pver_g18898,Upregulated,KCD21_MOUSEBTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1,159,5,8.59e-25,60.33,8,P:GO:0006511; P:GO:0009968; P:GO:0072359; F:GO:0005112; F:GO:0042802; C:GO:0005654; C:GO:0005829; C:GO:0032991,P:ubiquitin-dependent protein catabolic process; P:negative regulation of signal transduction; P:circulatory system development; F:Notch binding; F:identical protein binding; C:nucleoplasm; C:cytosol; C:protein-containing complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,159,IPR000210 (SMART); IPR011333 (G3DSA:3.30.710.GENE3D); IPR003131 (PFAM); PTHR14499 (PANTHER); IPR011333 (SUPERFAMILY),P:GO:0051260; F:GO:0005515,P:protein homooligomerization; F:protein binding,PFX29429.1,159,1,2.3999999999999998e-70,83.65,4,P:GO:0051260; F:GO:0005506; F:GO:0016491; F:GO:0071949,P:protein homooligomerization; F:iron ion binding; F:oxidoreductase activity; F:FAD binding,EC:1,Oxidoreductases
34.6359843296105,2.66399582821524,0.76139148043939,3.49885163763309,4.6726650289524e-4,0.0426478410753355,Pver_g10794,Upregulated,UBIE_VIBVYUbiquinone/menaquinone biosynthesis C-methyltransferase UbiE OS=Vibrio vulnificus (strain YJ016) OX=196600 GN=ubiE PE=3 SV=1,248,5,1.35e-14,55.59,2,P:GO:0008152; F:GO:0008168,P:metabolic process; F:methyltransferase activity,EC:2.1.1,Transferring one-carbon groups,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,247,G3DSA:3.40.50.150 (GENE3D); IPR025714 (PFAM); PIRSR000385-2 (PIRSR); PTHR42912:SF63 (PANTHER); PTHR42912 (PANTHER); cd02440 (CDD); IPR029063 (SUPERFAMILY),NA,NA,XP_027038887.1,248,1,3e-136,98.34,NA,NA,NA,NA,NA
111.597149704016,1.32346797703451,0.341565026176306,3.87471747868989,1.0674847294616e-4,0.0191613508938369,Pver_g25980,Upregulated,"GULDH_MYCTUL-gulono-1,4-lactone dehydrogenase OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv1771 PE=1 SV=1",598,5,3.5100000000000004e-27,40.4,2,F:GO:0016491; C:GO:0110165,F:oxidoreductase activity; C:cellular anatomical entity,EC:1,Oxidoreductases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,597,IPR006094 (PFAM); IPR016169 (G3DSA:3.30.465.GENE3D); G3DSA:3.30.70.2520 (GENE3D); IPR016167 (G3DSA:3.30.43.GENE3D); IPR007173 (PFAM); IPR010031 (PANTHER); PTHR43762:SF6 (PANTHER); IPR016166 (PROSITE_PROFILES); IPR036318 (SUPERFAMILY),F:GO:0003885; F:GO:0016491; F:GO:0016899; F:GO:0050660; F:GO:0071949; C:GO:0016020,"F:D-arabinono-1,4-lactone oxidase activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor; F:flavin adenine dinucleotide binding; F:FAD binding; C:membrane",RMX50649.1,598,1,5.2e-275,99.18,3,F:GO:0003885; F:GO:0071949; C:GO:0016020,"F:D-arabinono-1,4-lactone oxidase activity; F:FAD binding; C:membrane",EC:1.1.3.37,"D-arabinono-1,4-lactone oxidase"
768.31259438642,1.71963800307177,0.49230840242481,3.4930096553337,4.7760923969814e-4,0.0428328316587693,Pver_g19273,Upregulated,NA,766,NA,NA,NA,NA,NA,NA,NA,NA,A0A2B4SXY7_STYPIOTU domain-containing protein OS=Stylophora pistillata OX=50429 GN=AWC38_SpisGene1799 PE=4 SV=1,766,5,3.0799999999999998e-121,56.44,4,P:GO:0006278; P:GO:0009116; F:GO:0003824; F:GO:0003964,P:RNA-dependent DNA biosynthetic process; P:nucleoside metabolic process; F:catalytic activity; F:RNA-directed DNA polymerase activity,NA,NA,765,mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,PFX33287.1,766,1,6.499999999999999e-105,45.23,NA,NA,NA,NA,NA
4113.03210631176,-0.382112478563595,0.0863540602427579,-4.42495092285648,9.64642106465553e-6,0.00514512538385684,Pver_g7570,Downregulated,RASC_DICDIRas-like protein rasC OS=Dictyostelium discoideum OX=44689 GN=rasC PE=1 SV=1,195,5,3.72e-43,65.05,40,P:GO:0001558; P:GO:0003428; P:GO:0007163; P:GO:0007265; P:GO:0007507; P:GO:0009743; P:GO:0010753; P:GO:0019219; P:GO:0019954; P:GO:0030036; P:GO:0031152; P:GO:0031326; P:GO:0032525; P:GO:0043326; P:GO:0043406; P:GO:0048468; P:GO:0051291; P:GO:0051491; P:GO:0051602; P:GO:0051897; P:GO:0061122; P:GO:0071321; P:GO:0097211; P:GO:0106070; P:GO:0110094; P:GO:1903306; P:GO:1903669; P:GO:1904515; F:GO:0003925; F:GO:0004708; F:GO:0005515; F:GO:0005525; F:GO:0010856; F:GO:0030250; F:GO:1904841; C:GO:0005737; C:GO:0005911; C:GO:0016020; C:GO:0031252; C:GO:0031982,P:regulation of cell growth; P:chondrocyte intercalation involved in growth plate cartilage morphogenesis; P:establishment or maintenance of cell polarity; P:Ras protein signal transduction; P:heart development; P:response to carbohydrate; P:positive regulation of cGMP-mediated signaling; P:regulation of nucleobase-containing compound metabolic process; P:asexual reproduction; P:actin cytoskeleton organization; P:aggregation involved in sorocarp development; P:regulation of cellular biosynthetic process; P:somite rostral/caudal axis specification; P:chemotaxis to folate; P:positive regulation of MAP kinase activity; P:cell development; P:protein heterooligomerization; P:positive regulation of filopodium assembly; P:response to electrical stimulus; P:positive regulation of protein kinase B signaling; P:positive regulation of positive chemotaxis to cAMP; P:cellular response to cGMP; P:cellular response to gonadotropin-releasing hormone; P:regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:polyphosphate-mediated signaling; P:negative regulation of regulated secretory pathway; P:positive regulation of chemorepellent activity; P:positive regulation of TORC2 signaling; F:G protein activity; F:MAP kinase kinase activity; F:protein binding; F:GTP binding; F:adenylate cyclase activator activity; F:guanylate cyclase activator activity; F:TORC2 complex binding; C:cytoplasm; C:cell-cell junction; C:membrane; C:cell leading edge; C:vesicle,EC:2.7.12.1; EC:3.6.1; EC:2.7.12.2; EC:3.6.5.1; EC:3.6.5.2,Dual-specificity kinase; Acting on acid anhydrides; Mitogen-activated protein kinase kinase; Heterotrimeric G-protein GTPase; Small monomeric GTPase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,194,PR00449 (PRINTS); SM00175 (SMART); SM00173 (SMART); IPR001806 (SMART); IPR005225 (TIGRFAM); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); PTHR24070:SF420 (PANTHER); IPR020849 (PANTHER); IPR018247 (PROSITE_PATTERNS); PS51420 (PROSITE_PROFILES); IPR001806 (PROSITE_PROFILES); PS51419 (PROSITE_PROFILES); cd00876 (CDD); IPR027417 (SUPERFAMILY),P:GO:0007165; F:GO:0003924; F:GO:0005525; C:GO:0016020,P:signal transduction; F:GTPase activity; F:GTP binding; C:membrane,XP_022796943.1,195,1,1.9e-101,98.97,NA,NA,NA,NA,NA
1028.32527392549,-0.775716723262437,0.200878006198442,-3.86163093681907,1.1263262162843e-4,0.0196507082295297,Pver_g15,Downregulated,NA,362,NA,NA,NA,NA,NA,NA,NA,NA,A7S2W1_NEMVEPredicted protein OS=Nematostella vectensis OX=45351 GN=v1g205942 PE=4 SV=1,362,5,0,66.95,NA,NA,NA,NA,NA,361,G3DSA:2.10.80.10 (GENE3D); PTHR33459:SF7 (PANTHER); PTHR33459 (PANTHER),NA,NA,XP_027046531.1,362,1,5.599999999999999e-131,99.72,NA,NA,NA,NA,NA
1887.73524740928,-0.177572938321269,0.0518835491562251,-3.42252874387186,6.2041537751273e-4,0.0484598923322498,Pver_g14,Downregulated,PDCD5_BOVINProgrammed cell death protein 5 OS=Bos taurus OX=9913 GN=PDCD5 PE=2 SV=3,99,5,3.3999999999999997e-38,86.3,14,P:GO:0008285; P:GO:0010628; P:GO:0043065; P:GO:0043280; P:GO:0071560; P:GO:0090200; P:GO:1903638; P:GO:1903645; F:GO:0003677; F:GO:0008201; F:GO:0010698; F:GO:0048487; C:GO:0005634; C:GO:0005829,P:negative regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:cellular response to transforming growth factor beta stimulus; P:positive regulation of release of cytochrome c from mitochondria; P:positive regulation of protein insertion into mitochondrial outer membrane; P:negative regulation of chaperone-mediated protein folding; F:DNA binding; F:heparin binding; F:acetyltransferase activator activity; F:beta-tubulin binding; C:nucleus; C:cytosol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,98,IPR036883 (G3DSA:1.10.8.GENE3D); IPR002836 (PFAM); IPR002836 (PIRSF); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR002836 (PANTHER); IPR036883 (SUPERFAMILY),F:GO:0003677,F:DNA binding,XP_027046544.1,99,1,4.7e-40,100,NA,NA,NA,NA,NA
1763.69060427689,1.79228970000078,0.481227613058868,3.72441159103132,1.9577130265831e-4,0.0266763407155144,Pver_g14127,Upregulated,CAH2_HUMANCarbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,594,5,1.94e-44,49.78,10,P:GO:0006885; P:GO:0009725; P:GO:0044070; P:GO:0048522; P:GO:0048856; P:GO:0051716; F:GO:0016836; F:GO:0046872; C:GO:0005737; C:GO:0005886,P:regulation of pH; P:response to hormone; P:regulation of anion transport; P:positive regulation of cellular process; P:anatomical structure development; P:cellular response to stimulus; F:hydro-lyase activity; F:metal ion binding; C:cytoplasm; C:plasma membrane,EC:4.2.1,Carbon-oxygen lyases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,593,IPR001148 (SMART); IPR036398 (G3DSA:3.10.200.GENE3D); IPR036398 (G3DSA:3.10.200.GENE3D); IPR036398 (G3DSA:3.10.200.GENE3D); IPR001148 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR023561 (PANTHER); PTHR18952:SF141 (PANTHER); IPR023561 (PANTHER); PTHR18952:SF141 (PANTHER); IPR023561 (PANTHER); IPR001148 (PROSITE_PROFILES); IPR001148 (PROSITE_PROFILES); cd00326 (CDD); cd00326 (CDD); IPR036398 (SUPERFAMILY); IPR036398 (SUPERFAMILY); IPR036398 (SUPERFAMILY); IPR036398 (SUPERFAMILY),F:GO:0004089; F:GO:0008270,F:carbonate dehydratase activity; F:zinc ion binding,PFX18785.1,594,1,7.099999999999999e-216,72.27,2,F:GO:0046872; C:GO:0016020,F:metal ion binding; C:membrane,NA,NA
741.36545456354,-0.194121778408195,0.0564882171256711,-3.43650035858497,5.8928157344429e-4,0.0472907451474626,Pver_g13474,Downregulated,SNAG_MOUSEGamma-soluble NSF attachment protein OS=Mus musculus OX=10090 GN=Napg PE=1 SV=1,232,5,3.5299999999999996e-46,60.87,8,P:GO:0006891; P:GO:0015031; P:GO:0061025; F:GO:0005483; F:GO:0005515; C:GO:0005739; C:GO:0005774; C:GO:0031982,P:intra-Golgi vesicle-mediated transport; P:protein transport; P:membrane fusion; F:soluble NSF attachment protein activity; F:protein binding; C:mitochondrion; C:vacuolar membrane; C:vesicle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,231,PF14938 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000744 (PANTHER); PTHR13768:SF2 (PANTHER); IPR011990 (SUPERFAMILY),P:GO:0006886; F:GO:0005515,P:intracellular protein transport; F:protein binding,XP_027051789.1,232,1,4.7e-123,99.57,NA,NA,NA,NA,NA
111.65275487619,2.46173459289235,0.611604368146967,4.02504416433599,5.69646236485403e-5,0.0140535494264332,Pver_g10341,Upregulated,TRET1_CULQUFacilitated trehalose transporter Tret1 OS=Culex quinquefasciatus OX=7176 GN=Tret1 PE=3 SV=1,429,5,7.51e-74,57.99,12,P:GO:0001666; P:GO:0007141; P:GO:0008286; P:GO:0015755; P:GO:0070837; P:GO:1904659; F:GO:0005353; F:GO:0005355; F:GO:0005536; F:GO:0033300; C:GO:0005887; C:GO:0008021,P:response to hypoxia; P:male meiosis I; P:insulin receptor signaling pathway; P:fructose transmembrane transport; P:dehydroascorbic acid transport; P:glucose transmembrane transport; F:fructose transmembrane transporter activity; F:glucose transmembrane transporter activity; F:glucose binding; F:dehydroascorbic acid transmembrane transporter activity; C:integral component of plasma membrane; C:synaptic vesicle,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,428,Coil (COILS); IPR003663 (PRINTS); IPR005828 (PFAM); IPR036259 (G3DSA:1.20.1250.GENE3D); IPR003663 (TIGRFAM); PTHR48021:SF1 (PANTHER); PTHR48021 (PANTHER); IPR005829 (PROSITE_PATTERNS); IPR020846 (PROSITE_PROFILES); IPR036259 (SUPERFAMILY),P:GO:0055085; F:GO:0022857; C:GO:0016020; C:GO:0016021,P:transmembrane transport; F:transmembrane transporter activity; C:membrane; C:integral component of membrane,RMX53993.1,429,1,7.599999999999999e-212,99.22,3,P:GO:0034219; F:GO:0051119; C:GO:0016021,P:carbohydrate transmembrane transport; F:sugar transmembrane transporter activity; C:integral component of membrane,EC:7,Translocases
1414.55568394487,0.637268551723726,0.178925836967239,3.56163515859596,3.6855229703925e-4,0.0375963621919611,Pver_g10340,Upregulated,"GTR8_MOUSESolute carrier family 2, facilitated glucose transporter member 8 OS=Mus musculus OX=10090 GN=Slc2a8 PE=1 SV=2",495,5,3.82e-115,60.59,16,P:GO:0001666; P:GO:0006006; P:GO:0007141; P:GO:0008286; P:GO:0015755; P:GO:0015771; P:GO:0070837; P:GO:1904659; F:GO:0005353; F:GO:0005536; F:GO:0015574; F:GO:0033300; F:GO:0055056; C:GO:0005887; C:GO:0008021; C:GO:0030669,P:response to hypoxia; P:glucose metabolic process; P:male meiosis I; P:insulin receptor signaling pathway; P:fructose transmembrane transport; P:trehalose transport; P:dehydroascorbic acid transport; P:glucose transmembrane transport; F:fructose transmembrane transporter activity; F:glucose binding; F:trehalose transmembrane transporter activity; F:dehydroascorbic acid transmembrane transporter activity; F:D-glucose transmembrane transporter activity; C:integral component of plasma membrane; C:synaptic vesicle; C:clathrin-coated endocytic vesicle membrane,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,494,Coil (COILS); IPR003663 (PRINTS); IPR003663 (TIGRFAM); IPR005828 (PFAM); IPR036259 (G3DSA:1.20.1250.GENE3D); PTHR48021 (PANTHER); PTHR48021:SF18 (PANTHER); IPR005829 (PROSITE_PATTERNS); IPR020846 (PROSITE_PROFILES); IPR044775 (CDD); IPR036259 (SUPERFAMILY),P:GO:0008643; P:GO:0055085; F:GO:0022857; F:GO:0051119; C:GO:0016020; C:GO:0016021,P:carbohydrate transport; P:transmembrane transport; F:transmembrane transporter activity; F:sugar transmembrane transporter activity; C:membrane; C:integral component of membrane,XP_027055141.1,495,1,2.1000000000000002e-277,99.39,NA,NA,NA,NA,NA
365.263279808754,-2.21702681970408,0.49001568703849,-4.52439968422874,6.05671717121294e-6,0.00353333737975635,Pver_g23200,Downregulated,NA,300,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TGN4_POCDABRICHOS domain-containing protein OS=Pocillopora damicornis OX=46731 GN=pdam_00007524 PE=4 SV=1,300,5,1.74e-120,81.23,2,P:GO:0007585; C:GO:0005576,P:respiratory gaseous exchange by respiratory system; C:extracellular region,NA,NA,299,IPR007084 (SMART); G3DSA:3.30.390.150 (GENE3D); IPR007084 (PFAM); mobidb-lite (MOBIDB_LITE); PTHR16483 (PANTHER); IPR007084 (PROSITE_PROFILES),NA,NA,XP_027050497.1,300,1,7.199999999999999e-68,93.82,NA,NA,NA,NA,NA
63.9873020554252,1.12242498746509,0.321777260679187,3.4882048069399,4.8627544275171e-4,0.0428328316587693,Pver_g11579,Upregulated,"EXOG_XENLANuclease EXOG, mitochondrial OS=Xenopus laevis OX=8355 GN=exog PE=2 SV=1",311,1,5.93e-6,40.94,9,P:GO:0090305; F:GO:0003676; F:GO:0004518; F:GO:0004519; F:GO:0016787; F:GO:0046872; C:GO:0005739; C:GO:0005743; C:GO:0016020,P:nucleic acid phosphodiester bond hydrolysis; F:nucleic acid binding; F:nuclease activity; F:endonuclease activity; F:hydrolase activity; F:metal ion binding; C:mitochondrion; C:mitochondrial inner membrane; C:membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,310,IPR001604 (SMART); IPR020821 (SMART); IPR044929 (G3DSA:3.40.570.GENE3D); IPR001604 (PFAM); IPR039015 (PANTHER); IPR044925 (SUPERFAMILY),F:GO:0003676; F:GO:0016787; F:GO:0046872,F:nucleic acid binding; F:hydrolase activity; F:metal ion binding,XP_027057308.1,311,1,9.599999999999999e-148,88.73,NA,NA,NA,NA,NA
7480.85897392558,1.2395105540815201,0.345794800027522,3.58452629704919,3.3769054115323e-4,0.0360983956490794,Pver_g14710,Upregulated,AGRG4_MOUSEAdhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1,1442,5,5.3999999999999996e-70,48.66,8,P:GO:0007165; P:GO:0014037; P:GO:0021782; P:GO:0042552; P:GO:0048513; P:GO:0048646; F:GO:0005488; C:GO:0005886,P:signal transduction; P:Schwann cell differentiation; P:glial cell development; P:myelination; P:animal organ development; P:anatomical structure formation involved in morphogenesis; F:binding; C:plasma membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1441,IPR000832 (PRINTS); SM01411 (SMART); IPR003598 (SMART); IPR003599 (SMART); IPR000203 (SMART); G3DSA:2.60.220.50 (GENE3D); G3DSA:2.10.50.10 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR011641 (PFAM); IPR000832 (PFAM); IPR000203 (PFAM); IPR036364 (G3DSA:3.30.70.GENE3D); G3DSA:1.20.1070.10 (GENE3D); PF13927 (PFAM); PTHR47767 (PANTHER); IPR000203 (PROSITE_PROFILES); IPR017981 (PROSITE_PROFILES); IPR000082 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); cd00096 (CDD); cd15040 (CDD); SSF81321 (SUPERFAMILY); IPR036364 (SUPERFAMILY); IPR036179 (SUPERFAMILY),P:GO:0007166; P:GO:0007186; F:GO:0004888; F:GO:0004930; C:GO:0016021,P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway; F:transmembrane signaling receptor activity; F:G protein-coupled receptor activity; C:integral component of membrane,XP_027038600.1,1442,1,0,92.71,NA,NA,NA,NA,NA
1802.03932991235,0.702653673357487,0.203216946414753,3.45765294555412,5.4490284420481e-4,0.045820560129863,Pver_g7256,Upregulated,NA,497,NA,NA,NA,NA,NA,NA,NA,NA,A0A6P8J222_ACTTEeukaryotic translation initiation factor 5B-like OS=Actinia tenebrosa OX=6105 GN=LOC116305901 PE=4 SV=1,497,5,0,69.79,2,P:GO:0006413; F:GO:0003743,P:translational initiation; F:translation initiation factor activity,NA,NA,496,Coil (COILS); Coil (COILS); Coil (COILS); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,XP_027058572.1,497,1,1.4999999999999999e-179,97.38,NA,NA,NA,NA,NA
421.500935016547,-0.379886146286529,0.0995906826853467,-3.81447476855607,1.3647287888863e-4,0.0215256940737864,Pver_g22809,Downregulated,LCLT1_HUMANLysocardiolipin acyltransferase 1 OS=Homo sapiens OX=9606 GN=LCLAT1 PE=1 SV=1,373,5,5.009999999999999e-110,60.38,8,P:GO:0001885; P:GO:0006654; P:GO:0035965; P:GO:0046488; P:GO:0060217; F:GO:0003841; F:GO:0005515; C:GO:0005789,P:endothelial cell development; P:phosphatidic acid biosynthetic process; P:cardiolipin acyl-chain remodeling; P:phosphatidylinositol metabolic process; P:hemangioblast cell differentiation; F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:protein binding; C:endoplasmic reticulum membrane,EC:2.3.1.51,1-acylglycerol-3-phosphate O-acyltransferase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,372,IPR002123 (SMART); IPR002123 (PFAM); IPR032098 (PFAM); PTHR10983:SF59 (PANTHER); PTHR10983 (PANTHER); cd07990 (CDD); SSF69593 (SUPERFAMILY),F:GO:0016746,F:acyltransferase activity,XP_027050172.1,373,1,2.3999999999999998e-214,98.12,NA,NA,NA,NA,NA
2327.38035738163,0.550579106340919,0.150026450636745,3.66988023781235,2.426641319995e-4,0.0312403050441847,Pver_g1156,Upregulated,DICER_XENTREndoribonuclease Dicer OS=Xenopus tropicalis OX=8364 GN=dicer1 PE=2 SV=2,2787,5,6.689999999999999e-176,53.33,36,P:GO:0001942; P:GO:0003006; P:GO:0006357; P:GO:0007051; P:GO:0010628; P:GO:0014032; P:GO:0021537; P:GO:0030326; P:GO:0030422; P:GO:0031641; P:GO:0032989; P:GO:0034622; P:GO:0035051; P:GO:0035196; P:GO:0035239; P:GO:0045685; P:GO:0048565; P:GO:0048583; P:GO:0048589; P:GO:0048646; P:GO:0048666; P:GO:0048730; P:GO:0051240; P:GO:0051253; P:GO:0051254; P:GO:0051301; P:GO:0060253; P:GO:0061061; P:GO:0070828; P:GO:0090501; P:GO:2000628; F:GO:0005515; F:GO:0016891; F:GO:0061980; C:GO:0005737; C:GO:0032991,"P:hair follicle development; P:developmental process involved in reproduction; P:regulation of transcription by RNA polymerase II; P:spindle organization; P:positive regulation of gene expression; P:neural crest cell development; P:telencephalon development; P:embryonic limb morphogenesis; P:production of siRNA involved in RNA interference; P:regulation of myelination; P:cellular component morphogenesis; P:cellular protein-containing complex assembly; P:cardiocyte differentiation; P:production of miRNAs involved in gene silencing by miRNA; P:tube morphogenesis; P:regulation of glial cell differentiation; P:digestive tract development; P:regulation of response to stimulus; P:developmental growth; P:anatomical structure formation involved in morphogenesis; P:neuron development; P:epidermis morphogenesis; P:positive regulation of multicellular organismal process; P:negative regulation of RNA metabolic process; P:positive regulation of RNA metabolic process; P:cell division; P:negative regulation of glial cell proliferation; P:muscle structure development; P:heterochromatin organization; P:RNA phosphodiester bond hydrolysis; P:regulation of miRNA metabolic process; F:protein binding; F:endoribonuclease activity, producing 5'-phosphomonoesters; F:regulatory RNA binding; C:cytoplasm; C:protein-containing complex",EC:3.1.30; EC:3.1.26,Acting on ester bonds; Acting on ester bonds,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2786,IPR000999 (SMART); IPR001650 (SMART); IPR003100 (SMART); IPR014001 (SMART); IPR001650 (PFAM); IPR003100 (PFAM); IPR036389 (G3DSA:1.10.1520.GENE3D); IPR036389 (G3DSA:1.10.1520.GENE3D); IPR006935 (PFAM); IPR038248 (G3DSA:3.30.160.GENE3D); PF03368 (PFAM); G3DSA:2.170.260.10 (GENE3D); G3DSA:3.30.160.20 (GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (G3DSA:3.40.50.GENE3D); IPR000999 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR14950 (PANTHER); PTHR14950 (PANTHER); PTHR14950 (PANTHER); PTHR14950:SF46 (PANTHER); PTHR14950 (PANTHER); PTHR14950:SF46 (PANTHER); PTHR14950 (PANTHER); PTHR14950 (PANTHER); PTHR14950:SF46 (PANTHER); PTHR14950:SF46 (PANTHER); PTHR14950:SF46 (PANTHER); IPR000999 (PROSITE_PATTERNS); IPR000999 (PROSITE_PROFILES); IPR000999 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR000999 (PROSITE_PROFILES); IPR005034 (PROSITE_PROFILES); IPR014001 (PROSITE_PROFILES); IPR003100 (PROSITE_PROFILES); IPR003100 (PROSITE_PROFILES); IPR000999 (PROSITE_PROFILES); IPR005034 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); cd18034 (CDD); cd18034 (CDD); IPR000999 (CDD); cd18802 (CDD); IPR000999 (CDD); IPR000999 (CDD); IPR000999 (CDD); cd18802 (CDD); IPR036389 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036389 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036389 (SUPERFAMILY); IPR036389 (SUPERFAMILY),P:GO:0006396; F:GO:0003677; F:GO:0004525; F:GO:0005515; F:GO:0005524; F:GO:0016787; F:GO:0016891,"P:RNA processing; F:DNA binding; F:ribonuclease III activity; F:protein binding; F:ATP binding; F:hydrolase activity; F:endoribonuclease activity, producing 5'-phosphomonoesters",XP_022788048.1,2787,1,0,69.74,NA,NA,NA,NA,NA
1209.1200026207,1.27546825332301,0.327396238512346,3.8957938524847,9.78776134769665e-5,0.0186163505621773,Pver_g2753,Upregulated,PX11A_RATPeroxisomal membrane protein 11A OS=Rattus norvegicus OX=10116 GN=Pex11a PE=1 SV=1,233,5,7.81e-29,47.51,4,P:GO:0007031; F:GO:0005515; C:GO:0005777; C:GO:0016020,P:peroxisome organization; F:protein binding; C:peroxisome; C:membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,232,IPR008733 (PFAM); PTHR12652 (PANTHER),P:GO:0016559; C:GO:0005779,P:peroxisome fission; C:integral component of peroxisomal membrane,XP_027044685.1,233,1,9.4e-124,99.14,NA,NA,NA,NA,NA
312.724831552653,0.577454968825347,0.154306607555391,3.74225691286785,1.823749207681e-4,0.025989122296939,Pver_g4261,Upregulated,ACHA7_CHICKNeuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1,528,5,1.6500000000000002e-79,51.77,38,P:GO:0001505; P:GO:0001818; P:GO:0001934; P:GO:0006816; P:GO:0007613; P:GO:0009628; P:GO:0030534; P:GO:0031324; P:GO:0034220; P:GO:0035094; P:GO:0042698; P:GO:0043410; P:GO:0045471; P:GO:0046649; P:GO:0048585; P:GO:0050727; P:GO:0050808; P:GO:0051128; P:GO:0051240; P:GO:0051248; P:GO:0070372; P:GO:0098815; P:GO:0120036; P:GO:1902003; P:GO:1903530; P:GO:1905144; F:GO:0004888; F:GO:0005261; F:GO:0019899; F:GO:1904315; C:GO:0030424; C:GO:0032279; C:GO:0042734; C:GO:0043025; C:GO:0043197; C:GO:0045121; C:GO:0099055; C:GO:0099572,P:regulation of neurotransmitter levels; P:negative regulation of cytokine production; P:positive regulation of protein phosphorylation; P:calcium ion transport; P:memory; P:response to abiotic stimulus; P:adult behavior; P:negative regulation of cellular metabolic process; P:ion transmembrane transport; P:response to nicotine; P:ovulation cycle; P:positive regulation of MAPK cascade; P:response to ethanol; P:lymphocyte activation; P:negative regulation of response to stimulus; P:regulation of inflammatory response; P:synapse organization; P:regulation of cellular component organization; P:positive regulation of multicellular organismal process; P:negative regulation of protein metabolic process; P:regulation of ERK1 and ERK2 cascade; P:modulation of excitatory postsynaptic potential; P:plasma membrane bounded cell projection organization; P:regulation of amyloid-beta formation; P:regulation of secretion by cell; P:response to acetylcholine; F:transmembrane signaling receptor activity; F:cation channel activity; F:enzyme binding; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; C:axon; C:asymmetric synapse; C:presynaptic membrane; C:neuronal cell body; C:dendritic spine; C:membrane raft; C:integral component of postsynaptic membrane; C:postsynaptic specialization,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,527,IPR006201 (PRINTS); IPR002394 (PRINTS); IPR006029 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR006202 (PFAM); IPR006201 (PANTHER); PTHR18945:SF799 (PANTHER); IPR018000 (PROSITE_PATTERNS); cd19051 (CDD); cd18997 (CDD); IPR036734 (SUPERFAMILY); IPR036719 (SUPERFAMILY),P:GO:0006811; P:GO:0034220; F:GO:0004888; F:GO:0005216; F:GO:0005230; F:GO:0022848; C:GO:0016021; C:GO:0045211,P:ion transport; P:ion transmembrane transport; F:transmembrane signaling receptor activity; F:ion channel activity; F:extracellular ligand-gated ion channel activity; F:acetylcholine-gated cation-selective channel activity; C:integral component of membrane; C:postsynaptic membrane,XP_027054208.1,528,1,2.7e-299,96.67,NA,NA,NA,NA,NA
610.284334562518,1.33264567514715,0.330844608049324,4.02801086287757,5.62507452714242e-5,0.0140535494264332,Pver_g10859,Upregulated,NALD2_MOUSEN-acetylated-alpha-linked acidic dipeptidase 2 OS=Mus musculus OX=10090 GN=Naalad2 PE=1 SV=2,766,5,5.53e-122,52.23,7,P:GO:0019538; P:GO:0044237; P:GO:0065007; F:GO:0004180; F:GO:0005488; C:GO:0005886; C:GO:0016021,P:protein metabolic process; P:cellular metabolic process; P:biological regulation; F:carboxypeptidase activity; F:binding; C:plasma membrane; C:integral component of membrane,EC:3.4,Acting on peptide bonds (peptidases),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,765,G3DSA:3.40.630.10 (GENE3D); IPR007484 (PFAM); G3DSA:3.50.30.30 (GENE3D); IPR036757 (G3DSA:1.20.930.GENE3D); IPR007365 (PFAM); IPR039373 (PANTHER); SSF52025 (SUPERFAMILY); SSF53187 (SUPERFAMILY); IPR036757 (SUPERFAMILY),F:GO:0008235,F:metalloexopeptidase activity,XP_027054565.1,766,1,0,98.69,NA,NA,NA,NA,NA
392.498848029306,-0.363150981630669,0.0929869477523613,-3.90539737467022,9.4070674664249e-5,0.0185330897897075,Pver_g16339,Downregulated,RTCA_HUMANRNA 3'-terminal phosphate cyclase OS=Homo sapiens OX=9606 GN=RTCA PE=1 SV=1,312,5,3.6599999999999997e-109,73.65,4,F:GO:0000166; F:GO:0003723; F:GO:0003963; C:GO:0005654,F:nucleotide binding; F:RNA binding; F:RNA-3'-phosphate cyclase activity; C:nucleoplasm,EC:6.5.1.4,RNA 3'-terminal-phosphate cyclase (ATP),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,311,IPR036553 (G3DSA:3.30.360.GENE3D); IPR017770 (TIGRFAM); IPR037136 (G3DSA:3.65.10.GENE3D); IPR023797 (PFAM); IPR013791 (PFAM); IPR000228 (PIRSF); PIRSR005378-2 (PIRSR); IPR017770 (PTHR11096:PANTHER); IPR000228 (PANTHER); IPR020719 (PROSITE_PATTERNS); IPR036553 (SUPERFAMILY); IPR013792 (SUPERFAMILY),P:GO:0006396; F:GO:0003824; F:GO:0003963,P:RNA processing; F:catalytic activity; F:RNA-3'-phosphate cyclase activity,XP_027037080.1,312,1,1.3999999999999997e-167,97.75,NA,NA,NA,NA,NA
55.1293087038826,1.46093452378146,0.367629590353853,3.97393072297382,7.06961336113947e-5,0.016293276817994,Pver_g8906,Upregulated,NA,501,NA,NA,NA,NA,NA,NA,NA,NA,A7RTD6_NEMVEPredicted protein OS=Nematostella vectensis OX=45351 GN=v1g201856 PE=4 SV=1,501,5,0,62.08,1,C:GO:0016021,C:integral component of membrane,NA,NA,500,IPR007074 (PFAM); PTHR13627 (PANTHER); PTHR13627:SF28 (PANTHER),NA,NA,XP_027048935.1,501,1,3.1999999999999995e-294,99,NA,NA,NA,NA,NA
3975.0869967093,0.159912969681478,0.0446599854311866,3.58067670953176,3.4270547621565e-4,0.0363501467613282,Pver_g5890,Upregulated,EIF3C_DANREEukaryotic translation initiation factor 3 subunit C OS=Danio rerio OX=7955 GN=eif3c PE=1 SV=1,909,5,0,64.69,5,P:GO:0006413; P:GO:0045727; F:GO:0003743; F:GO:0005515; C:GO:0071541,"P:translational initiation; P:positive regulation of translation; F:translation initiation factor activity; F:protein binding; C:eukaryotic translation initiation factor 3 complex, eIF3m",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,908,Coil (COILS); Coil (COILS); IPR000717 (SMART); SM00753 (SMART); IPR008905 (PFAM); IPR000717 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR027516 (PANTHER); PTHR13937:SF0 (PANTHER); IPR027516 (PANTHER); PTHR13937:SF0 (PANTHER); IPR027516 (HAMAP); IPR000717 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY),P:GO:0006413; F:GO:0003723; F:GO:0003743; F:GO:0031369; C:GO:0005852,P:translational initiation; F:RNA binding; F:translation initiation factor activity; F:translation initiation factor binding; C:eukaryotic translation initiation factor 3 complex,XP_027052968.1,909,1,0,90.25,NA,NA,NA,NA,NA
322.458252014308,2.59747089492606,0.59166169891009,4.39012851382961,1.13283690253488e-5,0.00542251264013362,Pver_g13227,Upregulated,TRAF3_MOUSETNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,558,5,2.1399999999999998e-106,52.83,23,P:GO:0001934; P:GO:0002224; P:GO:0010628; P:GO:0030162; P:GO:0032088; P:GO:0032648; P:GO:0033209; P:GO:0043122; P:GO:0043408; P:GO:0048523; P:GO:0050688; P:GO:0051091; P:GO:1902533; F:GO:0005164; F:GO:0019901; F:GO:0019903; F:GO:0031625; F:GO:0031996; F:GO:0042802; C:GO:0005737; C:GO:0009898; C:GO:0035631; C:GO:0043231,P:positive regulation of protein phosphorylation; P:toll-like receptor signaling pathway; P:positive regulation of gene expression; P:regulation of proteolysis; P:negative regulation of NF-kappaB transcription factor activity; P:regulation of interferon-beta production; P:tumor necrosis factor-mediated signaling pathway; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of MAPK cascade; P:negative regulation of cellular process; P:regulation of defense response to virus; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of intracellular signal transduction; F:tumor necrosis factor receptor binding; F:protein kinase binding; F:protein phosphatase binding; F:ubiquitin protein ligase binding; F:thioesterase binding; F:identical protein binding; C:cytoplasm; C:cytoplasmic side of plasma membrane; C:CD40 receptor complex; C:intracellular membrane-bounded organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,557,Coil (COILS); Coil (COILS); IPR002083 (SMART); IPR001293 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR012227 (PIRSF); IPR013083 (G3DSA:3.30.40.GENE3D); IPR018957 (PFAM); IPR008974 (G3DSA:2.60.210.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR043211 (PANTHER); PTHR10131:SF132 (PANTHER); IPR017907 (PROSITE_PATTERNS); IPR001293 (PROSITE_PROFILES); IPR002083 (PROSITE_PROFILES); IPR001293 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); SSF49599 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF49599 (SUPERFAMILY),P:GO:0007165; P:GO:0042981; F:GO:0005515; F:GO:0008270; F:GO:0046872,P:signal transduction; P:regulation of apoptotic process; F:protein binding; F:zinc ion binding; F:metal ion binding,XP_022801892.1,558,1,7.4e-284,87.12,NA,NA,NA,NA,NA
1598.20437598619,-0.213780738377256,0.0599993814574205,-3.56304903791331,3.6657216901172e-4,0.0375963621919611,Pver_g1402,Downregulated,RAVR2_HUMANRibonucleoprotein PTB-binding 2 OS=Homo sapiens OX=9606 GN=RAVER2 PE=1 SV=2,936,5,7.14e-45,56.5,3,F:GO:0003676; F:GO:0005515; C:GO:0005634,F:nucleic acid binding; F:protein binding; C:nucleus,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,935,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR23189 (PANTHER); IPR034636 (PTHR23189:PANTHER); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); cd12389 (CDD); cd00590 (CDD); cd12390 (CDD); IPR035979 (SUPERFAMILY); IPR035979 (SUPERFAMILY),F:GO:0003676,F:nucleic acid binding,XP_027051019.1,936,1,0,95.61,NA,NA,NA,NA,NA
104.410018918938,0.747109858972787,0.206997088520598,3.60927713675762,3.0705143887487e-4,0.033601766527112,Pver_novel_607_5de57afd,Upregulated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
923.551467123185,1.39766538920051,0.29783620182894,4.69273171165152,2.69580926242853e-6,0.00201301469244063,Pver_g3301,Upregulated,SAX3_CAEELProtein sax-3 OS=Caenorhabditis elegans OX=6239 GN=sax-3 PE=2 SV=1,554,5,2.4199999999999998e-32,42.29,4,P:GO:0016043; P:GO:0050896; F:GO:0005488; C:GO:0071944,P:cellular component organization; P:response to stimulus; F:binding; C:cell periphery,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,553,PR01832 (PRINTS); IPR003599 (SMART); IPR003598 (SMART); PF13927 (PFAM); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR007110 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PTHR45080:SF8 (PANTHER); PTHR45080 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); cd00096 (CDD); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY),NA,NA,XP_027053587.1,554,1,0,98.55,NA,NA,NA,NA,NA
4332.66821682046,-0.175508684774092,0.0514560764042614,-3.41084468615949,6.4761970091889e-4,0.0489464152905021,Pver_g7352,Downregulated,TIKI1_NEMVEMetalloprotease TIKI homolog OS=Nematostella vectensis OX=45351 GN=v1g27680 PE=2 SV=2,630,5,1.81e-167,72.18,9,P:GO:0006508; P:GO:0030178; P:GO:0031334; P:GO:0060322; P:GO:1904808; F:GO:0004222; F:GO:0017147; C:GO:0005887; C:GO:0031301,P:proteolysis; P:negative regulation of Wnt signaling pathway; P:positive regulation of protein-containing complex assembly; P:head development; P:positive regulation of protein oxidation; F:metalloendopeptidase activity; F:Wnt-protein binding; C:integral component of plasma membrane; C:integral component of organelle membrane,EC:3.4.24,Acting on peptide bonds (peptidases),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,629,IPR008584 (PFAM); IPR002816 (PFAM); IPR040230 (PANTHER); cd14789 (CDD); SSF141678 (SUPERFAMILY),P:GO:0030178; F:GO:0004175,P:negative regulation of Wnt signaling pathway; F:endopeptidase activity,XP_027035999.1,630,1,2.4999999999999997e-251,99.34,NA,NA,NA,NA,NA
1340.57178918601,-0.305529105267119,0.0873378313108251,-3.49824469741842,4.6833123100727e-4,0.0426478410753355,Pver_g23130,Downregulated,RNF8B_XENLAE3 ubiquitin-protein ligase rnf8-B OS=Xenopus laevis OX=8355 GN=rnf8-B PE=2 SV=1,470,5,7.01e-42,48.84,8,P:GO:0006281; P:GO:0006325; P:GO:0016574; P:GO:0032501; P:GO:0048856; F:GO:0005515; F:GO:0016740; C:GO:0005694,P:DNA repair; P:chromatin organization; P:histone ubiquitination; P:multicellular organismal process; P:anatomical structure development; F:protein binding; F:transferase activity; C:chromosome,EC:2,Transferases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,469,Coil (COILS); Coil (COILS); Coil (COILS); IPR001841 (SMART); IPR000253 (SMART); IPR000253 (PFAM); G3DSA:2.60.200.20 (GENE3D); PF13920 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PTHR15067 (PANTHER); PTHR15067:SF4 (PANTHER); IPR017907 (PROSITE_PATTERNS); IPR000253 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR000253 (CDD); SSF57850 (SUPERFAMILY); IPR008984 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_027059415.1,470,1,7.299999999999999e-208,99.56,NA,NA,NA,NA,NA
791.424203247306,-0.244738871556327,0.0627158743263412,-3.90234329322799,9.52659141148322e-5,0.0185330897897075,Pver_g5996,Downregulated,CDC16_HUMANCell division cycle protein 16 homolog OS=Homo sapiens OX=9606 GN=CDC16 PE=1 SV=2,1378,5,0,62.84,12,P:GO:0010087; P:GO:0031145; P:GO:0032875; P:GO:0045842; P:GO:0051301; P:GO:0070979; F:GO:0005515; C:GO:0005654; C:GO:0005680; C:GO:0005813; C:GO:0005829; C:GO:0072686,P:phloem or xylem histogenesis; P:anaphase-promoting complex-dependent catabolic process; P:regulation of DNA endoreduplication; P:positive regulation of mitotic metaphase/anaphase transition; P:cell division; P:protein K11-linked ubiquitination; F:protein binding; C:nucleoplasm; C:anaphase-promoting complex; C:centrosome; C:cytosol; C:mitotic spindle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1377,IPR019734 (SMART); PF13424 (PFAM); G3DSA:3.40.50.720 (GENE3D); IPR027370 (PFAM); IPR013154 (PFAM); IPR011042 (G3DSA:2.120.10.GENE3D); G3DSA:3.90.180.10 (GENE3D); PF12895 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); IPR013149 (PFAM); IPR011990 (G3DSA:1.25.40.GENE3D); PTHR12558 (PANTHER); PTHR12558:SF9 (PANTHER); IPR002328 (PROSITE_PATTERNS); IPR017907 (PROSITE_PATTERNS); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR036291 (SUPERFAMILY); SSF57850 (SUPERFAMILY); IPR011990 (SUPERFAMILY); IPR011032 (SUPERFAMILY); SSF101898 (SUPERFAMILY); IPR011990 (SUPERFAMILY),F:GO:0005515; F:GO:0008270; F:GO:0016491,F:protein binding; F:zinc ion binding; F:oxidoreductase activity,PFX34707.1,1378,1,0,55.72,3,F:GO:0008270; F:GO:0016491; F:GO:0046872,F:zinc ion binding; F:oxidoreductase activity; F:metal ion binding,NA,NA
101.676815227919,2.07904862008481,0.59245920229586,3.50918445021735,4.4948306815915e-4,0.0415897990713089,Pver_g16001,Upregulated,UROM_CANLFUromodulin OS=Canis lupus familiaris OX=9615 GN=UMOD PE=2 SV=1,1242,5,2.07e-24,47.06,18,P:GO:0003014; P:GO:0006807; P:GO:0006810; P:GO:0006873; P:GO:0006950; P:GO:0006955; P:GO:0010033; P:GO:0043170; P:GO:0044237; P:GO:0044238; P:GO:0051716; P:GO:0055065; P:GO:0055081; P:GO:0072080; C:GO:0005615; C:GO:0031362; C:GO:0042589; C:GO:0098590,P:renal system process; P:nitrogen compound metabolic process; P:transport; P:cellular ion homeostasis; P:response to stress; P:immune response; P:response to organic substance; P:macromolecule metabolic process; P:cellular metabolic process; P:primary metabolic process; P:cellular response to stimulus; P:metal ion homeostasis; P:anion homeostasis; P:nephron tubule development; C:extracellular space; C:anchored component of external side of plasma membrane; C:zymogen granule membrane; C:plasma membrane region,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1241,IPR001304 (SMART); IPR001881 (SMART); IPR000742 (SMART); IPR001304 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR002859 (PFAM); IPR016186 (G3DSA:3.10.100.GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR016186 (G3DSA:3.10.100.GENE3D); IPR016186 (G3DSA:3.10.100.GENE3D); IPR024731 (PFAM); PTHR22803 (PANTHER); PTHR22803 (PANTHER); PTHR22803:SF110 (PANTHER); PTHR22803 (PANTHER); PTHR22803:SF110 (PANTHER); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR001304 (PROSITE_PROFILES); IPR001304 (PROSITE_PROFILES); IPR001304 (PROSITE_PROFILES); IPR001304 (PROSITE_PROFILES); cd00037 (CDD); cd00054 (CDD); cd00054 (CDD); cd00037 (CDD); cd00037 (CDD); IPR016187 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR016187 (SUPERFAMILY); IPR016187 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR016187 (SUPERFAMILY),F:GO:0005509,F:calcium ion binding,RMX54592.1,1242,1,7.4e-199,66.79,2,C:GO:0016020; C:GO:0016021,C:membrane; C:integral component of membrane,NA,NA
43.7253000191776,2.02670223733473,0.550199978228665,3.68357382321166,2.2998663659727e-4,0.0300237100139714,Pver_g25354,Upregulated,L3BPB_DANREGalectin-3-binding protein B OS=Danio rerio OX=7955 GN=lgals3bpb PE=2 SV=1,103,5,8.02e-40,75.05,11,P:GO:0006897; P:GO:0007155; P:GO:0018057; P:GO:0030199; F:GO:0004720; F:GO:0005044; F:GO:0005515; F:GO:0046872; C:GO:0005615; C:GO:0016020; C:GO:0043235,P:endocytosis; P:cell adhesion; P:peptidyl-lysine oxidation; P:collagen fibril organization; F:protein-lysine 6-oxidase activity; F:scavenger receptor activity; F:protein binding; F:metal ion binding; C:extracellular space; C:membrane; C:receptor complex,EC:1.4.3.13,Protein-lysine 6-oxidase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,103,IPR001190 (PRINTS); IPR017448 (SMART); IPR001190 (PFAM); IPR036772 (G3DSA:3.10.250.GENE3D); PTHR48071 (PANTHER); IPR001190 (PROSITE_PROFILES); IPR036772 (SUPERFAMILY),F:GO:0005044; C:GO:0016020,F:scavenger receptor activity; C:membrane,RMX46120.1,103,1,6.2e-51,92.23,3,P:GO:0006897; F:GO:0005044; C:GO:0016020,P:endocytosis; F:scavenger receptor activity; C:membrane,NA,NA
501.692713348834,-0.346418231637738,0.0891110538065603,-3.88748888987143,1.0128662214729e-4,0.0186163505621773,Pver_g23231,Downregulated,S2543_DANRESolute carrier family 25 member 43 OS=Danio rerio OX=7955 GN=slc25a43 PE=2 SV=1,338,5,1.75e-98,59.91,1,C:GO:0016020,C:membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,337,IPR002067 (PRINTS); IPR023395 (G3DSA:1.50.40.GENE3D); IPR018108 (PFAM); PTHR24089:SF246 (PANTHER); PTHR24089 (PANTHER); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR018108 (PROSITE_PROFILES); IPR023395 (SUPERFAMILY),P:GO:0055085,P:transmembrane transport,XP_027043263.1,338,1,1.6e-188,99.41,NA,NA,NA,NA,NA
6421.57656472755,1.40095045742466,0.409861275723563,3.41810885878752,6.3057880747666e-4,0.048634024504535,Pver_g5023,Upregulated,ZNF98_HUMANZinc finger protein 98 OS=Homo sapiens OX=9606 GN=ZNF98 PE=2 SV=4,929,5,6.32e-35,55.48,1,F:GO:0005488,F:binding,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,928,Coil (COILS); IPR013087 (SMART); G3DSA:3.30.160.60 (GENE3D); G3DSA:3.30.160.60 (GENE3D); G3DSA:3.30.160.60 (GENE3D); IPR013087 (PFAM); G3DSA:3.30.160.60 (GENE3D); G3DSA:3.30.160.60 (GENE3D); G3DSA:3.30.160.60 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR24377:SF901 (PANTHER); PTHR24377 (PANTHER); PTHR24377 (PANTHER); PTHR24377:SF901 (PANTHER); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR036236 (SUPERFAMILY); IPR036236 (SUPERFAMILY); IPR036236 (SUPERFAMILY); IPR036236 (SUPERFAMILY); IPR036236 (SUPERFAMILY); IPR036236 (SUPERFAMILY),NA,NA,XP_027042180.1,929,1,0,99.67,NA,NA,NA,NA,NA
2253.62847821126,0.940596090787324,0.184789439162724,5.09009657180162,3.57881204190897e-7,4.4539508798904e-4,Pver_g15783,Upregulated,ABHD4_MOUSE(Lyso)-N-acylphosphatidylethanolamine lipase OS=Mus musculus OX=10090 GN=Abhd4 PE=1 SV=1,356,5,6.35e-138,73.2,14,P:GO:0006654; P:GO:0010891; P:GO:0010898; P:GO:0036152; P:GO:0055088; P:GO:0070291; P:GO:0070292; F:GO:0003841; F:GO:0004622; F:GO:0005515; C:GO:0005739; C:GO:0005789; C:GO:0005811; C:GO:0005829,P:phosphatidic acid biosynthetic process; P:negative regulation of sequestering of triglyceride; P:positive regulation of triglyceride catabolic process; P:phosphatidylethanolamine acyl-chain remodeling; P:lipid homeostasis; P:N-acylethanolamine metabolic process; P:N-acylphosphatidylethanolamine metabolic process; F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:lysophospholipase activity; F:protein binding; C:mitochondrion; C:endoplasmic reticulum membrane; C:lipid droplet; C:cytosol,EC:2.3.1.51; EC:3.1.1.5; EC:3.1.1.1,1-acylglycerol-3-phosphate O-acyltransferase; Lysophospholipase; Carboxylesterase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,355,IPR000073 (PRINTS); IPR000073 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); PTHR42886 (PANTHER); PTHR42886:SF34 (PANTHER); IPR029058 (SUPERFAMILY),NA,NA,XP_027037657.1,356,1,1.9999999999999998e-210,99.44,NA,NA,NA,NA,NA
1117.10035485173,1.1393096673725,0.326550492264258,3.48892344173998,4.8497002596834e-4,0.0428328316587693,Pver_g14546,Upregulated,HBAP1_HUMANHSPB1-associated protein 1 OS=Homo sapiens OX=9606 GN=HSPBAP1 PE=1 SV=1,469,5,9.75e-93,60.69,1,F:GO:0005515,F:protein binding,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,468,IPR003347 (SMART); IPR041667 (PFAM); G3DSA:2.60.120.650 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR12461:SF43 (PANTHER); PTHR12461 (PANTHER); IPR003347 (PROSITE_PROFILES); SSF51197 (SUPERFAMILY),NA,NA,XP_027040257.1,469,1,2.4e-275,98.93,NA,NA,NA,NA,NA
393.212768598774,-0.305919349540273,0.0882301728871433,-3.46728720492908,5.2573982490105e-4,0.0453325788478778,Pver_g12211,Downregulated,CUBN_MOUSECubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3,812,5,1.7199999999999999e-37,41.79,8,P:GO:0009987; P:GO:0071702; P:GO:0071704; P:GO:0071705; F:GO:0005515; C:GO:0005886; C:GO:0012505; C:GO:0031410,P:cellular process; P:organic substance transport; P:organic substance metabolic process; P:nitrogen compound transport; F:protein binding; C:plasma membrane; C:endomembrane system; C:cytoplasmic vesicle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,811,IPR000276 (PRINTS); IPR000859 (SMART); IPR035914 (G3DSA:2.60.120.GENE3D); IPR000276 (PFAM); G3DSA:1.20.1070.10 (GENE3D); IPR035914 (G3DSA:2.60.120.GENE3D); IPR035914 (G3DSA:2.60.120.GENE3D); IPR035914 (G3DSA:2.60.120.GENE3D); IPR000859 (PFAM); PTHR45645 (PANTHER); IPR000276 (PROSITE_PATTERNS); IPR000859 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR017452 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR000859 (CDD); cd00637 (CDD); IPR000859 (CDD); IPR000859 (CDD); IPR000859 (CDD); IPR035914 (SUPERFAMILY); IPR035914 (SUPERFAMILY); IPR035914 (SUPERFAMILY); IPR035914 (SUPERFAMILY); SSF81321 (SUPERFAMILY),P:GO:0007186; F:GO:0004930; C:GO:0016021,P:G protein-coupled receptor signaling pathway; F:G protein-coupled receptor activity; C:integral component of membrane,XP_027050779.1,812,1,4.4e-301,81.35,NA,NA,NA,NA,NA
642.699984988689,-0.582401315650202,0.141354441215292,-4.12014868894827,3.78627976272702e-5,0.010549592628446,Pver_g12218,Downregulated,NPAS2_CHICKNeuronal PAS domain-containing protein 2 OS=Gallus gallus OX=9031 GN=NPAS2 PE=1 SV=1,584,5,3.72e-45,50.03,16,P:GO:0006355; P:GO:0007623; P:GO:0010604; P:GO:0032501; P:GO:0044267; P:GO:0045935; P:GO:0048523; P:GO:0048584; P:GO:0051716; P:GO:0080134; F:GO:0000978; F:GO:0005515; F:GO:0016740; C:GO:0005634; C:GO:0005737; C:GO:0043232,"P:regulation of transcription, DNA-templated; P:circadian rhythm; P:positive regulation of macromolecule metabolic process; P:multicellular organismal process; P:cellular protein metabolic process; P:positive regulation of nucleobase-containing compound metabolic process; P:negative regulation of cellular process; P:positive regulation of response to stimulus; P:cellular response to stimulus; P:regulation of response to stress; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:protein binding; F:transferase activity; C:nucleus; C:cytoplasm; C:intracellular non-membrane-bounded organelle",EC:2,Transferases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,583,Coil (COILS); IPR000014 (SMART); PF14598 (PFAM); IPR036638 (G3DSA:4.10.280.GENE3D); G3DSA:3.30.450.20 (GENE3D); IPR013767 (PFAM); IPR011598 (PFAM); G3DSA:3.30.450.20 (GENE3D); PTHR46055:SF3 (PANTHER); PTHR46055 (PANTHER); IPR011598 (PROSITE_PROFILES); IPR000014 (PROSITE_PROFILES); IPR000014 (PROSITE_PROFILES); IPR000014 (CDD); IPR000014 (CDD); cd11441 (CDD); IPR035965 (SUPERFAMILY); IPR035965 (SUPERFAMILY); IPR036638 (SUPERFAMILY),P:GO:0006355; F:GO:0046983,"P:regulation of transcription, DNA-templated; F:protein dimerization activity",XP_027039268.1,584,1,0,99.31,NA,NA,NA,NA,NA
84.7676254754627,2.4778963976413,0.572401573080082,4.32894756788978,1.49823594851473e-5,0.00635660651974387,Pver_g5919,Upregulated,CAS4_EPHMUShort-chain collagen C4 (Fragment) OS=Ephydatia muelleri OX=6052 PE=2 SV=1,302,1,8.64e-13,41.72,2,C:GO:0005576; C:GO:0005581,C:extracellular region; C:collagen trimer,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,301,PTHR24024 (PANTHER); PTHR24024:SF18 (PANTHER),NA,NA,XP_027050701.1,302,1,8.699999999999999e-154,96.01,NA,NA,NA,NA,NA
1597.73047933458,0.663186450250248,0.193073216623794,3.4348961593284,5.9278092803226e-4,0.0472907451474626,Pver_g14591,Upregulated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
678.211781192821,0.967665055756432,0.266835703743199,3.6264451952341,2.8734977157677e-4,0.0333773074442569,Pver_g19702,Upregulated,CO6A6_MOUSECollagen alpha-6(VI) chain OS=Mus musculus OX=10090 GN=Col6a6 PE=1 SV=2,721,5,1.21e-28,44.68,1,C:GO:0031012,C:extracellular matrix,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,720,PR00453 (PRINTS); IPR002035 (SMART); IPR002035 (PFAM); IPR036465 (G3DSA:3.40.50.GENE3D); PIRSR038023-1 (PIRSR); PTHR22588 (PANTHER); IPR002035 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); cd01450 (CDD); IPR036465 (SUPERFAMILY); IPR036465 (SUPERFAMILY); IPR036465 (SUPERFAMILY),NA,NA,RMX57236.1,721,1,2.1999999999999998e-296,94.61,NA,NA,NA,NA,NA
51.2846529418587,0.99495521780311,0.278949779673172,3.56678976039643,3.6138117936801e-4,0.0375963621919611,Pver_g616,Upregulated,NA,145,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6UZJ7_POCDAIlGF domain-containing protein OS=Pocillopora damicornis OX=46731 GN=pdam_00009959 PE=4 SV=1,145,5,2.1e-76,57.48,3,P:GO:0007165; F:GO:0005179; C:GO:0005576,P:signal transduction; F:hormone activity; C:extracellular region,NA,NA,144,G3DSA:1.10.100.10 (GENE3D); PIRSR037038-1 (PIRSR); IPR036438 (SUPERFAMILY),NA,NA,XP_027048860.1,145,1,1e-59,91.67,NA,NA,NA,NA,NA
2424.182164485,0.997878616859566,0.288902135576525,3.45403683108201,5.5226194714051e-4,0.045820560129863,Pver_g12634,Upregulated,SPNS1_DANREProtein spinster homolog 1 OS=Danio rerio OX=7955 GN=spns1 PE=2 SV=1,507,5,1.34e-18,43.57,18,P:GO:0002376; P:GO:0007399; P:GO:0009653; P:GO:0016043; P:GO:0016192; P:GO:0016477; P:GO:0019953; P:GO:0030154; P:GO:0044237; P:GO:0048513; P:GO:0048609; P:GO:0050793; P:GO:0050794; P:GO:0051716; P:GO:0065008; P:GO:0072359; C:GO:0005768; C:GO:0098588,P:immune system process; P:nervous system development; P:anatomical structure morphogenesis; P:cellular component organization; P:vesicle-mediated transport; P:cell migration; P:sexual reproduction; P:cell differentiation; P:cellular metabolic process; P:animal organ development; P:multicellular organismal reproductive process; P:regulation of developmental process; P:regulation of cellular process; P:cellular response to stimulus; P:regulation of biological quality; P:circulatory system development; C:endosome; C:bounding membrane of organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,506,IPR036259 (G3DSA:1.20.1250.GENE3D); IPR011701 (PFAM); IPR036259 (G3DSA:1.20.1250.GENE3D); PTHR23505:SF19 (PANTHER); PTHR23505 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR044770 (CDD); IPR036259 (SUPERFAMILY),P:GO:0055085; F:GO:0022857,P:transmembrane transport; F:transmembrane transporter activity,XP_027049548.1,507,1,1.5e-291,99.6,NA,NA,NA,NA,NA
2042.78742327672,0.823100975214345,0.225392469986486,3.65185658271412,2.6035127680008e-4,0.0321771148859735,Pver_g10672,Upregulated,C74A2_PARARAllene oxide synthase OS=Parthenium argentatum OX=35935 GN=CYP74A2 PE=1 SV=2,451,5,1.1799999999999999e-31,49.12,4,P:GO:0009611; P:GO:0010597; F:GO:0016829; C:GO:0009941,P:response to wounding; P:green leaf volatile biosynthetic process; F:lyase activity; C:chloroplast envelope,EC:4,Lyases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,450,IPR002403 (PRINTS); IPR036396 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PTHR24286:SF270 (PANTHER); PTHR24286 (PANTHER); IPR036396 (SUPERFAMILY),F:GO:0004497; F:GO:0005506; F:GO:0016705; F:GO:0020037,"F:monooxygenase activity; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:heme binding",XP_027060359.1,451,1,6.2e-265,99.56,NA,NA,NA,NA,NA
2338.33379085865,0.320168341795007,0.0931995554399577,3.43529902351595,5.9190031722167e-4,0.0472907451474626,Pver_g6350,Upregulated,CCD40_HUMANCoiled-coil domain-containing protein 40 OS=Homo sapiens OX=9606 GN=CCDC40 PE=1 SV=2,1005,5,0,55.54,16,P:GO:0001947; P:GO:0003146; P:GO:0003356; P:GO:0030317; P:GO:0030324; P:GO:0035469; P:GO:0036159; P:GO:0044458; P:GO:0048793; P:GO:0060287; P:GO:0061512; P:GO:0071907; P:GO:0071910; F:GO:0005515; C:GO:0005930; C:GO:0031514,P:heart looping; P:heart jogging; P:regulation of cilium beat frequency; P:flagellated sperm motility; P:lung development; P:determination of pancreatic left/right asymmetry; P:inner dynein arm assembly; P:motile cilium assembly; P:pronephros development; P:epithelial cilium movement involved in determination of left/right asymmetry; P:protein localization to cilium; P:determination of digestive tract left/right asymmetry; P:determination of liver left/right asymmetry; F:protein binding; C:axoneme; C:motile cilium,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1004,Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); PF08647 (PFAM); G3DSA:1.20.5.170 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR037386 (PANTHER),P:GO:0035082,P:axoneme assembly,XP_027053265.1,1005,1,0,96.73,NA,NA,NA,NA,NA
8286.00890323103,0.329417477133982,0.0746847399746864,4.41077356961588,1.03001983275944e-5,0.005185668894373,Pver_g25700,Upregulated,LFG2_BOVINProtein lifeguard 2 OS=Bos taurus OX=9913 GN=FAIM2 PE=2 SV=1,346,5,2.5e-63,57.74,5,P:GO:0021695; P:GO:0043523; P:GO:1902042; F:GO:0005515; C:GO:0045121,P:cerebellar cortex development; P:regulation of neuron apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; F:protein binding; C:membrane raft,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,345,IPR006214 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR006214 (PANTHER); PTHR23291:SF81 (PANTHER); cd10428 (CDD),NA,NA,XP_027038239.1,346,1,4.899999999999999e-177,93.65,NA,NA,NA,NA,NA
1077.97974897167,-0.236189493713607,0.0682079907304324,-3.4627833364431,5.3461870297921e-4,0.0454782424274007,Pver_g1188,Downregulated,NA,324,NA,NA,NA,NA,NA,NA,NA,NA,A7SDQ7_NEMVEPredicted protein OS=Nematostella vectensis OX=45351 GN=v1g244548 PE=4 SV=1,324,5,0,73.39,1,C:GO:0016021,C:integral component of membrane,NA,NA,323,PTHR38568:SF1 (PANTHER); PTHR38568 (PANTHER),NA,NA,XP_027044448.1,324,1,1.0999999999999999e-175,99.69,NA,NA,NA,NA,NA
1488.27295111113,0.59703039967845,0.153568111154799,3.88772379362428,1.0118867791166e-4,0.0186163505621773,Pver_g14886,Upregulated,MPEG1_BOVINMacrophage-expressed gene 1 protein OS=Bos taurus OX=9913 GN=MPEG1 PE=2 SV=2,751,5,5.739999999999999e-158,56.16,4,P:GO:0035915; P:GO:0050829; P:GO:0050830; C:GO:0045335,P:pore formation in membrane of other organism; P:defense response to Gram-negative bacterium; P:defense response to Gram-positive bacterium; C:phagocytic vesicle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,750,IPR020864 (SMART); IPR020864 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR039707 (PANTHER); PTHR31463:SF4 (PANTHER); IPR020864 (PROSITE_PROFILES),NA,NA,XP_022807111.1,751,1,0,83.22,NA,NA,NA,NA,NA
394.66431186775,-0.387917891152755,0.104460417063609,-3.71353955935806,2.043804995942e-4,0.0274487422044942,Pver_g8459,Downregulated,NOL11_XENLANucleolar protein 11 OS=Xenopus laevis OX=8355 GN=nol11 PE=2 SV=2,556,5,1.6e-18,41.82,10,P:GO:0006364; P:GO:0030490; P:GO:0042254; P:GO:1901838; F:GO:0003723; F:GO:0005515; C:GO:0005634; C:GO:0005654; C:GO:0005730; C:GO:0034455,P:rRNA processing; P:maturation of SSU-rRNA; P:ribosome biogenesis; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; F:RNA binding; F:protein binding; C:nucleus; C:nucleoplasm; C:nucleolus; C:t-UTP complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,555,IPR015943 (G3DSA:2.130.10.GENE3D); IPR042859 (PANTHER); IPR036322 (SUPERFAMILY),P:GO:0030490; F:GO:0005515,P:maturation of SSU-rRNA; F:protein binding,XP_027045847.1,556,1,3.2999999999999995e-300,89.26,NA,NA,NA,NA,NA
322.069443050391,0.511596119613826,0.116680161222116,4.3846024401692,1.16197792749839e-5,0.00542295098763497,Pver_g25577,Upregulated,PTPRA_HUMANReceptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3,123,5,1.2699999999999998e-35,69.09,18,P:GO:0006468; P:GO:0006470; P:GO:0007185; P:GO:0007229; P:GO:0033003; P:GO:0046627; P:GO:0048714; P:GO:0050804; P:GO:0051893; F:GO:0005001; F:GO:0042802; F:GO:0044877; C:GO:0005737; C:GO:0005925; C:GO:0043231; C:GO:0043235; C:GO:0098685; C:GO:0099699,P:protein phosphorylation; P:protein dephosphorylation; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; P:integrin-mediated signaling pathway; P:regulation of mast cell activation; P:negative regulation of insulin receptor signaling pathway; P:positive regulation of oligodendrocyte differentiation; P:modulation of chemical synaptic transmission; P:regulation of focal adhesion assembly; F:transmembrane receptor protein tyrosine phosphatase activity; F:identical protein binding; F:protein-containing complex binding; C:cytoplasm; C:focal adhesion; C:intracellular membrane-bounded organelle; C:receptor complex; C:Schaffer collateral - CA1 synapse; C:integral component of synaptic membrane,EC:3.1.3.48,Protein-tyrosine-phosphatase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,122,IPR000242 (PRINTS); IPR003595 (SMART); IPR029021 (G3DSA:3.90.190.GENE3D); IPR000242 (PFAM); PTHR19134:SF508 (PANTHER); PTHR19134 (PANTHER); IPR000387 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR029021 (SUPERFAMILY),P:GO:0006470; P:GO:0016311; F:GO:0004725; F:GO:0016791,P:protein dephosphorylation; P:dephosphorylation; F:protein tyrosine phosphatase activity; F:phosphatase activity,XP_027045599.1,123,1,3.8e-63,99.18,NA,NA,NA,NA,NA
4003.78673285514,1.03814695433728,0.304063033328416,3.41424915410873,6.3958058193564e-4,0.0487334298105083,Pver_g4764,Upregulated,PRDM6_HUMANPutative histone-lysine N-methyltransferase PRDM6 OS=Homo sapiens OX=9606 GN=PRDM6 PE=1 SV=2,387,5,6.14e-36,57.01,14,P:GO:0000122; P:GO:0009653; P:GO:0016571; P:GO:0019827; P:GO:0019953; P:GO:0022008; P:GO:0040029; P:GO:0045165; P:GO:0048518; P:GO:0051151; F:GO:0003677; F:GO:0016740; F:GO:0042802; C:GO:0005634,"P:negative regulation of transcription by RNA polymerase II; P:anatomical structure morphogenesis; P:histone methylation; P:stem cell population maintenance; P:sexual reproduction; P:neurogenesis; P:regulation of gene expression, epigenetic; P:cell fate commitment; P:positive regulation of biological process; P:negative regulation of smooth muscle cell differentiation; F:DNA binding; F:transferase activity; F:identical protein binding; C:nucleus",EC:2,Transferases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,386,IPR001214 (SMART); IPR001214 (PFAM); G3DSA:2.170.270.10 (GENE3D); mobidb-lite (MOBIDB_LITE); PTHR16515 (PANTHER); PTHR16515:SF22 (PANTHER); IPR001214 (PROSITE_PROFILES); SSF82199 (SUPERFAMILY),F:GO:0005515,F:protein binding,RMX45320.1,387,1,2.0999999999999998e-189,97.92,NA,NA,NA,NA,NA
176.660330479653,1.44499504297256,0.411618433626678,3.51052072726925,4.4722993987534e-4,0.0415897990713089,Pver_g630,Upregulated,CDC20_MOUSECell division cycle protein 20 homolog OS=Mus musculus OX=10090 GN=Cdc20 PE=1 SV=2,522,5,7.159999999999999e-178,66.99,19,P:GO:0007064; P:GO:0008284; P:GO:0031145; P:GO:0031915; P:GO:0040020; P:GO:0050773; P:GO:0090129; P:GO:0090307; P:GO:1904146; P:GO:1904668; F:GO:0008022; F:GO:0042826; F:GO:0097027; C:GO:0005654; C:GO:0005680; C:GO:0005813; C:GO:0005819; C:GO:0005829; C:GO:0048471,P:mitotic sister chromatid cohesion; P:positive regulation of cell population proliferation; P:anaphase-promoting complex-dependent catabolic process; P:positive regulation of synaptic plasticity; P:regulation of meiotic nuclear division; P:regulation of dendrite development; P:positive regulation of synapse maturation; P:mitotic spindle assembly; P:positive regulation of meiotic cell cycle process involved in oocyte maturation; P:positive regulation of ubiquitin protein ligase activity; F:protein C-terminus binding; F:histone deacetylase binding; F:ubiquitin-protein transferase activator activity; C:nucleoplasm; C:anaphase-promoting complex; C:centrosome; C:spindle; C:cytosol; C:perinuclear region of cytoplasm,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,521,IPR001680 (SMART); IPR001680 (PFAM); IPR024977 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR19918:SF3 (PANTHER); IPR033010 (PANTHER); PS50294 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); PS50294 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY),P:GO:1904668; F:GO:0005515; F:GO:0010997; F:GO:0097027,P:positive regulation of ubiquitin protein ligase activity; F:protein binding; F:anaphase-promoting complex binding; F:ubiquitin-protein transferase activator activity,XP_027049149.1,522,1,4.999999999999999e-298,98.85,NA,NA,NA,NA,NA
278.285018208294,-0.379277027321639,0.107542612078917,-3.52676041607877,4.2067724040009e-4,0.0406901695533109,Pver_g16367,Downregulated,LOG7_ARATHCytokinin riboside 5'-monophosphate phosphoribohydrolase LOG7 OS=Arabidopsis thaliana OX=3702 GN=LOG7 PE=1 SV=2,197,5,4.59e-56,63.68,3,F:GO:0016799; C:GO:0005634; C:GO:0005829,"F:hydrolase activity, hydrolyzing N-glycosyl compounds; C:nucleus; C:cytosol",EC:3.2.2,Glycosylases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,196,IPR031100 (PFAM); IPR005269 (TIGRFAM); G3DSA:3.40.50.450 (GENE3D); PTHR31223 (PANTHER); PTHR31223:SF11 (PANTHER); SSF102405 (SUPERFAMILY),NA,NA,XP_027043453.1,197,1,9.8e-106,99.49,NA,NA,NA,NA,NA
1161.84111138984,-0.251975542792532,0.0727175898879156,-3.46512505682489,5.2998496923945e-4,0.0453842174576249,Pver_g696,Downregulated,CRLF3_XENLACytokine receptor-like factor 3 OS=Xenopus laevis OX=8355 GN=crlf3 PE=2 SV=1,449,4,9.49e-56,47.14,3,P:GO:0048522; F:GO:0005488; C:GO:0005622,P:positive regulation of cellular process; F:binding; C:intracellular anatomical structure,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,448,IPR013783 (G3DSA:2.60.40.GENE3D); PTHR23389 (PANTHER); PTHR23389:SF12 (PANTHER); IPR003961 (PROSITE_PROFILES); IPR003961 (CDD); IPR036116 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_027057857.1,449,1,5.2999999999999997e-256,99.78,NA,NA,NA,NA,NA
7639.29537575258,-0.942471863052888,0.0897300086816824,-10.5034188327821,8.330713038952139e-26,3.88794377527896e-22,Pver_g8642,Downregulated,HEY_DROMEHairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,556,5,2.91e-24,54.72,18,P:GO:0000122; P:GO:0001967; P:GO:0007219; P:GO:0007417; P:GO:0007507; P:GO:0009791; P:GO:0009888; P:GO:0010259; P:GO:0021858; P:GO:0035264; P:GO:0045944; P:GO:0048664; P:GO:0048844; F:GO:0000978; F:GO:0001227; F:GO:0042802; C:GO:0005634; C:GO:0005667,"P:negative regulation of transcription by RNA polymerase II; P:suckling behavior; P:Notch signaling pathway; P:central nervous system development; P:heart development; P:post-embryonic development; P:tissue development; P:multicellular organism aging; P:GABAergic neuron differentiation in basal ganglia; P:multicellular organism growth; P:positive regulation of transcription by RNA polymerase II; P:neuron fate determination; P:artery morphogenesis; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:identical protein binding; C:nucleus; C:transcription regulator complex",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,555,IPR011598 (SMART); IPR036638 (G3DSA:4.10.280.GENE3D); IPR003650 (PFAM); G3DSA:6.10.250.980 (GENE3D); IPR011598 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR10985:SF77 (PANTHER); PTHR10985 (PANTHER); IPR011598 (PROSITE_PROFILES); cd11389 (CDD); IPR036638 (SUPERFAMILY); SSF158457 (SUPERFAMILY),P:GO:0006355; F:GO:0003677; F:GO:0046983,"P:regulation of transcription, DNA-templated; F:DNA binding; F:protein dimerization activity",RMX41052.1,556,1,2.2999999999999998e-237,98.74,3,P:GO:0006355; F:GO:0003677; F:GO:0046983,"P:regulation of transcription, DNA-templated; F:DNA binding; F:protein dimerization activity",NA,NA
294.105788266796,1.20814736486193,0.322730906753046,3.74351306175459,1.8146516457138e-4,0.025989122296939,Pver_g11363,Upregulated,TX60A_ACTVLDELTA-thalatoxin-Avl2a OS=Actineria villosa OX=227975 PE=1 SV=1,493,3,2.0499999999999998e-88,54.82,6,P:GO:0019835; P:GO:0035821; P:GO:0044179; F:GO:0090729; C:GO:0005576; C:GO:0042151,P:cytolysis; P:modulation of process of other organism; P:hemolysis in other organism; F:toxin activity; C:extracellular region; C:nematocyst,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,492,IPR020864 (PFAM); PTHR45742 (PANTHER); IPR020864 (PROSITE_PROFILES),NA,NA,XP_027053114.1,493,1,2.3e-220,81.64,NA,NA,NA,NA,NA
2089.60437247909,-0.214033741039472,0.0502200927867801,-4.26191448805555,2.02683004394314e-5,0.00700682652969083,Pver_g13298,Downregulated,TCPR2_HUMANTectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=TECPR2 PE=1 SV=4,1413,5,9.23e-74,44.67,1,P:GO:0009987,P:cellular process,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1412,IPR006624 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR006624 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR029772 (PTHR23287:PANTHER); PTHR23287 (PANTHER); IPR009091 (SUPERFAMILY); IPR036322 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_027052642.1,1413,1,0,99.01,NA,NA,NA,NA,NA
1626.92297794201,-0.24284983432195,0.0702304033489593,-3.45790174542047,5.4439988920988e-4,0.045820560129863,Pver_g5863,Downregulated,EPT1_BOVINEthanolaminephosphotransferase 1 OS=Bos taurus OX=9913 GN=SELENOI PE=2 SV=3,412,5,3.19e-108,61.75,3,P:GO:0006646; F:GO:0004307; C:GO:0005789,P:phosphatidylethanolamine biosynthetic process; F:ethanolaminephosphotransferase activity; C:endoplasmic reticulum membrane,EC:2.7.8.1,Ethanolaminephosphotransferase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,411,Coil (COILS); IPR000462 (PFAM); IPR014472 (PIRSF); IPR043130 (G3DSA:1.20.120.GENE3D); PTHR10414:SF71 (PANTHER); IPR014472 (PANTHER); IPR000462 (PROSITE_PATTERNS),P:GO:0008654; F:GO:0016780; C:GO:0016020,"P:phospholipid biosynthetic process; F:phosphotransferase activity, for other substituted phosphate groups; C:membrane",XP_022802086.1,412,1,8.299999999999999e-224,93.43,NA,NA,NA,NA,NA
1061.84816081005,2.44275246266166,0.676148768665889,3.61274408216621,3.0297369009842e-4,0.033601766527112,Pver_g26107,Upregulated,NAS30_CAEELZinc metalloproteinase nas-30 OS=Caenorhabditis elegans OX=6239 GN=nas-30 PE=3 SV=5,382,5,6.9699999999999994e-46,54.42,2,F:GO:0008233; C:GO:0110165,F:peptidase activity; C:cellular anatomical entity,EC:3.4,Acting on peptide bonds (peptidases),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,381,IPR001506 (PRINTS); IPR006026 (SMART); IPR003582 (SMART); G3DSA:1.10.10.1940 (GENE3D); IPR024079 (G3DSA:3.40.390.GENE3D); IPR003582 (PFAM); IPR001506 (PFAM); PIRSR001196-2 (PIRSR); PTHR10127 (PANTHER); IPR003582 (PROSITE_PROFILES); IPR003582 (PROSITE_PROFILES); IPR001506 (PROSITE_PROFILES); IPR034035 (CDD); SSF55486 (SUPERFAMILY),P:GO:0006508; F:GO:0004222; F:GO:0008237; F:GO:0008270,P:proteolysis; F:metalloendopeptidase activity; F:metallopeptidase activity; F:zinc ion binding,XP_027045347.1,382,1,2.4e-217,99.74,NA,NA,NA,NA,NA
2041.60084261023,0.169134918551741,0.0449614124577495,3.76177947502601,1.6870876822078e-4,0.0244143820553927,Pver_g19013,Upregulated,NA,596,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TH18_POCDAOTU domain-containing protein OS=Pocillopora damicornis OX=46731 GN=pdam_00007528 PE=4 SV=1,596,3,0,72.37,NA,NA,NA,NA,NA,596,Coil (COILS); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,XP_027050546.1,596,1,3.4999999999999995e-300,98.29,NA,NA,NA,NA,NA
10205.345044761,0.220384495153336,0.0619586962970202,3.55695823709472,3.7517377210027e-4,0.0378580755544214,Pver_g1553,Upregulated,ELAP2_HUMANEndosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Homo sapiens OX=9606 GN=ELAPOR2 PE=1 SV=2,1003,5,8.87e-28,36.25,5,P:GO:0050789; C:GO:0005737; C:GO:0012505; C:GO:0016020; C:GO:0043231,P:regulation of biological process; C:cytoplasm; C:endomembrane system; C:membrane; C:intracellular membrane-bounded organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1002,SM01411 (SMART); IPR009011 (G3DSA:2.70.130.GENE3D); G3DSA:2.10.50.10 (GENE3D); G3DSA:2.10.50.10 (GENE3D); IPR039181 (PANTHER); PTHR22727:SF15 (PANTHER); IPR044865 (PROSITE_PROFILES); IPR009011 (SUPERFAMILY),NA,NA,RMX34749.1,1003,1,0,96.01,2,C:GO:0005886; C:GO:0016021,C:plasma membrane; C:integral component of membrane,NA,NA
223.205976882375,1.41387192299586,0.315300560815876,4.48420364155811,7.31867436912292e-6,0.00414015191281172,Pver_g24074,Upregulated,NA,819,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6V3N2_POCDAPNPLA domain-containing protein OS=Pocillopora damicornis OX=46731 GN=pdam_00021544 PE=4 SV=1,819,5,0,84.46,2,P:GO:0006629; C:GO:0016021,P:lipid metabolic process; C:integral component of membrane,NA,NA,818,G3DSA:3.40.1090.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR10728:SF40 (PANTHER); PTHR10728 (PANTHER); IPR016035 (SUPERFAMILY),NA,NA,XP_027040289.1,819,1,0,87.03,NA,NA,NA,NA,NA
9571.69602678731,0.469535708740196,0.128307308572717,3.65946191189953,2.5274540413929e-4,0.0316661154662573,Pver_g10284,Upregulated,NUCL_HUMANNucleolin OS=Homo sapiens OX=9606 GN=NCL PE=1 SV=3,707,5,1.24e-15,57.03,10,P:GO:0017148; P:GO:1901838; F:GO:0042162; F:GO:0042802; F:GO:0048027; C:GO:0005654; C:GO:0005730; C:GO:0005938; C:GO:0036464; C:GO:1990904,P:negative regulation of translation; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; F:telomeric DNA binding; F:identical protein binding; F:mRNA 5'-UTR binding; C:nucleoplasm; C:nucleolus; C:cell cortex; C:cytoplasmic ribonucleoprotein granule; C:ribonucleoprotein complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,706,IPR000504 (SMART); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR23236:SF9 (PANTHER); PTHR23236 (PANTHER); IPR000504 (PROSITE_PROFILES); IPR035979 (SUPERFAMILY),F:GO:0003676,F:nucleic acid binding,XP_027059163.1,707,1,9.499999999999999e-135,98.16,NA,NA,NA,NA,NA
8957.38712368758,0.374451000621088,0.0864776544799758,4.33003187786266,1.49087758053443e-5,0.00635660651974387,Pver_g18546,Upregulated,METK2_RATS-adenosylmethionine synthase isoform type-2 OS=Rattus norvegicus OX=10116 GN=Mat2a PE=1 SV=1,818,5,6.7e-162,84.12,18,P:GO:0006556; P:GO:0006730; P:GO:0007623; P:GO:0009087; P:GO:0009416; P:GO:0009725; P:GO:0034214; P:GO:0051289; P:GO:0051291; P:GO:0051591; P:GO:1990830; F:GO:0004478; F:GO:0005524; F:GO:0016597; F:GO:0042802; F:GO:0046872; C:GO:0005829; C:GO:0048269,P:S-adenosylmethionine biosynthetic process; P:one-carbon metabolic process; P:circadian rhythm; P:methionine catabolic process; P:response to light stimulus; P:response to hormone; P:protein hexamerization; P:protein homotetramerization; P:protein heterooligomerization; P:response to cAMP; P:cellular response to leukemia inhibitory factor; F:methionine adenosyltransferase activity; F:ATP binding; F:amino acid binding; F:identical protein binding; F:metal ion binding; C:cytosol; C:methionine adenosyltransferase complex,EC:2.5.1.6,Methionine adenosyltransferase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,817,Coil (COILS); Coil (COILS); G3DSA:3.30.300.10 (GENE3D); G3DSA:3.30.300.10 (GENE3D); IPR022630 (PFAM); G3DSA:3.30.300.10 (GENE3D); IPR002133 (TIGRFAM); G3DSA:3.30.300.10 (GENE3D); IPR022628 (PFAM); IPR022629 (PFAM); IPR002133 (PANTHER); PTHR11964:SF53 (PANTHER); IPR002133 (PANTHER); PTHR11964:SF53 (PANTHER); IPR022631 (PROSITE_PATTERNS); IPR022631 (PROSITE_PATTERNS); cd18079 (CDD); IPR022636 (SUPERFAMILY); IPR022636 (SUPERFAMILY); IPR022636 (SUPERFAMILY); IPR022636 (SUPERFAMILY),P:GO:0006556; F:GO:0004478; F:GO:0005524,P:S-adenosylmethionine biosynthetic process; F:methionine adenosyltransferase activity; F:ATP binding,XP_027037547.1,818,1,2.2e-215,90.14,NA,NA,NA,NA,NA
2843.50511210354,1.00389554053355,0.293713681026934,3.41793932452704,6.3097171513831e-4,0.048634024504535,Pver_g6935,Upregulated,OIT3_BOVINOncoprotein-induced transcript 3 protein OS=Bos taurus OX=9913 GN=OIT3 PE=2 SV=1,2243,5,5.28e-72,45.53,1,C:GO:0110165,C:cellular anatomical entity,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2242,IPR001881 (SMART); IPR000742 (SMART); IPR001507 (SMART); IPR000859 (SMART); G3DSA:2.60.40.3210 (GENE3D); IPR000859 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR001507 (PFAM); PF14670 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR026823 (PFAM); IPR042235 (G3DSA:2.60.40.GENE3D); IPR035914 (G3DSA:2.60.120.GENE3D); PIRSR036960-1 (PIRSR); PTHR23343 (PANTHER); PTHR23343:SF118 (PANTHER); PTHR23343:SF118 (PANTHER); IPR001507 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); IPR001507 (PROSITE_PROFILES); IPR000859 (PROSITE_PROFILES); cd00054 (CDD); IPR000859 (CDD); IPR000859 (CDD); cd00054 (CDD); cd00054 (CDD); cd00054 (CDD); IPR000859 (CDD); IPR009030 (SUPERFAMILY); IPR035914 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR035914 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR035914 (SUPERFAMILY),F:GO:0005509,F:calcium ion binding,RMX58314.1,2243,1,0,86.3,2,F:GO:0005509; C:GO:0016021,F:calcium ion binding; C:integral component of membrane,NA,NA
69.2307091778689,-0.776640699857694,0.199625884991738,-3.89048093582573,1.0004573720561e-4,0.0186163505621773,Pver_g11057,Downregulated,NA,191,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TCL2_POCDAUncharacterized protein OS=Pocillopora damicornis OX=46731 GN=pdam_00020524 PE=4 SV=1,191,1,1.6100000000000002e-91,99.26,NA,NA,NA,NA,NA,190,mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,XP_027052285.1,191,1,3.4999999999999997e-68,99.26,NA,NA,NA,NA,NA
1860.70476411913,1.36774346509845,0.312494940828196,4.37684994666972,1.20406805482895e-5,0.00548232742623095,Pver_g4366,Upregulated,NA,210,NA,NA,NA,NA,NA,NA,NA,NA,A0A2B4SI37_STYPISHSP domain-containing protein OS=Stylophora pistillata OX=50429 GN=AWC38_SpisGene7055 PE=4 SV=1,210,5,6.99e-120,63.98,NA,NA,NA,NA,NA,209,IPR002068 (PFAM); IPR008978 (G3DSA:2.60.40.GENE3D); IPR001436 (PANTHER); PTHR45640:SF28 (PANTHER); cd06526 (CDD),NA,NA,PFX28238.1,210,1,9.799999999999998e-88,79.43,NA,NA,NA,NA,NA
1227.28182497319,-0.479597000174298,0.131387783076948,-3.65024044810482,2.6199493586179e-4,0.0321771148859735,Pver_g8856,Downregulated,NA,207,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6T927_POCDAAAA_28 domain-containing protein OS=Pocillopora damicornis OX=46731 GN=pdam_00007093 PE=4 SV=1,207,5,1.67e-148,82.87,NA,NA,NA,NA,NA,206,Coil (COILS); IPR038727 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR027417 (SUPERFAMILY),NA,NA,XP_027053696.1,207,1,9.999999999999999e-109,99.51,NA,NA,NA,NA,NA
870.042382220825,0.988813532532786,0.27919090588351,3.54171110768686,3.9754060539849e-4,0.0396496534852503,Pver_g19090,Upregulated,HMCN2_MOUSEHemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1,1444,5,2.08e-26,45.6,7,P:GO:0009987; P:GO:0032502; P:GO:0050896; F:GO:0003824; F:GO:0005488; C:GO:0016020; C:GO:0031012,P:cellular process; P:developmental process; P:response to stimulus; F:catalytic activity; F:binding; C:membrane; C:extracellular matrix,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1443,IPR003598 (SMART); IPR001452 (SMART); IPR003599 (SMART); IPR008160 (PFAM); G3DSA:2.30.30.40 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR001452 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); PF13927 (PFAM); G3DSA:2.60.120.260 (GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR000421 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR12231 (PANTHER); IPR000421 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000421 (PROSITE_PROFILES); cd00096 (CDD); IPR036179 (SUPERFAMILY); IPR036028 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_027053324.1,1444,1,0,97.27,NA,NA,NA,NA,NA
4142.21140511949,1.61905728477978,0.404956977680747,3.9980970177434,6.3853779955047e-5,0.0154808099246859,Pver_g15541,Upregulated,SNXAA_DANRESorting nexin-10A OS=Danio rerio OX=7955 GN=snx10a PE=1 SV=1,448,5,2.36e-24,55.7,7,P:GO:0007389; P:GO:0008104; P:GO:0016050; P:GO:0030030; F:GO:0005515; F:GO:1901981; C:GO:0005768,P:pattern specification process; P:protein localization; P:vesicle organization; P:cell projection organization; F:protein binding; F:phosphatidylinositol phosphate binding; C:endosome,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,447,IPR001683 (SMART); IPR036871 (G3DSA:3.30.1520.GENE3D); IPR001683 (PFAM); IPR043544 (PANTHER); PTHR46209:SF3 (PANTHER); IPR001683 (PROSITE_PROFILES); IPR036871 (SUPERFAMILY),P:GO:0006886; F:GO:0035091,P:intracellular protein transport; F:phosphatidylinositol binding,XP_027050912.1,448,1,2.8e-249,96.87,NA,NA,NA,NA,NA
54.9918725257751,1.02953387875356,0.263051795633589,3.91380669450978,9.08523768907117e-5,0.0185330897897075,Pver_g5949,Upregulated,PK1L2_HUMANPolycystic kidney disease protein 1-like 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5,2588,5,6.229999999999999e-54,45.66,20,P:GO:0007154; P:GO:0009628; P:GO:0023052; P:GO:0030001; P:GO:0042221; P:GO:0050794; P:GO:0050909; P:GO:0051262; P:GO:0051606; P:GO:0051716; P:GO:0098662; F:GO:0005267; F:GO:0008092; F:GO:0022836; C:GO:0005737; C:GO:0005886; C:GO:0005929; C:GO:0016021; C:GO:0032991; C:GO:0043231,P:cell communication; P:response to abiotic stimulus; P:signaling; P:metal ion transport; P:response to chemical; P:regulation of cellular process; P:sensory perception of taste; P:protein tetramerization; P:detection of stimulus; P:cellular response to stimulus; P:inorganic cation transmembrane transport; F:potassium channel activity; F:cytoskeletal protein binding; F:gated channel activity; C:cytoplasm; C:plasma membrane; C:cilium; C:integral component of membrane; C:protein-containing complex; C:intracellular membrane-bounded organelle,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2587,Coil (COILS); Coil (COILS); IPR003915 (PRINTS); IPR001881 (SMART); IPR001024 (SMART); IPR000421 (SMART); G3DSA:2.60.120.260 (GENE3D); G3DSA:2.60.60.20 (GENE3D); G3DSA:1.10.287.70 (GENE3D); IPR000421 (PFAM); IPR001024 (PFAM); IPR002859 (PFAM); IPR013122 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); G3DSA:2.60.120.260 (GENE3D); PTHR10877:SF150 (PANTHER); PTHR10877 (PANTHER); IPR000152 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000421 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000421 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000421 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR014010 (PROSITE_PROFILES); IPR000421 (PROSITE_PROFILES); cd00054 (CDD); IPR000421 (CDD); IPR000421 (CDD); SSF57196 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR008979 (SUPERFAMILY); IPR008979 (SUPERFAMILY),F:GO:0005509; F:GO:0005515; C:GO:0016020,F:calcium ion binding; F:protein binding; C:membrane,PFX20488.1,2588,1,0,70.69,1,C:GO:0016020,C:membrane,NA,NA
78.0541310523062,-1.9561753230582,0.411952137557967,-4.74855000062462,2.04880238938738e-6,0.0016629149132645,Pver_g4156,Downregulated,FBN2_HUMANFibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3,472,5,1.15e-45,57.63,10,P:GO:0030326; P:GO:0030501; P:GO:0035583; P:GO:0045669; P:GO:0045671; P:GO:0060346; F:GO:0005201; F:GO:0005515; C:GO:0001527; C:GO:0005576,P:embryonic limb morphogenesis; P:positive regulation of bone mineralization; P:sequestering of TGFbeta in extracellular matrix; P:positive regulation of osteoblast differentiation; P:negative regulation of osteoclast differentiation; P:bone trabecula formation; F:extracellular matrix structural constituent; F:protein binding; C:microfibril; C:extracellular region,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,471,IPR000742 (SMART); IPR001881 (SMART); IPR024731 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR001881 (PFAM); G3DSA:2.10.25.10 (GENE3D); PTHR24039 (PANTHER); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); cd00054 (CDD); cd00054 (CDD); cd00054 (CDD); cd00054 (CDD); cd00054 (CDD); cd00054 (CDD); IPR009030 (SUPERFAMILY); IPR009030 (SUPERFAMILY),F:GO:0005509,F:calcium ion binding,PFX26095.1,472,1,9.999999999999999e-69,44.18,3,P:GO:0015074; F:GO:0003676; F:GO:0005509,P:DNA integration; F:nucleic acid binding; F:calcium ion binding,NA,NA
2242.89593806704,0.246518444555659,0.071585270291586,3.4437034818968,5.7380462897443e-4,0.0465729774508469,Pver_g14920,Upregulated,MOT10_DANREMonocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,509,5,4.6199999999999995e-74,52.22,5,P:GO:0006865; P:GO:0009914; P:GO:0042403; F:GO:0015291; C:GO:0098590,P:amino acid transport; P:hormone transport; P:thyroid hormone metabolic process; F:secondary active transmembrane transporter activity; C:plasma membrane region,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,508,IPR011701 (PFAM); IPR036259 (G3DSA:1.20.1250.GENE3D); PTHR11360 (PANTHER); PTHR11360:SF251 (PANTHER); IPR020846 (PROSITE_PROFILES); cd17352 (CDD); IPR036259 (SUPERFAMILY),P:GO:0055085; F:GO:0022857,P:transmembrane transport; F:transmembrane transporter activity,XP_027047262.1,509,1,3.1999999999999996e-286,98.62,NA,NA,NA,NA,NA
222.461088345951,-0.960436533944893,0.265114853788839,-3.62271868293682,2.9152281909286e-4,0.0333874109621207,Pver_g21328,Downregulated,ZMYM1_HUMANZinc finger MYM-type protein 1 OS=Homo sapiens OX=9606 GN=ZMYM1 PE=1 SV=1,404,3,2.1100000000000002e-29,48.98,1,F:GO:0005488,F:binding,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,403,Coil (COILS); IPR006580 (SMART); IPR025398 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR45749:SF8 (PANTHER); PTHR45749 (PANTHER),NA,NA,XP_029203455.1,404,1,9.699999999999999e-201,97.84,NA,NA,NA,NA,NA
3722.61477779209,2.87221632401715,0.61550463451657,4.66644142537294,3.06460955056511e-6,0.00220038965730575,Pver_g19191,Upregulated,MCAS_MYCBOMycocerosic acid synthase OS=Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) OX=233413 GN=mas PE=1 SV=2,3355,5,1.4199999999999998e-160,43.29,5,P:GO:0006629; P:GO:0009987; P:GO:0044281; F:GO:0003824; C:GO:0110165,P:lipid metabolic process; P:cellular process; P:small molecule metabolic process; F:catalytic activity; C:cellular anatomical entity,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3354,IPR014043 (SMART); SM00822 (SMART); IPR020841 (SMART); IPR020843 (SMART); IPR020807 (SMART); IPR029058 (G3DSA:3.40.50.GENE3D); IPR014043 (PFAM); IPR042104 (G3DSA:3.10.129.GENE3D); IPR014031 (PFAM); IPR003392 (PFAM); IPR001227 (G3DSA:3.40.366.GENE3D); G3DSA:3.40.50.720 (GENE3D); G3DSA:3.90.180.10 (GENE3D); IPR016039 (G3DSA:3.40.47.GENE3D); IPR001031 (PFAM); G3DSA:3.40.50.720 (GENE3D); IPR013968 (PFAM); G3DSA:3.30.70.3290 (GENE3D); G3DSA:1.20.1640.10 (GENE3D); IPR020807 (PFAM); IPR014030 (PFAM); IPR032821 (PFAM); PIRSR000446-1 (PIRSR); PIRSR000447-1 (PIRSR); mobidb-lite (MOBIDB_LITE); PTHR43775 (PANTHER); IPR018201 (PROSITE_PATTERNS); IPR000731 (PROSITE_PROFILES); IPR009081 (PROSITE_PROFILES); IPR000731 (PROSITE_PROFILES); cd00833 (CDD); IPR016039 (SUPERFAMILY); IPR016036 (SUPERFAMILY); IPR036291 (SUPERFAMILY); IPR036291 (SUPERFAMILY); IPR016035 (SUPERFAMILY); IPR036291 (SUPERFAMILY); IPR036736 (SUPERFAMILY); SSF82866 (SUPERFAMILY); IPR029058 (SUPERFAMILY); SSF82866 (SUPERFAMILY),P:GO:0006633; P:GO:0009058; F:GO:0004315; F:GO:0016491; F:GO:0016740; F:GO:0016746; C:GO:0016021,P:fatty acid biosynthetic process; P:biosynthetic process; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; F:oxidoreductase activity; F:transferase activity; F:acyltransferase activity; C:integral component of membrane,XP_022785512.1,3355,1,0,66.2,NA,NA,NA,NA,NA
1637.61047838089,3.18125174272052,0.622222033614026,5.11272756485813,3.17540098049301e-7,4.2341703931316e-4,Pver_g19192,Upregulated,PTHD3_MOUSEPatched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1,1107,5,1.58e-88,45.11,10,P:GO:0009987; P:GO:0030301; P:GO:0032501; P:GO:0042221; P:GO:0044238; P:GO:0071704; C:GO:0005737; C:GO:0012505; C:GO:0016020; C:GO:0043231,P:cellular process; P:cholesterol transport; P:multicellular organismal process; P:response to chemical; P:primary metabolic process; P:organic substance metabolic process; C:cytoplasm; C:endomembrane system; C:membrane; C:intracellular membrane-bounded organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1106,Coil (COILS); G3DSA:1.20.1640.10 (GENE3D); IPR003392 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR10796:SF92 (PANTHER); PTHR10796 (PANTHER); IPR000731 (PROSITE_PROFILES); IPR000731 (PROSITE_PROFILES); SSF82866 (SUPERFAMILY); SSF82866 (SUPERFAMILY),C:GO:0016021,C:integral component of membrane,XP_022809601.1,1107,1,0,71.4,NA,NA,NA,NA,NA
208.633406171458,0.426894812486965,0.0996323801802726,4.28469952955606,1.82986321944769e-5,0.00676337619459548,Pver_g488,Upregulated,CNTP2_MOUSEContactin-associated protein-like 2 OS=Mus musculus OX=10090 GN=Cntnap2 PE=1 SV=2,790,5,1.61e-78,48.94,9,P:GO:0007610; P:GO:0016043; P:GO:0021537; P:GO:0048666; P:GO:0050877; C:GO:0016020; C:GO:0030054; C:GO:0030424; C:GO:0036477,P:behavior; P:cellular component organization; P:telencephalon development; P:neuron development; P:nervous system process; C:membrane; C:cell junction; C:axon; C:somatodendritic compartment,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,789,IPR001791 (SMART); G3DSA:2.60.120.200 (GENE3D); IPR001791 (PFAM); G3DSA:2.60.120.1000 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.60.120.200 (GENE3D); IPR028875 (PTHR15036:PANTHER); PTHR15036 (PANTHER); IPR001791 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR001791 (PROSITE_PROFILES); cd00110 (CDD); cd00110 (CDD); cd00054 (CDD); IPR013320 (SUPERFAMILY); SSF57196 (SUPERFAMILY); IPR013320 (SUPERFAMILY),NA,NA,XP_027057831.1,790,1,0,96.58,NA,NA,NA,NA,NA
91.576235262411,0.952477146068975,0.270761001795528,3.51777818723045,4.3517595223834e-4,0.0413749963472268,Pver_g7958,Upregulated,NA,227,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6UIP2_POCDAUncharacterized protein OS=Pocillopora damicornis OX=46731 GN=pdam_00017354 PE=4 SV=1,227,4,3.2999999999999994e-163,72.83,1,C:GO:0016021,C:integral component of membrane,NA,NA,226,mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,XP_027060242.1,227,1,4.4000000000000006e-118,99.56,NA,NA,NA,NA,NA
498.096519138351,-0.248817805326471,0.0689133197918809,-3.61059089995816,3.0550020808427e-4,0.033601766527112,Pver_g9385,Downregulated,HACD3_DANREVery-long-chain (3R)-3-hydroxyacyl-CoA dehydratase OS=Danio rerio OX=7955 GN=hacd3 PE=2 SV=2,1087,5,4.99e-45,49.85,5,P:GO:0006633; P:GO:0007264; F:GO:0016836; C:GO:0005783; C:GO:0031090,P:fatty acid biosynthetic process; P:small GTPase mediated signal transduction; F:hydro-lyase activity; C:endoplasmic reticulum; C:organelle membrane,EC:4.2.1,Carbon-oxygen lyases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1086,Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); Coil (COILS); IPR007482 (PFAM); IPR008978 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007482 (PANTHER); PTHR11035:SF35 (PANTHER); IPR007052 (PROSITE_PROFILES); IPR007052 (PROSITE_PROFILES); IPR008978 (SUPERFAMILY); IPR008978 (SUPERFAMILY),NA,NA,XP_022784274.1,1087,1,5.7e-139,41.14,NA,NA,NA,NA,NA
2812.68975232294,1.07841098930083,0.283898336621439,3.7985815702007,1.4552653607207e-4,0.0220869054910034,Pver_g10191,Upregulated,NA,620,NA,NA,NA,NA,NA,NA,NA,NA,A7SYN4_NEMVEPredicted protein OS=Nematostella vectensis OX=45351 GN=v1g248115 PE=4 SV=1,620,5,0,75.98,1,C:GO:0016021,C:integral component of membrane,NA,NA,619,NA,NA,NA,XP_027046756.1,620,1,0,96.94,NA,NA,NA,NA,NA
334.553793522152,0.675166297944931,0.197521832619702,3.41818567087143,6.3040086496368e-4,0.048634024504535,Pver_g7590,Upregulated,TRAF3_HUMANTNF receptor-associated factor 3 OS=Homo sapiens OX=9606 GN=TRAF3 PE=1 SV=2,901,5,5.37e-63,46.04,12,P:GO:0007166; P:GO:0010604; P:GO:0044093; P:GO:0048522; P:GO:0051090; P:GO:0051246; P:GO:1902531; F:GO:0019899; C:GO:0005737; C:GO:0005886; C:GO:0043231; C:GO:0043232,P:cell surface receptor signaling pathway; P:positive regulation of macromolecule metabolic process; P:positive regulation of molecular function; P:positive regulation of cellular process; P:regulation of DNA-binding transcription factor activity; P:regulation of protein metabolic process; P:regulation of intracellular signal transduction; F:enzyme binding; C:cytoplasm; C:plasma membrane; C:intracellular membrane-bounded organelle; C:intracellular non-membrane-bounded organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,900,Coil (COILS); Coil (COILS); Coil (COILS); IPR001841 (SMART); IPR002083 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR001293 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); PF13923 (PFAM); IPR008974 (G3DSA:2.60.210.GENE3D); IPR013083 (G3DSA:3.30.40.GENE3D); IPR008974 (G3DSA:2.60.210.GENE3D); PIRSR000071-1 (PIRSR); PTHR10131:SF138 (PANTHER); IPR043211 (PANTHER); IPR043211 (PANTHER); PTHR10131:SF138 (PANTHER); IPR017907 (PROSITE_PATTERNS); IPR017907 (PROSITE_PATTERNS); IPR002083 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR001293 (PROSITE_PROFILES); IPR001293 (PROSITE_PROFILES); IPR001293 (PROSITE_PROFILES); IPR002083 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR001293 (PROSITE_PROFILES); SSF49599 (SUPERFAMILY); SSF49599 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF57850 (SUPERFAMILY); SSF49599 (SUPERFAMILY); SSF49599 (SUPERFAMILY); SSF49599 (SUPERFAMILY),F:GO:0005515; F:GO:0008270,F:protein binding; F:zinc ion binding,XP_027037295.1,901,1,1.3999999999999998e-287,54.15,NA,NA,NA,NA,NA
212.572387498753,1.07496671023436,0.247976468936385,4.33495450130847,1.45790273399117e-5,0.00635660651974387,Pver_g7331,Upregulated,CAH1_SHEEPCarbonic anhydrase 1 OS=Ovis aries OX=9940 GN=CA1 PE=2 SV=2,677,5,2.52e-32,49.73,1,F:GO:0003824,F:catalytic activity,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,676,Coil (COILS); Coil (COILS); IPR001148 (SMART); IPR036398 (G3DSA:3.10.200.GENE3D); IPR001148 (PFAM); PTHR18952:SF141 (PANTHER); IPR023561 (PANTHER); IPR023561 (PANTHER); PTHR18952:SF141 (PANTHER); IPR018338 (PROSITE_PATTERNS); IPR018338 (PROSITE_PATTERNS); IPR001148 (PROSITE_PROFILES); IPR001148 (PROSITE_PROFILES); cd00326 (CDD); cd00326 (CDD); IPR036398 (SUPERFAMILY); IPR036398 (SUPERFAMILY),F:GO:0004089; F:GO:0008270,F:carbonate dehydratase activity; F:zinc ion binding,XP_027049359.1,677,1,6.399999999999999e-189,96.18,NA,NA,NA,NA,NA
1638.00887370438,0.686435848253465,0.180282764327135,3.80755115895539,1.4034971073319e-4,0.0215256940737864,Pver_g2772,Upregulated,R10B2_HUMANRadial spoke head 10 homolog B2 OS=Homo sapiens OX=9606 GN=RSPH10B2 PE=2 SV=2,209,4,8.69e-7,61.7,3,P:GO:0008150; F:GO:0003674; C:GO:0005575,P:biological_process; F:molecular_function; C:cellular_component,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,208,Coil (COILS); IPR003409 (SMART); G3DSA:2.20.110.10 (GENE3D); IPR003409 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR46613 (PANTHER); SSF82185 (SUPERFAMILY),NA,NA,XP_027047838.1,209,1,5.5e-99,98.08,NA,NA,NA,NA,NA
2849.01766769355,0.542466492206556,0.149932487036944,3.618071726329,2.9680614926559e-4,0.033580467845395,Pver_g16312,Upregulated,LKHA4_HUMANLeukotriene A-4 hydrolase OS=Homo sapiens OX=9606 GN=LTA4H PE=1 SV=2,626,5,0,69.97,16,P:GO:0010043; P:GO:0019370; P:GO:0043171; P:GO:0043434; P:GO:0044267; P:GO:0060509; F:GO:0004301; F:GO:0004463; F:GO:0005515; F:GO:0008270; F:GO:0070006; C:GO:0005576; C:GO:0005654; C:GO:0005829; C:GO:1904724; C:GO:1904813,P:response to zinc ion; P:leukotriene biosynthetic process; P:peptide catabolic process; P:response to peptide hormone; P:cellular protein metabolic process; P:type I pneumocyte differentiation; F:epoxide hydrolase activity; F:leukotriene-A4 hydrolase activity; F:protein binding; F:zinc ion binding; F:metalloaminopeptidase activity; C:extracellular region; C:nucleoplasm; C:cytosol; C:tertiary granule lumen; C:ficolin-1-rich granule lumen,EC:3.4.11; EC:3.3.2.6; EC:3.3.2.10,Acting on peptide bonds (peptidases); Leukotriene-A(4) hydrolase; Soluble epoxide hydrolase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,625,IPR001930 (PRINTS); IPR015211 (SMART); IPR027268 (G3DSA:1.10.390.GENE3D); IPR014782 (PFAM); IPR012777 (TIGRFAM); IPR015211 (PFAM); G3DSA:3.30.2010.30 (GENE3D); IPR038502 (G3DSA:1.25.40.GENE3D); IPR042097 (G3DSA:2.60.40.GENE3D); PF17900 (PFAM); IPR034015 (PANTHER); PTHR45726:SF3 (PANTHER); IPR034015 (CDD); IPR016024 (SUPERFAMILY); IPR042097 (SUPERFAMILY); SSF55486 (SUPERFAMILY),P:GO:0006508; F:GO:0008237; F:GO:0008270,P:proteolysis; F:metallopeptidase activity; F:zinc ion binding,XP_027049104.1,626,1,0,98.72,NA,NA,NA,NA,NA
500.964810087461,1.22337764012987,0.254769637237473,4.80189732730806,1.57169279212216e-6,0.00142690998100517,Pver_g8671,Upregulated,ZN626_HUMANZinc finger protein 626 OS=Homo sapiens OX=9606 GN=ZNF626 PE=2 SV=2,782,5,4.05e-62,64.85,7,P:GO:0006357; F:GO:0003677; F:GO:0005515; F:GO:0008201; F:GO:0008270; C:GO:0005730; C:GO:0005829,P:regulation of transcription by RNA polymerase II; F:DNA binding; F:protein binding; F:heparin binding; F:zinc ion binding; C:nucleolus; C:cytosol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,781,IPR013087 (SMART); G3DSA:3.30.160.60 (GENE3D); IPR043504 (G3DSA:2.40.10.GENE3D); IPR043504 (G3DSA:2.40.10.GENE3D); G3DSA:3.30.160.60 (GENE3D); G3DSA:3.30.160.60 (GENE3D); G3DSA:3.30.160.60 (GENE3D); G3DSA:3.30.160.60 (GENE3D); IPR013087 (PFAM); IPR001254 (PFAM); G3DSA:3.30.160.60 (GENE3D); PTHR23226:SF284 (PANTHER); PTHR23226 (PANTHER); PTHR23226:SF284 (PANTHER); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR018114 (PROSITE_PATTERNS); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR001254 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR036236 (SUPERFAMILY); IPR036236 (SUPERFAMILY); IPR036236 (SUPERFAMILY); IPR036236 (SUPERFAMILY); IPR009003 (SUPERFAMILY),P:GO:0006508; F:GO:0004252,P:proteolysis; F:serine-type endopeptidase activity,RMX46921.1,782,1,9.1e-187,96.2,NA,NA,NA,NA,NA
1489.63344328991,1.60265240443914,0.419893550329015,3.81680643387677,1.3519014565358e-4,0.0215256940737864,Pver_g5098,Upregulated,ROBO1_HUMANRoundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,655,5,2.1e-27,45.7,22,P:GO:0001568; P:GO:0003007; P:GO:0003279; P:GO:0006928; P:GO:0006935; P:GO:0007420; P:GO:0009888; P:GO:0009967; P:GO:0010604; P:GO:0035239; P:GO:0048523; P:GO:0048646; P:GO:0048666; P:GO:0048705; P:GO:0051128; P:GO:0051179; P:GO:0051246; F:GO:0005515; C:GO:0005737; C:GO:0005886; C:GO:0031012; C:GO:0042995,P:blood vessel development; P:heart morphogenesis; P:cardiac septum development; P:movement of cell or subcellular component; P:chemotaxis; P:brain development; P:tissue development; P:positive regulation of signal transduction; P:positive regulation of macromolecule metabolic process; P:tube morphogenesis; P:negative regulation of cellular process; P:anatomical structure formation involved in morphogenesis; P:neuron development; P:skeletal system morphogenesis; P:regulation of cellular component organization; P:localization; P:regulation of protein metabolic process; F:protein binding; C:cytoplasm; C:plasma membrane; C:extracellular matrix; C:cell projection,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,654,IPR003599 (SMART); IPR000421 (SMART); IPR003598 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013098 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); G3DSA:2.60.120.260 (GENE3D); IPR008160 (PFAM); IPR000421 (PFAM); PF13927 (PFAM); PTHR12231 (PANTHER); PTHR12231:SF250 (PANTHER); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000421 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000421 (CDD); IPR008979 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY),NA,NA,XP_027040835.1,655,1,0,98.32,NA,NA,NA,NA,NA
746.727700140003,1.64628511003024,0.47795658041038,3.44442398641466,5.7227752507465e-4,0.0465729774508469,Pver_g5097,Upregulated,PXDNL_HUMANPeroxidasin-like protein OS=Homo sapiens OX=9606 GN=PXDNL PE=1 SV=3,700,5,4.1e-31,47.75,8,P:GO:0007417; P:GO:0009653; P:GO:0030198; P:GO:0048513; P:GO:0048699; F:GO:0004601; F:GO:0005515; C:GO:0005615,P:central nervous system development; P:anatomical structure morphogenesis; P:extracellular matrix organization; P:animal organ development; P:generation of neurons; F:peroxidase activity; F:protein binding; C:extracellular space,EC:1.11.1,Acting on a peroxide as acceptor,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,699,Coil (COILS); IPR003599 (SMART); IPR003598 (SMART); IPR000421 (SMART); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PF13927 (PFAM); IPR008160 (PFAM); IPR013098 (PFAM); G3DSA:2.60.120.260 (GENE3D); IPR000421 (PFAM); IPR043204 (PANTHER); IPR000421 (PROSITE_PATTERNS); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000421 (PROSITE_PROFILES); cd00096 (CDD); IPR000421 (CDD); cd00096 (CDD); IPR008979 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY),P:GO:0007155; P:GO:0007411; F:GO:0005515; C:GO:0005886,P:cell adhesion; P:axon guidance; F:protein binding; C:plasma membrane,XP_027040800.1,700,1,0,98.86,NA,NA,NA,NA,NA
84.2845775430991,0.941976849462968,0.245443760855128,3.83785208546802,1.2411520317327e-4,0.0206873447574883,Pver_g21404,Upregulated,NLRC3_HUMANNLR family CARD domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NLRC3 PE=1 SV=2,185,5,7.3e-20,55.48,32,P:GO:0001819; P:GO:0009595; P:GO:0012501; P:GO:0014067; P:GO:0031396; P:GO:0032088; P:GO:0032496; P:GO:0032687; P:GO:0032688; P:GO:0032691; P:GO:0032695; P:GO:0032715; P:GO:0032720; P:GO:0042110; P:GO:0042742; P:GO:0043124; P:GO:0043280; P:GO:0045824; P:GO:0048147; P:GO:0050680; P:GO:0050728; P:GO:1900016; P:GO:1900226; P:GO:1901223; P:GO:1902533; F:GO:0036312; F:GO:0042802; C:GO:0005829; C:GO:0034451; C:GO:0043231; C:GO:0048471; C:GO:0098590,P:positive regulation of cytokine production; P:detection of biotic stimulus; P:programmed cell death; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein ubiquitination; P:negative regulation of NF-kappaB transcription factor activity; P:response to lipopolysaccharide; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-6 production; P:negative regulation of tumor necrosis factor production; P:T cell activation; P:defense response to bacterium; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of innate immune response; P:negative regulation of fibroblast proliferation; P:negative regulation of epithelial cell proliferation; P:negative regulation of inflammatory response; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of NIK/NF-kappaB signaling; P:positive regulation of intracellular signal transduction; F:phosphatidylinositol 3-kinase regulatory subunit binding; F:identical protein binding; C:cytosol; C:centriolar satellite; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm; C:plasma membrane region,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,184,SM00368 (SMART); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); PTHR24112 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY),F:GO:0005515,F:protein binding,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
69.8686723636964,2.18385952046442,0.617369074024697,3.53736462085411,4.0414131229509e-4,0.0399180424228826,Pver_g19655,Upregulated,KCD21_MOUSEBTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1,291,5,8.58e-10,65.58,7,P:GO:0006511; P:GO:0045879; P:GO:0065008; F:GO:0042802; F:GO:0042826; F:GO:0097602; C:GO:0016020,P:ubiquitin-dependent protein catabolic process; P:negative regulation of smoothened signaling pathway; P:regulation of biological quality; F:identical protein binding; F:histone deacetylase binding; F:cullin family protein binding; C:membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,290,IPR006571 (SMART); IPR003131 (PFAM); IPR011333 (G3DSA:3.30.710.GENE3D); IPR006571 (PFAM); PTHR24410:SF34 (PANTHER); PTHR24410 (PANTHER); IPR006571 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY),P:GO:0051260,P:protein homooligomerization,XP_022784367.1,291,1,1.3e-85,85.39,NA,NA,NA,NA,NA
165.267706183493,-1.19245143204122,0.305527084197892,-3.90293199430025,9.50344112195622e-5,0.0185330897897075,Pver_g8880,Downregulated,NA,404,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TNU6_POCDAUncharacterized protein OS=Pocillopora damicornis OX=46731 GN=pdam_00006845 PE=4 SV=1,404,4,0,71.2,1,C:GO:0016021,C:integral component of membrane,NA,NA,403,mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,XP_027047524.1,404,1,8.199999999999998e-216,96.28,NA,NA,NA,NA,NA
1644.29435010859,1.9629650143201,0.433627419676776,4.52684707019516,5.98702338986282e-6,0.00353333737975635,Pver_g13770,Upregulated,TLR2_CAPIBToll-like receptor 2 OS=Capra ibex OX=72542 GN=TLR2 PE=3 SV=1,431,5,6.46e-20,62.29,6,P:GO:0002224; P:GO:0071221; F:GO:0016799; C:GO:0005737; C:GO:0005886; C:GO:0043231,"P:toll-like receptor signaling pathway; P:cellular response to bacterial lipopeptide; F:hydrolase activity, hydrolyzing N-glycosyl compounds; C:cytoplasm; C:plasma membrane; C:intracellular membrane-bounded organelle",EC:3.2.2,Glycosylases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,430,IPR000157 (SMART); IPR035897 (G3DSA:3.40.50.GENE3D); IPR000157 (PFAM); IPR017241 (PANTHER); PTHR24365:SF543 (PANTHER); IPR000157 (PROSITE_PROFILES); IPR035897 (SUPERFAMILY),P:GO:0002224; P:GO:0006955; P:GO:0007165; F:GO:0003953; F:GO:0004888; C:GO:0016021,P:toll-like receptor signaling pathway; P:immune response; P:signal transduction; F:NAD+ nucleosidase activity; F:transmembrane signaling receptor activity; C:integral component of membrane,XP_027059282.1,431,1,4.4999999999999993e-212,81.08,NA,NA,NA,NA,NA
606.719024906432,-0.523713946876516,0.149254657360411,-3.5088616739904,4.5002889502916e-4,0.0415897990713089,Pver_g10560,Downregulated,NA,455,NA,NA,NA,NA,NA,NA,NA,NA,A0A0D2WUW8_CAPO3Hydroxymethylglutaryl-CoA reductase (NADPH) OS=Capsaspora owczarzaki (strain ATCC 30864) OX=595528 GN=CAOG_006251 PE=3 SV=1,455,5,0,69.57,4,P:GO:0015936; F:GO:0004420; F:GO:0016491; F:GO:0016616,"P:coenzyme A metabolic process; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity; F:oxidoreductase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",NA,NA,454,IPR004119 (PFAM); G3DSA:3.90.1200.10 (GENE3D); IPR011009 (SUPERFAMILY),NA,NA,XP_027042707.1,455,1,5.7e-266,98.68,NA,NA,NA,NA,NA
1536.9493225559,-0.204161890053771,0.0573049360300825,-3.56272782411964,3.6702115151374e-4,0.0375963621919611,Pver_g18482,Downregulated,NA,281,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TR09_POCDAPlsC domain-containing protein OS=Pocillopora damicornis OX=46731 GN=pdam_00023094 PE=3 SV=1,281,5,2.4299999999999997e-171,83.93,2,P:GO:0006644; F:GO:0016746,P:phospholipid metabolic process; F:acyltransferase activity,EC:2.3,Acyltransferases,280,Coil (COILS); PTHR36058 (PANTHER),NA,NA,XP_027046722.1,281,1,2.0999999999999997e-149,99.29,NA,NA,NA,NA,NA
274.917241092671,-0.560446289669081,0.143621652533665,-3.9022409210736,9.53062256166661e-5,0.0185330897897075,Pver_g13043,Downregulated,POED1_ORYSJPolyprenol reductase 1 OS=Oryza sativa subsp. japonica OX=39947 GN=Os04g0576800 PE=2 SV=2,228,5,1.4799999999999999e-40,52.25,4,P:GO:0006487; P:GO:0006629; F:GO:0016491; C:GO:0005783,P:protein N-linked glycosylation; P:lipid metabolic process; F:oxidoreductase activity; C:endoplasmic reticulum,EC:1,Oxidoreductases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,227,IPR001104 (PFAM); IPR039698 (PANTHER); PTHR14624:SF0 (PANTHER); IPR001104 (PROSITE_PROFILES),P:GO:0006488; P:GO:0006629; F:GO:0003865; F:GO:0016627,"P:dolichol-linked oligosaccharide biosynthetic process; P:lipid metabolic process; F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; F:oxidoreductase activity, acting on the CH-CH group of donors",XP_027057598.1,228,1,1.3e-125,96.92,NA,NA,NA,NA,NA
1087.45643451495,-0.452607304379131,0.0991577567408157,-4.56451738377041,5.00644717475188e-6,0.003337869852081,Pver_g9786,Downregulated,NA,173,NA,NA,NA,NA,NA,NA,NA,NA,A7RLD4_NEMVEPredicted protein OS=Nematostella vectensis OX=45351 GN=v1g239103 PE=4 SV=1,173,3,2.0899999999999997e-116,81.57,2,P:GO:0050896; C:GO:0016021,P:response to stimulus; C:integral component of membrane,NA,NA,172,mobidb-lite (MOBIDB_LITE),NA,NA,XP_027036948.1,173,1,4.3e-81,99.4,NA,NA,NA,NA,NA
5175.41234806475,0.347730058718924,0.072478830678056,4.7976775489592,1.60515907441121e-6,0.00142690998100517,Pver_g18523,Upregulated,LAMC1_DROMELaminin subunit gamma-1 OS=Drosophila melanogaster OX=7227 GN=LanB2 PE=2 SV=2,1979,5,4.9899999999999994e-144,44.9,6,P:GO:0009653; P:GO:0022607; P:GO:0048731; P:GO:0050789; C:GO:0030054; C:GO:0062023,P:anatomical structure morphogenesis; P:cellular component assembly; P:system development; P:regulation of biological process; C:cell junction; C:collagen-containing extracellular matrix,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1978,Coil (COILS); Coil (COILS); Coil (COILS); PR00011 (PRINTS); IPR002049 (SMART); IPR000034 (SMART); IPR000034 (PFAM); G3DSA:2.60.120.260 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR002049 (PFAM); G3DSA:2.10.25.10 (GENE3D); mobidb-lite (MOBIDB_LITE); PTHR10574:SF240 (PANTHER); PTHR10574:SF240 (PANTHER); PTHR10574 (PANTHER); PTHR10574 (PANTHER); PTHR10574:SF240 (PANTHER); IPR002049 (PROSITE_PATTERNS); IPR002049 (PROSITE_PATTERNS); IPR002049 (PROSITE_PATTERNS); IPR002049 (PROSITE_PATTERNS); IPR002049 (PROSITE_PATTERNS); IPR002049 (PROSITE_PATTERNS); IPR002049 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR008211 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR000034 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); cd00055 (CDD); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY),NA,NA,PFX13764.1,1979,1,0,85.18,NA,NA,NA,NA,NA
896.032314969549,1.66457051099631,0.421483268002041,3.94931575549102,7.83749099714768e-5,0.0174178907065182,Pver_g15656,Upregulated,RHO_APLCARas-like GTP-binding protein RHO OS=Aplysia californica OX=6500 GN=RHO PE=2 SV=1,385,5,5.23e-100,84.01,23,P:GO:0000281; P:GO:0007163; P:GO:0007264; P:GO:0008360; P:GO:0030335; P:GO:0030865; P:GO:0031334; P:GO:0043297; P:GO:0044319; P:GO:0051496; P:GO:0060193; P:GO:1902766; F:GO:0003924; F:GO:0005525; F:GO:0019901; C:GO:0005634; C:GO:0005789; C:GO:0005829; C:GO:0005856; C:GO:0005938; C:GO:0031410; C:GO:0032154; C:GO:0032420,"P:mitotic cytokinesis; P:establishment or maintenance of cell polarity; P:small GTPase mediated signal transduction; P:regulation of cell shape; P:positive regulation of cell migration; P:cortical cytoskeleton organization; P:positive regulation of protein-containing complex assembly; P:apical junction assembly; P:wound healing, spreading of cells; P:positive regulation of stress fiber assembly; P:positive regulation of lipase activity; P:skeletal muscle satellite cell migration; F:GTPase activity; F:GTP binding; F:protein kinase binding; C:nucleus; C:endoplasmic reticulum membrane; C:cytosol; C:cytoskeleton; C:cell cortex; C:cytoplasmic vesicle; C:cleavage furrow; C:stereocilium",EC:3.6.1,Acting on acid anhydrides,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,384,PR00449 (PRINTS); SM00173 (SMART); IPR001806 (SMART); SM00175 (SMART); IPR005225 (TIGRFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR001806 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR003578 (PANTHER); IPR003578 (PANTHER); PTHR24072:SF0 (PANTHER); PTHR24072:SF0 (PANTHER); IPR001806 (PROSITE_PROFILES); PS51419 (PROSITE_PROFILES); PS51420 (PROSITE_PROFILES); IPR001806 (PROSITE_PROFILES); PS51419 (PROSITE_PROFILES); PS51420 (PROSITE_PROFILES); cd01870 (CDD); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY),P:GO:0007264; F:GO:0003924; F:GO:0005525,P:small GTPase mediated signal transduction; F:GTPase activity; F:GTP binding,PFX29363.1,385,1,9.999999999999999e-176,77.94,3,P:GO:0007264; F:GO:0003924; F:GO:0005525,P:small GTPase mediated signal transduction; F:GTPase activity; F:GTP binding,NA,NA
190.76228787529,-0.387427455026483,0.106562692981791,-3.63567627830768,2.7725232543143e-4,0.0327578886781904,Pver_g15034,Downregulated,NA,479,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TID4_POCDA5'-nucleotidase OS=Pocillopora damicornis OX=46731 GN=pdam_00011577 PE=3 SV=1,479,5,0,67.47,6,P:GO:0009117; P:GO:0016311; F:GO:0000287; F:GO:0008253; C:GO:0005737; C:GO:0016021,P:nucleotide metabolic process; P:dephosphorylation; F:magnesium ion binding; F:5'-nucleotidase activity; C:cytoplasm; C:integral component of membrane,EC:3.1.3.5,5'-nucleotidase,478,Coil (COILS); IPR029343 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR029343 (PANTHER),NA,NA,XP_027049976.1,479,1,4e-238,99.16,NA,NA,NA,NA,NA
782.589092392396,1.38069374704303,0.366238079390483,3.76993498147672,1.6329008161527e-4,0.0240023562487705,Pver_g18313,Upregulated,PAQR9_HUMANMembrane progestin receptor epsilon OS=Homo sapiens OX=9606 GN=PAQR9 PE=1 SV=1,1083,5,1.62e-29,45.45,9,P:GO:0030154; P:GO:0048477; F:GO:0005496; F:GO:0005515; F:GO:0008289; F:GO:0038023; C:GO:0005886; C:GO:0016020; C:GO:0016021,P:cell differentiation; P:oogenesis; F:steroid binding; F:protein binding; F:lipid binding; F:signaling receptor activity; C:plasma membrane; C:membrane; C:integral component of membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1081,IPR000276 (PRINTS); G3DSA:1.20.1070.10 (GENE3D); IPR036188 (G3DSA:3.50.50.GENE3D); IPR004254 (PFAM); IPR000276 (PFAM); IPR002937 (PFAM); PTHR20855:SF58 (PANTHER); IPR004254 (PANTHER); IPR000742 (PROSITE_PATTERNS); IPR017452 (PROSITE_PROFILES); cd00055 (CDD); cd00637 (CDD); IPR036188 (SUPERFAMILY); SSF81321 (SUPERFAMILY),P:GO:0007186; F:GO:0004930; F:GO:0016491; C:GO:0016021,P:G protein-coupled receptor signaling pathway; F:G protein-coupled receptor activity; F:oxidoreductase activity; C:integral component of membrane,RMX39406.1,1083,1,1.6999999999999998e-305,98.44,1,F:GO:0016491,F:oxidoreductase activity,EC:1,Oxidoreductases
804.71705791888,-0.404657622154433,0.112135449720789,-3.60865028108424,3.0779419735034e-4,0.033601766527112,Pver_g15598,Downregulated,"PLR1_ARATHPyridoxal reductase, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=PLR1 PE=1 SV=1",340,5,1.28e-18,46.97,4,P:GO:0006081; P:GO:0042816; F:GO:0016616; C:GO:0009507,"P:cellular aldehyde metabolic process; P:vitamin B6 metabolic process; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; C:chloroplast",EC:1.1.1,Acting on the CH-OH group of donors,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,339,IPR020471 (PRINTS); IPR023210 (PFAM); IPR036812 (G3DSA:3.20.20.GENE3D); PIRSR000097-2 (PIRSR); PIRSR000097-3 (PIRSR); PTHR43147:SF1 (PANTHER); PTHR43147 (PANTHER); cd19101 (CDD); IPR036812 (SUPERFAMILY),F:GO:0016491; F:GO:0047834,F:oxidoreductase activity; F:D-threo-aldose 1-dehydrogenase activity,XP_027054104.1,340,1,3.899999999999999e-195,99.12,NA,NA,NA,NA,NA
83.5978697305856,0.906576579854207,0.204784657421291,4.42697510287189,9.5563757741901e-6,0.00514512538385684,Pver_g1502,Upregulated,NA,94,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TXT0_POCDAUncharacterized protein OS=Pocillopora damicornis OX=46731 GN=pdam_00000635 PE=4 SV=1,94,1,9.97e-49,100,NA,NA,NA,NA,NA,93,mobidb-lite (MOBIDB_LITE),NA,NA,RMX46243.1,94,1,8.100000000000001e-34,100,NA,NA,NA,NA,NA
410.570648883992,-0.407272930067462,0.116759903160624,-3.48812322589191,4.8642384356434e-4,0.0428328316587693,Pver_g774,Downregulated,"SELO_MOUSEProtein adenylyltransferase SelO, mitochondrial OS=Mus musculus OX=10090 GN=Selenoo PE=1 SV=4",1007,5,4.619999999999999e-161,62.86,5,P:GO:0018117; F:GO:0043167; F:GO:0070733; C:GO:0005694; C:GO:0005739,P:protein adenylylation; F:ion binding; F:protein adenylyltransferase activity; C:chromosome; C:mitochondrion,EC:2.7.7,Transferring phosphorus-containing groups,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1006,IPR022669 (SMART); IPR002171 (SMART); G3DSA:2.40.50.140 (GENE3D); IPR022666 (PFAM); IPR003846 (PFAM); IPR022669 (PFAM); IPR014722 (G3DSA:2.30.30.GENE3D); PTHR12153:SF15 (PANTHER); PTHR12153 (PANTHER); IPR008991 (SUPERFAMILY); IPR012340 (SUPERFAMILY),P:GO:0006412; F:GO:0003735; C:GO:0005840,P:translation; F:structural constituent of ribosome; C:ribosome,PFX28673.1,1007,1,0,88.6,7,P:GO:0006412; F:GO:0003723; F:GO:0003735; F:GO:0005524; F:GO:0016779; F:GO:0046872; C:GO:0015934,P:translation; F:RNA binding; F:structural constituent of ribosome; F:ATP binding; F:nucleotidyltransferase activity; F:metal ion binding; C:large ribosomal subunit,EC:2.7.7,Transferring phosphorus-containing groups
888.984658308206,2.92955781630001,0.195515590902795,14.9837555295347,9.37654455059697e-51,1.7504133367054402e-46,Pver_g6818,Upregulated,MOT10_MOUSEMonocarboxylate transporter 10 OS=Mus musculus OX=10090 GN=Slc16a10 PE=1 SV=1,847,5,3.3499999999999997e-34,46.2,6,P:GO:0009987; P:GO:0010817; P:GO:0071702; P:GO:0071705; F:GO:0022857; C:GO:0005886,P:cellular process; P:regulation of hormone levels; P:organic substance transport; P:nitrogen compound transport; F:transmembrane transporter activity; C:plasma membrane,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,846,IPR036259 (G3DSA:1.20.1250.GENE3D); IPR011701 (PFAM); PTHR11360:SF270 (PANTHER); PTHR11360 (PANTHER); PTHR11360 (PANTHER); PTHR11360:SF270 (PANTHER); IPR020846 (PROSITE_PROFILES); cd17352 (CDD); cd17352 (CDD); IPR036259 (SUPERFAMILY); IPR036259 (SUPERFAMILY),P:GO:0055085; F:GO:0022857,P:transmembrane transport; F:transmembrane transporter activity,RMX37708.1,847,1,0,82.72,3,P:GO:0055085; F:GO:0022857; C:GO:0016021,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane,EC:7,Translocases
353.275007282257,1.60334231814705,0.218357461660182,7.34274114544454,2.09263015641779e-13,5.58074568000103e-10,Pver_g6817,Upregulated,MOT10_RATMonocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=1,896,5,5.07e-44,48.42,6,P:GO:0006865; P:GO:0009914; P:GO:0044237; P:GO:1901564; F:GO:0022857; C:GO:0005886,P:amino acid transport; P:hormone transport; P:cellular metabolic process; P:organonitrogen compound metabolic process; F:transmembrane transporter activity; C:plasma membrane,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,895,IPR036259 (G3DSA:1.20.1250.GENE3D); IPR011701 (PFAM); IPR036259 (G3DSA:1.20.1250.GENE3D); PTHR11360:SF270 (PANTHER); PTHR11360 (PANTHER); PTHR11360:SF270 (PANTHER); IPR020846 (PROSITE_PROFILES); IPR020846 (PROSITE_PROFILES); cd17352 (CDD); cd17352 (CDD); IPR036259 (SUPERFAMILY); IPR036259 (SUPERFAMILY),P:GO:0055085; F:GO:0022857,P:transmembrane transport; F:transmembrane transporter activity,RMX37709.1,896,1,0,96.98,3,P:GO:0055085; F:GO:0022857; C:GO:0016021,P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane,EC:7,Translocases
465.954641511905,4.22686314235818,0.665442000656057,6.351963263802,2.1258409863566801e-10,4.9606499416633e-7,Pver_g17012,Upregulated,SIDT1_HUMANSID1 transmembrane family member 1 OS=Homo sapiens OX=9606 GN=SIDT1 PE=2 SV=2,828,5,1.47e-18,41.04,2,F:GO:0097159; C:GO:0016020,F:organic cyclic compound binding; C:membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,827,IPR025958 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR025958 (PANTHER); PTHR12185:SF14 (PANTHER),C:GO:0016021,C:integral component of membrane,XP_022779279.1,828,1,1.2e-298,68.82,NA,NA,NA,NA,NA
2923.92500413689,0.784420855314378,0.220487935719333,3.55765884766093,3.7417483249247e-4,0.0378580755544214,Pver_g23276,Upregulated,RHG32_XENLARho GTPase-activating protein 32 OS=Xenopus laevis OX=8355 GN=arhgap32 PE=2 SV=1,926,5,4.84e-170,61.75,12,P:GO:0007165; F:GO:0005096; F:GO:0019901; C:GO:0001650; C:GO:0005654; C:GO:0005794; C:GO:0005829; C:GO:0005886; C:GO:0005938; C:GO:0014069; C:GO:0015629; C:GO:0032991,P:signal transduction; F:GTPase activator activity; F:protein kinase binding; C:fibrillar center; C:nucleoplasm; C:Golgi apparatus; C:cytosol; C:plasma membrane; C:cell cortex; C:postsynaptic density; C:actin cytoskeleton; C:protein-containing complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,925,IPR001452 (SMART); IPR000198 (SMART); IPR001452 (PFAM); IPR008936 (G3DSA:1.10.555.GENE3D); IPR000198 (PFAM); G3DSA:2.30.30.40 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR15729:SF10 (PANTHER); PTHR15729 (PANTHER); IPR001452 (PROSITE_PROFILES); IPR000198 (PROSITE_PROFILES); cd11835 (CDD); IPR008936 (SUPERFAMILY); IPR036028 (SUPERFAMILY),P:GO:0007165; F:GO:0005515,P:signal transduction; F:protein binding,XP_027040513.1,926,1,0,99.46,NA,NA,NA,NA,NA
648.893131482916,1.61377919868039,0.415231419853744,3.88645733805213,1.017177928724e-4,0.0186163505621773,Pver_g13927,Upregulated,NA,402,NA,NA,NA,NA,NA,NA,NA,NA,A7RQZ2_NEMVEPredicted protein OS=Nematostella vectensis OX=45351 GN=v1g180953 PE=4 SV=1,402,5,8.93e-114,90.17,1,C:GO:0016021,C:integral component of membrane,NA,NA,401,IPR007593 (PFAM); IPR013869 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR38636 (PANTHER); PTHR38636:SF1 (PANTHER),C:GO:0016021,C:integral component of membrane,XP_027042910.1,402,1,6.7e-85,97.63,NA,NA,NA,NA,NA
2938.98893096935,0.284803676053017,0.0788944229308736,3.60993420666196,3.0627468153147e-4,0.033601766527112,Pver_g15186,Upregulated,DLL1_RATDelta-like protein 1 OS=Rattus norvegicus OX=10116 GN=Dll1 PE=1 SV=1,647,5,8.93e-104,57.9,67,P:GO:0001757; P:GO:0001947; P:GO:0002315; P:GO:0003140; P:GO:0003323; P:GO:0007386; P:GO:0008217; P:GO:0008284; P:GO:0008285; P:GO:0009954; P:GO:0010628; P:GO:0014002; P:GO:0014032; P:GO:0014807; P:GO:0021514; P:GO:0021523; P:GO:0021536; P:GO:0021688; P:GO:0021693; P:GO:0030155; P:GO:0030901; P:GO:0032693; P:GO:0033504; P:GO:0034351; P:GO:0035265; P:GO:0035469; P:GO:0045608; P:GO:0045638; P:GO:0045662; P:GO:0045747; P:GO:0045807; P:GO:0045944; P:GO:0046331; P:GO:0048546; P:GO:0048633; P:GO:0048665; P:GO:0050767; P:GO:0051302; P:GO:0055016; P:GO:0060034; P:GO:0060042; P:GO:0060271; P:GO:0060853; P:GO:0061056; P:GO:0070986; P:GO:0071910; P:GO:0072014; P:GO:0072070; P:GO:0072583; P:GO:0097009; P:GO:0097102; P:GO:0097150; P:GO:0098773; P:GO:1900746; P:GO:1902036; P:GO:1903672; P:GO:2000726; F:GO:0005112; F:GO:0030165; F:GO:0030957; F:GO:0097110; C:GO:0005912; C:GO:0005938; C:GO:0016324; C:GO:0031410; C:GO:0045121; C:GO:0048471,P:somite specification; P:heart looping; P:marginal zone B cell differentiation; P:determination of left/right asymmetry in lateral mesoderm; P:type B pancreatic cell development; P:compartment pattern specification; P:regulation of blood pressure; P:positive regulation of cell population proliferation; P:negative regulation of cell population proliferation; P:proximal/distal pattern formation; P:positive regulation of gene expression; P:astrocyte development; P:neural crest cell development; P:regulation of somitogenesis; P:ventral spinal cord interneuron differentiation; P:somatic motor neuron differentiation; P:diencephalon development; P:cerebellar molecular layer formation; P:cerebellar Purkinje cell layer structural organization; P:regulation of cell adhesion; P:midbrain development; P:negative regulation of interleukin-10 production; P:floor plate development; P:negative regulation of glial cell apoptotic process; P:organ growth; P:determination of pancreatic left/right asymmetry; P:negative regulation of inner ear auditory receptor cell differentiation; P:negative regulation of myeloid cell differentiation; P:negative regulation of myoblast differentiation; P:positive regulation of Notch signaling pathway; P:positive regulation of endocytosis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:digestive tract morphogenesis; P:positive regulation of skeletal muscle tissue growth; P:neuron fate specification; P:regulation of neurogenesis; P:regulation of cell division; P:hypochord development; P:notochord cell differentiation; P:retina morphogenesis in camera-type eye; P:cilium assembly; P:Notch signaling pathway involved in arterial endothelial cell fate commitment; P:sclerotome development; P:left/right axis specification; P:determination of liver left/right asymmetry; P:proximal tubule development; P:loop of Henle development; P:clathrin-dependent endocytosis; P:energy homeostasis; P:endothelial tip cell fate specification; P:neuronal stem cell population maintenance; P:skin epidermis development; P:regulation of vascular endothelial growth factor signaling pathway; P:regulation of hematopoietic stem cell differentiation; P:positive regulation of sprouting angiogenesis; P:negative regulation of cardiac muscle cell differentiation; F:Notch binding; F:PDZ domain binding; F:Tat protein binding; F:scaffold protein binding; C:adherens junction; C:cell cortex; C:apical plasma membrane; C:cytoplasmic vesicle; C:membrane raft; C:perinuclear region of cytoplasm,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,646,PR00010 (PRINTS); IPR000742 (SMART); IPR001881 (SMART); IPR001774 (SMART); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.10 (GENE3D); G3DSA:2.10.25.140 (GENE3D); G3DSA:2.60.40.3510 (GENE3D); G3DSA:2.10.25.10 (GENE3D); IPR001774 (PFAM); IPR000742 (PFAM); G3DSA:2.10.25.10 (GENE3D); IPR011651 (PFAM); mobidb-lite (MOBIDB_LITE); PTHR24044:SF380 (PANTHER); PTHR24044 (PANTHER); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR001774 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); cd00054 (CDD); cd00054 (CDD); cd00054 (CDD); cd12087 (CDD); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY); SSF57196 (SUPERFAMILY),P:GO:0007154; P:GO:0007219; P:GO:0007275; F:GO:0005509; C:GO:0016020; C:GO:0016021,P:cell communication; P:Notch signaling pathway; P:multicellular organism development; F:calcium ion binding; C:membrane; C:integral component of membrane,XP_027054380.1,647,1,2.3999999999999996e-294,96.59,NA,NA,NA,NA,NA
208.204264567999,-0.498834285501629,0.132473888065672,-3.76552913774479,1.6619673954479e-4,0.0242387557329854,Pver_novel_374_5de57afd,Downregulated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
95.8339068720899,-2.21218929377719,0.577138019386338,-3.83303338104354,1.2657277011282e-4,0.0209102696678427,Pver_g8700,Downregulated,NA,652,NA,NA,NA,NA,NA,NA,NA,NA,A0A2B4RD39_STYPIPlatelet glycoprotein V OS=Stylophora pistillata OX=50429 GN=GP5 PE=4 SV=1,652,5,0,89.77,1,C:GO:0016021,C:integral component of membrane,NA,NA,651,SM01411 (SMART); G3DSA:2.10.50.10 (GENE3D); PTHR11319 (PANTHER); SSF57586 (SUPERFAMILY),NA,NA,RMX51652.1,652,1,0,88.31,1,C:GO:0016021,C:integral component of membrane,NA,NA
4499.65519328183,1.90996963420717,0.50166808661278,3.80723766405617,1.4052768179602e-4,0.0215256940737864,Pver_g1821,Upregulated,NPTX2_MOUSENeuronal pentraxin-2 OS=Mus musculus OX=10090 GN=Nptx2 PE=2 SV=1,241,5,3.72e-22,55.5,9,P:GO:0008306; P:GO:0048856; P:GO:0098962; P:GO:0099645; F:GO:0005515; C:GO:0005737; C:GO:0043231; C:GO:0098892; C:GO:0098978,P:associative learning; P:anatomical structure development; P:regulation of postsynaptic neurotransmitter receptor activity; P:neurotransmitter receptor localization to postsynaptic specialization membrane; F:protein binding; C:cytoplasm; C:intracellular membrane-bounded organelle; C:extrinsic component of postsynaptic specialization membrane; C:glutamatergic synapse,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,240,IPR001759 (PRINTS); IPR001759 (SMART); G3DSA:2.60.120.200 (GENE3D); IPR001759 (PFAM); PTHR19277 (PANTHER); IPR001759 (PROSITE_PROFILES); IPR013320 (SUPERFAMILY),NA,NA,RMX40008.1,241,1,1.3000000000000001e-123,89.71,2,F:GO:0046872; C:GO:0005576,F:metal ion binding; C:extracellular region,NA,NA
983.645157642827,0.712254345904591,0.195446993206985,3.64423281329423,2.6819057720293e-4,0.032591846256442,Pver_g7702,Upregulated,HRH2_CANLFHistamine H2 receptor OS=Canis lupus familiaris OX=9615 GN=HRH2 PE=1 SV=1,365,5,1.12e-32,48.17,3,P:GO:0007165; F:GO:0038023; C:GO:0016020,P:signal transduction; F:signaling receptor activity; C:membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,364,IPR000276 (PRINTS); IPR000276 (SMART); IPR000276 (PFAM); G3DSA:1.20.1070.10 (GENE3D); PTHR24247 (PANTHER); PTHR24247:SF202 (PANTHER); IPR000276 (PROSITE_PATTERNS); IPR017452 (PROSITE_PROFILES); cd14967 (CDD); SSF81321 (SUPERFAMILY),P:GO:0007186; F:GO:0004930; C:GO:0016021,P:G protein-coupled receptor signaling pathway; F:G protein-coupled receptor activity; C:integral component of membrane,XP_027050223.1,365,1,2.6e-200,97.8,NA,NA,NA,NA,NA
646.569287186391,-0.328683721535483,0.08795817173056,-3.73681847938281,1.8636335963964e-4,0.0261581293064129,Pver_g13183,Downregulated,TV23A_HUMANGolgi apparatus membrane protein TVP23 homolog A OS=Homo sapiens OX=9606 GN=TVP23A PE=1 SV=3,324,5,1.43e-44,72.49,4,P:GO:0009306; P:GO:0016192; F:GO:0005515; C:GO:0030173,P:protein secretion; P:vesicle-mediated transport; F:protein binding; C:integral component of Golgi membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,323,IPR038577 (G3DSA:3.40.50.GENE3D); IPR001503 (PFAM); IPR008564 (PFAM); IPR001503 (PANTHER); PTHR11929:SF187 (PANTHER); SSF53756 (SUPERFAMILY),P:GO:0006486; F:GO:0008417; C:GO:0016020; C:GO:0016021,P:protein glycosylation; F:fucosyltransferase activity; C:membrane; C:integral component of membrane,XP_027048690.1,324,1,7.7e-124,98.14,NA,NA,NA,NA,NA
413.794304873566,1.06050384061734,0.284720450707362,3.72471959068138,1.9553244490419e-4,0.0266763407155144,Pver_g8933,Upregulated,ACHA4_CHICKNeuronal acetylcholine receptor subunit alpha-4 OS=Gallus gallus OX=9031 GN=CHRNA4 PE=1 SV=1,551,5,5.4700000000000005e-80,56.83,43,P:GO:0001505; P:GO:0001933; P:GO:0001988; P:GO:0006811; P:GO:0006897; P:GO:0007271; P:GO:0007613; P:GO:0008306; P:GO:0009409; P:GO:0014061; P:GO:0030317; P:GO:0032094; P:GO:0032225; P:GO:0032691; P:GO:0032715; P:GO:0032720; P:GO:0033138; P:GO:0035095; P:GO:0042110; P:GO:0042113; P:GO:0048149; P:GO:0050728; P:GO:0050893; P:GO:0060112; P:GO:0070374; P:GO:0097061; P:GO:0140059; P:GO:1900273; P:GO:1901214; P:GO:1902004; P:GO:1904645; P:GO:1905906; P:GO:1905920; P:GO:2000463; F:GO:0019899; F:GO:0022848; C:GO:0009897; C:GO:0016324; C:GO:0030425; C:GO:0030673; C:GO:0098981; C:GO:0099056; C:GO:0099060,"P:regulation of neurotransmitter levels; P:negative regulation of protein phosphorylation; P:positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure; P:ion transport; P:endocytosis; P:synaptic transmission, cholinergic; P:memory; P:associative learning; P:response to cold; P:regulation of norepinephrine secretion; P:flagellated sperm motility; P:response to food; P:regulation of synaptic transmission, dopaminergic; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-6 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of peptidyl-serine phosphorylation; P:behavioral response to nicotine; P:T cell activation; P:B cell activation; P:behavioral response to ethanol; P:negative regulation of inflammatory response; P:sensory processing; P:generation of ovulation cycle rhythm; P:positive regulation of ERK1 and ERK2 cascade; P:dendritic spine organization; P:dendrite arborization; P:positive regulation of long-term synaptic potentiation; P:regulation of neuron death; P:positive regulation of amyloid-beta formation; P:response to amyloid-beta; P:regulation of amyloid fibril formation; P:positive regulation of CoA-transferase activity; P:positive regulation of excitatory postsynaptic potential; F:enzyme binding; F:acetylcholine-gated cation-selective channel activity; C:external side of plasma membrane; C:apical plasma membrane; C:dendrite; C:axolemma; C:cholinergic synapse; C:integral component of presynaptic membrane; C:integral component of postsynaptic specialization membrane",EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,550,IPR006201 (PRINTS); IPR006202 (PFAM); IPR006029 (PFAM); IPR036734 (G3DSA:2.70.170.GENE3D); G3DSA:1.20.58.390 (GENE3D); PIRSR608127-51 (PIRSR); mobidb-lite (MOBIDB_LITE); PTHR18945:SF401 (PANTHER); IPR006201 (PANTHER); IPR018000 (PROSITE_PATTERNS); cd19051 (CDD); cd18997 (CDD); IPR036734 (SUPERFAMILY); IPR036719 (SUPERFAMILY),P:GO:0006811; P:GO:0034220; F:GO:0004888; F:GO:0005216; F:GO:0005230; C:GO:0016021,P:ion transport; P:ion transmembrane transport; F:transmembrane signaling receptor activity; F:ion channel activity; F:extracellular ligand-gated ion channel activity; C:integral component of membrane,XP_027057563.1,551,1,0,99.64,NA,NA,NA,NA,NA
1792.44347212098,0.593655654892209,0.174302515612109,3.40589263905591,6.5948107626304e-4,0.0492447709267142,Pver_g3638,Upregulated,CP3AO_SHEEPCytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1,502,5,3.899999999999999e-108,58.72,11,P:GO:0002933; P:GO:0008210; P:GO:0009617; P:GO:0042573; P:GO:0071357; F:GO:0005488; F:GO:0008401; F:GO:0101020; F:GO:0101021; C:GO:0005783; C:GO:0016020,P:lipid hydroxylation; P:estrogen metabolic process; P:response to bacterium; P:retinoic acid metabolic process; P:cellular response to type I interferon; F:binding; F:retinoic acid 4-hydroxylase activity; F:estrogen 16-alpha-hydroxylase activity; F:estrogen 2-hydroxylase activity; C:endoplasmic reticulum; C:membrane,EC:1.14,"Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,501,IPR001128 (PRINTS); IPR002401 (PRINTS); IPR036396 (G3DSA:1.10.630.GENE3D); IPR001128 (PFAM); PIRSR000209-1 (PIRSR); PTHR24291 (PANTHER); PTHR24291:SF50 (PANTHER); IPR017972 (PROSITE_PATTERNS); IPR036396 (SUPERFAMILY),F:GO:0004497; F:GO:0005506; F:GO:0016705; F:GO:0020037,"F:monooxygenase activity; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:heme binding",RMX43461.1,502,1,2.7e-293,99,5,F:GO:0004497; F:GO:0005506; F:GO:0016705; F:GO:0020037; C:GO:0016021,"F:monooxygenase activity; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:heme binding; C:integral component of membrane",EC:1.14,"Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2)"
1373.28030027222,0.645499985827023,0.163972754857191,3.93662951134296,8.26340324522914e-5,0.0179015744321941,Pver_g5351,Upregulated,NA,1057,NA,NA,NA,NA,NA,NA,NA,NA,A7SBP3_NEMVEPredicted protein OS=Nematostella vectensis OX=45351 GN=v1g244159 PE=4 SV=1,1057,5,0,68.61,NA,NA,NA,NA,NA,1056,mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,XP_027054591.1,1057,1,0,98.86,NA,NA,NA,NA,NA
229.604030970627,2.23456790925893,0.631136540766234,3.54054592774179,3.9930013152062e-4,0.0396496534852503,Pver_g15108,Upregulated,KCD21_MOUSEBTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1,312,5,1.6499999999999998e-23,60.24,8,P:GO:0006511; P:GO:0035024; P:GO:0050806; P:GO:0072359; F:GO:0019899; F:GO:0042802; C:GO:0005634; C:GO:0032991,P:ubiquitin-dependent protein catabolic process; P:negative regulation of Rho protein signal transduction; P:positive regulation of synaptic transmission; P:circulatory system development; F:enzyme binding; F:identical protein binding; C:nucleus; C:protein-containing complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,311,IPR000210 (SMART); IPR006571 (SMART); IPR006571 (PFAM); IPR011333 (G3DSA:3.30.710.GENE3D); IPR003131 (PFAM); PTHR14499 (PANTHER); IPR006571 (PROSITE_PROFILES); IPR011333 (SUPERFAMILY),P:GO:0051260; F:GO:0005515,P:protein homooligomerization; F:protein binding,XP_022784367.1,312,1,2.8e-139,85.46,NA,NA,NA,NA,NA
4906.67392545809,1.40235840915829,0.385011966813557,3.64237615979709,2.7013294466537e-4,0.032591846256442,Pver_g12659,Upregulated,NA,1145,NA,NA,NA,NA,NA,NA,NA,NA,A0A2B4RY57_STYPITumor necrosis factor receptor superfamily member 6 OS=Stylophora pistillata OX=50429 GN=FAS PE=4 SV=1,1145,5,0,75.71,3,P:GO:0006915; P:GO:0007165; C:GO:0016021,P:apoptotic process; P:signal transduction; C:integral component of membrane,NA,NA,1144,IPR001368 (SMART); IPR000488 (PFAM); G3DSA:2.10.50.10 (GENE3D); IPR001368 (PFAM); IPR011029 (G3DSA:1.10.533.GENE3D); G3DSA:2.10.50.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR46605:SF2 (PANTHER); PTHR46605 (PANTHER); PTHR46605:SF2 (PANTHER); PTHR46605 (PANTHER); IPR001368 (PROSITE_PATTERNS); IPR001368 (PROSITE_PATTERNS); IPR001368 (PROSITE_PATTERNS); IPR001368 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR001368 (PROSITE_PROFILES); cd00185 (CDD); cd00185 (CDD); cd00185 (CDD); cd01670 (CDD); IPR011029 (SUPERFAMILY),P:GO:0007165; F:GO:0005515,P:signal transduction; F:protein binding,RMX44554.1,1145,1,0,73.96,2,P:GO:0009987; C:GO:0016020,P:cellular process; C:membrane,NA,NA
363.547586607901,0.578971979224598,0.145140137228833,3.98905492497758,6.63370617233401e-5,0.0156756995981179,Pver_g26406,Upregulated,"SQOR_HUMANSulfide:quinone oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=SQOR PE=1 SV=1",362,5,1.36e-124,60.43,8,P:GO:0006750; P:GO:0070219; P:GO:0070221; P:GO:0070813; P:GO:0098849; F:GO:0070224; F:GO:0071949; C:GO:0005743,"P:glutathione biosynthetic process; P:cellular sulfide ion homeostasis; P:sulfide oxidation, using sulfide:quinone oxidoreductase; P:hydrogen sulfide metabolic process; P:cellular detoxification of cadmium ion; F:sulfide:quinone oxidoreductase activity; F:FAD binding; C:mitochondrial inner membrane",EC:1.8.5,Acting on a sulfur group of donors,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,362,IPR023753 (PFAM); IPR036188 (G3DSA:3.50.50.GENE3D); IPR036188 (G3DSA:3.50.50.GENE3D); IPR015904 (PANTHER); IPR036188 (SUPERFAMILY); IPR036188 (SUPERFAMILY),F:GO:0016491,F:oxidoreductase activity,XP_027042768.1,362,1,4e-206,98.9,NA,NA,NA,NA,NA
72.5190130197912,1.25430742003022,0.326720153124949,3.83908800247938,1.2349216539636e-4,0.0206873447574883,Pver_g20129,Upregulated,NLRC3_HUMANNLR family CARD domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NLRC3 PE=1 SV=2,499,5,1.47e-47,50.8,24,P:GO:0014067; P:GO:0031396; P:GO:0032088; P:GO:0032496; P:GO:0032687; P:GO:0032688; P:GO:0032691; P:GO:0032695; P:GO:0032715; P:GO:0032720; P:GO:0042110; P:GO:0043124; P:GO:0045824; P:GO:0048147; P:GO:0050680; P:GO:0050728; P:GO:1900016; P:GO:1900226; P:GO:1901223; F:GO:0036312; C:GO:0005829; C:GO:0034451; C:GO:0043231; C:GO:0048471,P:negative regulation of phosphatidylinositol 3-kinase signaling; P:regulation of protein ubiquitination; P:negative regulation of NF-kappaB transcription factor activity; P:response to lipopolysaccharide; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-6 production; P:negative regulation of tumor necrosis factor production; P:T cell activation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of innate immune response; P:negative regulation of fibroblast proliferation; P:negative regulation of epithelial cell proliferation; P:negative regulation of inflammatory response; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of NIK/NF-kappaB signaling; F:phosphatidylinositol 3-kinase regulatory subunit binding; C:cytosol; C:centriolar satellite; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,498,SM00368 (SMART); IPR032675 (G3DSA:3.80.10.GENE3D); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR24112:SF50 (PANTHER); PTHR24112 (PANTHER); PTHR24112:SF50 (PANTHER); PTHR24112 (PANTHER); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY); SSF52047 (SUPERFAMILY),F:GO:0005515,F:protein binding,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
1073.99565566257,0.488127933049965,0.13590884969692,3.59158313927681,3.2867528825651e-4,0.0356727341928641,Pver_g17502,Upregulated,SPAT6_HUMANSpermatogenesis-associated protein 6 OS=Homo sapiens OX=9606 GN=SPATA6 PE=1 SV=1,419,5,4.99e-18,50.31,4,P:GO:0009987; P:GO:0032502; F:GO:0005515; C:GO:0031514,P:cellular process; P:developmental process; F:protein binding; C:motile cilium,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,418,Coil (COILS); IPR032732 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR042769 (PANTHER); PTHR16435:SF6 (PANTHER); IPR042769 (PANTHER); PTHR16435:SF6 (PANTHER),P:GO:0007283; F:GO:0032027; C:GO:0097224,P:spermatogenesis; F:myosin light chain binding; C:sperm connecting piece,XP_027052379.1,419,1,1.6999999999999997e-232,99.28,NA,NA,NA,NA,NA
3607.61237780416,0.646413446301603,0.18633264211254,3.46913691005994,5.2213330136722e-4,0.0453325788478778,Pver_g10413,Upregulated,NA,244,NA,NA,NA,NA,NA,NA,NA,NA,A0A2B4RW45_STYPIUncharacterized protein OS=Stylophora pistillata OX=50429 GN=AWC38_SpisGene14137 PE=4 SV=1,244,1,8.79e-42,96.86,NA,NA,NA,NA,NA,243,PR00021 (PRINTS); mobidb-lite (MOBIDB_LITE),NA,NA,XP_022797403.1,244,1,7.999999999999999e-33,87.25,NA,NA,NA,NA,NA
72.7943057953285,1.31303998009094,0.322824163696999,4.06735346280755,4.75500907750793e-5,0.0121597958162901,Pver_g23334,Upregulated,GP2_RATPancreatic secretory granule membrane major glycoprotein GP2 OS=Rattus norvegicus OX=10116 GN=Gp2 PE=1 SV=1,153,5,3.3200000000000004e-26,57.14,19,P:GO:0002412; P:GO:0003014; P:GO:0006807; P:GO:0006873; P:GO:0006950; P:GO:0010033; P:GO:0043170; P:GO:0044237; P:GO:0044238; P:GO:0051716; P:GO:0055065; P:GO:0055081; P:GO:0072080; F:GO:0003823; C:GO:0005615; C:GO:0005768; C:GO:0016324; C:GO:0031362; C:GO:0042589,P:antigen transcytosis by M cells in mucosal-associated lymphoid tissue; P:renal system process; P:nitrogen compound metabolic process; P:cellular ion homeostasis; P:response to stress; P:response to organic substance; P:macromolecule metabolic process; P:cellular metabolic process; P:primary metabolic process; P:cellular response to stimulus; P:metal ion homeostasis; P:anion homeostasis; P:nephron tubule development; F:antigen binding; C:extracellular space; C:endosome; C:apical plasma membrane; C:anchored component of external side of plasma membrane; C:zymogen granule membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,152,PTHR36191 (PANTHER); PTHR36191:SF4 (PANTHER),NA,NA,XP_015760281.1,153,1,1.5e-45,63.71,NA,NA,NA,NA,NA
140.136143855626,-0.908196187951726,0.263671852906288,-3.44441842366281,5.7228930077517e-4,0.0465729774508469,Pver_g25550,Downregulated,ZMYM1_HUMANZinc finger MYM-type protein 1 OS=Homo sapiens OX=9606 GN=ZMYM1 PE=1 SV=1,234,1,5.35e-12,39.93,4,F:GO:0008270; F:GO:0046872; F:GO:0046983; C:GO:0005634,F:zinc ion binding; F:metal ion binding; F:protein dimerization activity; C:nucleus,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,234,IPR012337 (SUPERFAMILY),NA,NA,PFX22036.1,234,1,3.3000000000000003e-124,86.03,2,F:GO:0003677; F:GO:0046872,F:DNA binding; F:metal ion binding,NA,NA
3090.8466982873,-0.341457520631435,0.0920200963979058,-3.71068423091986,2.066998050835e-4,0.0275619425807063,Pver_g13481,Downregulated,NKD2L_DANREProtein naked cuticle homolog 2-like OS=Danio rerio OX=7955 GN=nkd2l PE=2 SV=1,460,5,7.56e-14,48.67,9,P:GO:0030111; P:GO:0032502; P:GO:0048519; P:GO:0048522; P:GO:0051179; P:GO:0051247; F:GO:0005515; C:GO:0005737; C:GO:0005886,P:regulation of Wnt signaling pathway; P:developmental process; P:negative regulation of biological process; P:positive regulation of cellular process; P:localization; P:positive regulation of protein metabolic process; F:protein binding; C:cytoplasm; C:plasma membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,459,mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR22611:SF9 (PANTHER); IPR040140 (PANTHER),P:GO:0030178,P:negative regulation of Wnt signaling pathway,XP_027051754.1,460,1,5.899999999999999e-271,99.56,NA,NA,NA,NA,NA
943.377221364005,-0.35938596141707,0.101812655896485,-3.52987512458631,4.1575585054775e-4,0.0404235948855497,Pver_g9166,Downregulated,MAAI_MOUSEMaleylacetoacetate isomerase OS=Mus musculus OX=10090 GN=Gstz1 PE=1 SV=1,460,5,1.06e-82,75.83,9,P:GO:0006559; P:GO:0006572; P:GO:0006749; F:GO:0004364; F:GO:0004602; F:GO:0016034; F:GO:0042803; C:GO:0005759; C:GO:0005829,P:L-phenylalanine catabolic process; P:tyrosine catabolic process; P:glutathione metabolic process; F:glutathione transferase activity; F:glutathione peroxidase activity; F:maleylacetoacetate isomerase activity; F:protein homodimerization activity; C:mitochondrial matrix; C:cytosol,EC:2.5.1.18; EC:5.2.1.2; EC:1.11.1.9,Glutathione transferase; Maleylacetoacetate isomerase; Glutathione peroxidase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,459,G3DSA:3.40.50.150 (GENE3D); IPR004046 (PFAM); IPR005955 (TIGRFAM); G3DSA:3.40.30.10 (GENE3D); IPR004045 (PFAM); G3DSA:1.20.1050.10 (GENE3D); SFLDG00358 (SFLD); IPR040079 (SFLD); PTHR42673 (PANTHER); PTHR42673:SF4 (PANTHER); IPR010987 (PROSITE_PROFILES); IPR004045 (PROSITE_PROFILES); IPR034330 (CDD); IPR036282 (SUPERFAMILY); IPR036249 (SUPERFAMILY); IPR029063 (SUPERFAMILY),P:GO:0006749; P:GO:0009072; F:GO:0003824; F:GO:0005515; C:GO:0005737,P:glutathione metabolic process; P:aromatic amino acid family metabolic process; F:catalytic activity; F:protein binding; C:cytoplasm,XP_027050169.1,460,1,3.8999999999999995e-129,96.71,NA,NA,NA,NA,NA
190.274367423311,1.27206465620761,0.366941655307902,3.46666735108124,5.2695358956446e-4,0.0453325788478778,Pver_g18021,Upregulated,NA,1554,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6UC50_POCDAF5/8 type C domain-containing protein OS=Pocillopora damicornis OX=46731 GN=pdam_00022281 PE=4 SV=1,1554,5,0,74.61,2,F:GO:0008237; F:GO:0046872,F:metallopeptidase activity; F:metal ion binding,EC:3.4,Acting on peptide bonds (peptidases),1553,mobidb-lite (MOBIDB_LITE),NA,NA,RMX51250.1,1554,1,0,70.17,NA,NA,NA,NA,NA
171.958694283781,-0.958257244696994,0.248340530015495,-3.85864218231798,1.1401872809928e-4,0.0197083482977545,Pver_g8017,Downregulated,NA,130,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6U636_POCDAUncharacterized protein OS=Pocillopora damicornis OX=46731 GN=pdam_00003924 PE=4 SV=1,130,5,1.57e-30,61.9,2,C:GO:0016020; C:GO:0016021,C:membrane; C:integral component of membrane,NA,NA,129,G3DSA:2.10.60.10 (GENE3D); SSF57302 (SUPERFAMILY),NA,NA,XP_027040018.1,130,1,6.6e-26,50.38,NA,NA,NA,NA,NA
4112.97632069796,0.641310349015866,0.176678550427651,3.62981441416387,2.8362506645989e-4,0.0333000801300207,Pver_g17503,Upregulated,UBP54_RATInactive ubiquitin carboxyl-terminal hydrolase 54 OS=Rattus norvegicus OX=10116 GN=Usp54 PE=1 SV=2,1070,5,3.46e-120,70.43,6,P:GO:0001508; P:GO:0007605; P:GO:0010996; P:GO:0051402; F:GO:0005515; C:GO:0005911,P:action potential; P:sensory perception of sound; P:response to auditory stimulus; P:neuron apoptotic process; F:protein binding; C:cell-cell junction,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1069,Coil (COILS); IPR001394 (PFAM); G3DSA:3.90.70.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR040142 (PTHR22975:PANTHER); PTHR22975 (PANTHER); IPR028889 (PROSITE_PROFILES); IPR038765 (SUPERFAMILY),P:GO:0016579; F:GO:0004843,P:protein deubiquitination; F:thiol-dependent deubiquitinase,RMX39038.1,1070,1,0,88.49,2,P:GO:0016579; F:GO:0004843,P:protein deubiquitination; F:thiol-dependent deubiquitinase,EC:3.4.19.12,Ubiquitinyl hydrolase 1
294.0064197483,-0.439953052621021,0.12089928369685,-3.63900462573612,2.7369388380846e-4,0.032591846256442,Pver_g708,Downregulated,GLYG_MOUSEGlycogenin-1 OS=Mus musculus OX=10090 GN=Gyg1 PE=1 SV=3,386,5,2.3599999999999998e-23,49.22,4,F:GO:0005488; F:GO:0016757; C:GO:0005737; C:GO:0043229,F:binding; F:glycosyltransferase activity; C:cytoplasm; C:intracellular organelle,EC:2.4,Glycosyltransferases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,385,IPR029044 (G3DSA:3.90.550.GENE3D); IPR002495 (PFAM); PTHR11183 (PANTHER); PTHR11183:SF133 (PANTHER); IPR029044 (SUPERFAMILY),F:GO:0016757,F:glycosyltransferase activity,XP_027057934.1,386,1,5.599999999999998e-230,99.22,NA,NA,NA,NA,NA
328.524507696724,0.667755664062656,0.182344833726045,3.66204871516071,2.5020626398326e-4,0.0315598009191867,Pver_g16616,Upregulated,C1QB_RATComplement C1q subcomponent subunit B OS=Rattus norvegicus OX=10116 GN=C1qb PE=1 SV=2,199,2,2.33e-6,56.9,41,P:GO:0002376; P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0006955; P:GO:0006958; P:GO:0007420; P:GO:0007568; P:GO:0010033; P:GO:0010629; P:GO:0010744; P:GO:0010886; P:GO:0030301; P:GO:0031638; P:GO:0034381; P:GO:0042953; P:GO:0045087; P:GO:0048839; P:GO:0051384; P:GO:0070207; P:GO:0097242; P:GO:0098883; F:GO:0001540; F:GO:0003674; F:GO:0004252; F:GO:0005044; F:GO:0019899; F:GO:0030169; F:GO:0030544; F:GO:0038024; F:GO:0042802; F:GO:0051879; C:GO:0005576; C:GO:0005581; C:GO:0005602; C:GO:0005886; C:GO:0016020; C:GO:0016021; C:GO:0034362; C:GO:0045202; C:GO:0098794,"P:immune system process; P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:immune response; P:complement activation, classical pathway; P:brain development; P:aging; P:response to organic substance; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; P:cholesterol transport; P:zymogen activation; P:plasma lipoprotein particle clearance; P:lipoprotein transport; P:innate immune response; P:inner ear development; P:response to glucocorticoid; P:protein homotrimerization; P:amyloid-beta clearance; P:synapse pruning; F:amyloid-beta binding; F:molecular_function; F:serine-type endopeptidase activity; F:scavenger receptor activity; F:enzyme binding; F:low-density lipoprotein particle binding; F:Hsp70 protein binding; F:cargo receptor activity; F:identical protein binding; F:Hsp90 protein binding; C:extracellular region; C:collagen trimer; C:complement component C1 complex; C:plasma membrane; C:membrane; C:integral component of membrane; C:low-density lipoprotein particle; C:synapse; C:postsynapse",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,198,IPR008160 (PFAM),NA,NA,RMX47340.1,199,1,2.7e-42,95.52,NA,NA,NA,NA,NA
443.630952665452,0.768805424450326,0.202633946058188,3.79406037046507,1.482036150903e-4,0.0223118152137571,Pver_g16615,Upregulated,CO6A1_XENLACollagen alpha-1(VI) chain OS=Xenopus laevis OX=8355 GN=col6a1 PE=1 SV=1,168,2,3.75e-6,57.46,28,P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0007155; P:GO:0010629; P:GO:0010744; P:GO:0010886; P:GO:0030301; P:GO:0031638; P:GO:0034381; P:GO:0042953; P:GO:0070207; P:GO:0097242; F:GO:0001540; F:GO:0004252; F:GO:0005044; F:GO:0019899; F:GO:0030169; F:GO:0030544; F:GO:0038024; F:GO:0042802; F:GO:0051879; C:GO:0005576; C:GO:0005581; C:GO:0005886; C:GO:0016020; C:GO:0016021; C:GO:0034362,"P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:cell adhesion; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; P:cholesterol transport; P:zymogen activation; P:plasma lipoprotein particle clearance; P:lipoprotein transport; P:protein homotrimerization; P:amyloid-beta clearance; F:amyloid-beta binding; F:serine-type endopeptidase activity; F:scavenger receptor activity; F:enzyme binding; F:low-density lipoprotein particle binding; F:Hsp70 protein binding; F:cargo receptor activity; F:identical protein binding; F:Hsp90 protein binding; C:extracellular region; C:collagen trimer; C:plasma membrane; C:membrane; C:integral component of membrane; C:low-density lipoprotein particle",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,167,PR01217 (PRINTS); IPR008160 (PFAM),NA,NA,XP_022804287.1,168,1,7.199999999999999e-33,95.24,NA,NA,NA,NA,NA
549.218888634443,-0.331265339820818,0.0902546372645308,-3.67034149004332,2.4222664272405e-4,0.0312403050441847,Pver_g9616,Downregulated,F204A_PONABProtein FAM204A OS=Pongo abelii OX=9601 GN=FAM204A PE=2 SV=1,221,4,3.66e-11,52.28,4,P:GO:0008150; F:GO:0003674; F:GO:0005515; C:GO:0005575,P:biological_process; F:molecular_function; F:protein binding; C:cellular_component,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,220,Coil (COILS); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR037690 (PANTHER),NA,NA,XP_027042213.1,221,1,5.6e-110,97.27,NA,NA,NA,NA,NA
2137.67864312666,0.818172706135514,0.232818049923353,3.51421509803414,4.410555106652e-4,0.0413749963472268,Pver_g542,Upregulated,HXK2_MOUSEHexokinase-2 OS=Mus musculus OX=10090 GN=Hk2 PE=1 SV=1,467,5,2.1199999999999996e-133,65.11,22,P:GO:0001666; P:GO:0002931; P:GO:0006002; P:GO:0006007; P:GO:0007595; P:GO:0008637; P:GO:0046835; P:GO:0051156; P:GO:0070585; P:GO:1901299; P:GO:2000378; F:GO:0004340; F:GO:0005524; F:GO:0005536; F:GO:0008865; F:GO:0019899; F:GO:0042562; C:GO:0005741; C:GO:0005829; C:GO:0005886; C:GO:0016529; C:GO:0032991,P:response to hypoxia; P:response to ischemia; P:fructose 6-phosphate metabolic process; P:glucose catabolic process; P:lactation; P:apoptotic mitochondrial changes; P:carbohydrate phosphorylation; P:glucose 6-phosphate metabolic process; P:protein localization to mitochondrion; P:negative regulation of hydrogen peroxide-mediated programmed cell death; P:negative regulation of reactive oxygen species metabolic process; F:glucokinase activity; F:ATP binding; F:glucose binding; F:fructokinase activity; F:enzyme binding; F:hormone binding; C:mitochondrial outer membrane; C:cytosol; C:plasma membrane; C:sarcoplasmic reticulum; C:protein-containing complex,EC:2.7.1.4; EC:2.7.1.2; EC:2.7.1.1,Fructokinase; Glucokinase; Hexokinase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,466,PR00475 (PRINTS); IPR022672 (PFAM); G3DSA:3.40.367.20 (GENE3D); G3DSA:3.30.420.40 (GENE3D); IPR022673 (PFAM); PTHR19443:SF4 (PANTHER); IPR001312 (PANTHER); IPR019807 (PROSITE_PATTERNS); IPR001312 (PROSITE_PROFILES); cd00012 (CDD); IPR043129 (SUPERFAMILY); IPR043129 (SUPERFAMILY),P:GO:0001678; P:GO:0005975; P:GO:0006096; F:GO:0004396; F:GO:0005524; F:GO:0005536; F:GO:0016773,"P:cellular glucose homeostasis; P:carbohydrate metabolic process; P:glycolytic process; F:hexokinase activity; F:ATP binding; F:glucose binding; F:phosphotransferase activity, alcohol group as acceptor",XP_027041869.1,467,1,1e-257,99.14,NA,NA,NA,NA,NA
598.988522686917,0.411033857225789,0.119839517401034,3.42986909610371,6.0387250500303e-4,0.0475657887063149,Pver_g14162,Upregulated,NA,1840,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TN90_POCDAFibronectin type-III domain-containing protein OS=Pocillopora damicornis OX=46731 GN=pdam_00005120 PE=4 SV=1,1840,3,0,90.37,NA,NA,NA,NA,NA,1839,Coil (COILS); Coil (COILS); IPR003961 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),F:GO:0005515,F:protein binding,PFX31003.1,1840,1,0,70.15,NA,NA,NA,NA,NA
3334.15391686256,-0.482554817450006,0.0965097365784339,-5.00006356413409,5.73114169712864e-7,6.6868095751248e-4,Pver_g22963,Downregulated,S6A19_MOUSESodium-dependent neutral amino acid transporter B(0)AT1 OS=Mus musculus OX=10090 GN=Slc6a19 PE=1 SV=1,601,5,0,62.2,8,P:GO:0003333; P:GO:0007584; P:GO:0015804; F:GO:0005515; F:GO:0015175; C:GO:0016021; C:GO:0016324; C:GO:0031526,P:amino acid transmembrane transport; P:response to nutrient; P:neutral amino acid transport; F:protein binding; F:neutral amino acid transmembrane transporter activity; C:integral component of membrane; C:apical plasma membrane; C:brush border membrane,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,600,IPR000175 (PRINTS); IPR000175 (PFAM); mobidb-lite (MOBIDB_LITE); IPR000175 (PANTHER); IPR000175 (PROSITE_PATTERNS); IPR000175 (PROSITE_PROFILES); IPR037272 (SUPERFAMILY),C:GO:0016021,C:integral component of membrane,XP_027042860.1,601,1,0,99,NA,NA,NA,NA,NA
235.64020174646,0.656222558729662,0.180349214342023,3.6386216658819,2.7410112825484e-4,0.032591846256442,Pver_g7210,Upregulated,RIC1_DANREGuanine nucleotide exchange factor subunit RIC1 OS=Danio rerio OX=7955 GN=ric1 PE=3 SV=1,199,1,5.26e-7,63.51,3,P:GO:0046907; C:GO:0005794; C:GO:0016020,P:intracellular transport; C:Golgi apparatus; C:membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,198,Coil (COILS); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,XP_027053390.1,199,1,3.2000000000000003e-27,86.21,NA,NA,NA,NA,NA
191.731781221506,1.19952071796348,0.310165704173452,3.86735445545158,1.1002245305087e-4,0.01956094431956,Pver_g8096,Upregulated,PP16A_MOUSEProtein phosphatase 1 regulatory subunit 16A OS=Mus musculus OX=10090 GN=Ppp1r16a PE=1 SV=1,215,5,5.73e-12,51.78,10,P:GO:0007049; P:GO:0035507; P:GO:0045893; F:GO:0019208; F:GO:0019899; C:GO:0005856; C:GO:0016020; C:GO:0031981; C:GO:0043292; C:GO:0071944,"P:cell cycle; P:regulation of myosin-light-chain-phosphatase activity; P:positive regulation of transcription, DNA-templated; F:phosphatase regulator activity; F:enzyme binding; C:cytoskeleton; C:membrane; C:nuclear lumen; C:contractile fiber; C:cell periphery",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,214,IPR002110 (SMART); IPR036770 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR46899 (PANTHER); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY),F:GO:0005515,F:protein binding,XP_027051247.1,215,1,4.3999999999999994e-83,99.53,NA,NA,NA,NA,NA
1163.20841308981,0.441000390533179,0.125394524449918,3.51690309020879,4.3661315857881e-4,0.0413749963472268,Pver_g25793,Upregulated,NA,440,NA,NA,NA,NA,NA,NA,NA,NA,A7SQZ4_NEMVEPredicted protein OS=Nematostella vectensis OX=45351 GN=v1g216044 PE=4 SV=1,440,5,0,68.25,NA,NA,NA,NA,NA,439,Coil (COILS); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,RMX48795.1,440,1,2.8999999999999997e-251,99.32,NA,NA,NA,NA,NA
2861.44403367327,0.462280670461337,0.101949369112042,4.53441423412136,5.77635672619611e-6,0.00353333737975635,Pver_g11293,Upregulated,LWA_ANTELLWamide neuropeptides OS=Anthopleura elegantissima OX=6110 PE=1 SV=1,245,2,8.94e-9,43.96,2,P:GO:0007218; C:GO:0005576,P:neuropeptide signaling pathway; C:extracellular region,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,244,PTHR34716 (PANTHER),NA,NA,XP_027059472.1,245,1,6.999999999999999e-45,100,NA,NA,NA,NA,NA
408.229547080567,1.38330632808559,0.327144585004029,4.22842495793887,2.35332981286122e-5,0.00770736156956022,Pver_g2049,Upregulated,CHAC1_DANREGlutathione-specific gamma-glutamylcyclotransferase 1 OS=Danio rerio OX=7955 GN=chac1 PE=3 SV=1,217,5,8.29e-59,65.19,10,P:GO:0006750; P:GO:0006751; P:GO:0010955; P:GO:0022008; P:GO:0045746; P:GO:0070059; F:GO:0003839; F:GO:0005112; C:GO:0005802; C:GO:0005829,P:glutathione biosynthetic process; P:glutathione catabolic process; P:negative regulation of protein processing; P:neurogenesis; P:negative regulation of Notch signaling pathway; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; F:gamma-glutamylcyclotransferase activity; F:Notch binding; C:trans-Golgi network; C:cytosol,EC:4.3.2.9,Gamma-glutamylcyclotransferase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,216,IPR006840 (PFAM); G3DSA:3.10.490.10 (GENE3D); PTHR12192:SF20 (PANTHER); IPR006840 (PANTHER); IPR013024 (CDD); IPR036568 (SUPERFAMILY),P:GO:0006751; F:GO:0003839,P:glutathione catabolic process; F:gamma-glutamylcyclotransferase activity,XP_027055425.1,217,1,9.1e-121,98.61,NA,NA,NA,NA,NA
118.747754096763,1.0083340018095,0.270171308473124,3.73220238487985,1.8981289774277e-4,0.0264434863810612,Pver_g15488,Upregulated,NA,579,NA,NA,NA,NA,NA,NA,NA,NA,A0A2B4RZB5_STYPIUncharacterized protein OS=Stylophora pistillata OX=50429 GN=AWC38_SpisGene13928 PE=4 SV=1,579,5,0,82.25,NA,NA,NA,NA,NA,578,mobidb-lite (MOBIDB_LITE); PTHR33995 (PANTHER); PTHR33995:SF7 (PANTHER); PTHR33995 (PANTHER); PTHR33995:SF7 (PANTHER); IPR029034 (SUPERFAMILY),NA,NA,PFX21582.1,579,1,2.4999999999999997e-218,66.5,NA,NA,NA,NA,NA
402.061319815795,1.36966241583401,0.352220737149339,3.88864786020047,1.0080425086415e-4,0.0186163505621773,Pver_g22846,Upregulated,PUB4_ARATHU-box domain-containing protein 4 OS=Arabidopsis thaliana OX=3702 GN=PUB4 PE=1 SV=3,736,4,5.76e-8,45.17,7,P:GO:0007399; P:GO:0007472; P:GO:0030154; P:GO:0050794; F:GO:0005515; C:GO:0016020; C:GO:0043231,P:nervous system development; P:wing disc morphogenesis; P:cell differentiation; P:regulation of cellular process; F:protein binding; C:membrane; C:intracellular membrane-bounded organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,735,IPR000225 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR035897 (G3DSA:3.40.50.GENE3D); IPR000225 (PFAM); IPR013761 (G3DSA:1.10.150.GENE3D); IPR000157 (PFAM); mobidb-lite (MOBIDB_LITE); PTHR46270 (PANTHER); IPR000225 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY); IPR035897 (SUPERFAMILY); IPR016024 (SUPERFAMILY),P:GO:0007165; F:GO:0003953; F:GO:0005515,P:signal transduction; F:NAD+ nucleosidase activity; F:protein binding,XP_022804009.1,736,1,0,84.35,NA,NA,NA,NA,NA
904.668404660846,1.34641385776664,0.334594527377063,4.0240163768409,5.72139359550526e-5,0.0140535494264332,Pver_g15307,Upregulated,MOV10_CHICKPutative helicase MOV-10 OS=Gallus gallus OX=9031 GN=MOV10 PE=2 SV=1,981,5,0,56.22,6,P:GO:0035194; P:GO:0048523; F:GO:0004386; F:GO:0097159; F:GO:1901363; C:GO:0036464,P:post-transcriptional gene silencing by RNA; P:negative regulation of cellular process; F:helicase activity; F:organic cyclic compound binding; F:heterocyclic compound binding; C:cytoplasmic ribonucleoprotein granule,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,980,IPR027417 (G3DSA:3.40.50.GENE3D); IPR041677 (PFAM); IPR027417 (G3DSA:3.40.50.GENE3D); IPR041679 (PFAM); IPR026122 (PTHR10887:PANTHER); IPR045055 (PANTHER); IPR013087 (PROSITE_PATTERNS); cd18038 (CDD); IPR041679 (CDD); IPR027417 (SUPERFAMILY),P:GO:0035194; F:GO:0003723; F:GO:0004386; F:GO:0032574,P:post-transcriptional gene silencing by RNA; F:RNA binding; F:helicase activity; F:5'-3' RNA helicase activity,XP_022803152.1,981,1,0,85.06,NA,NA,NA,NA,NA
2905.50432957213,-0.22309474073516,0.0616555502608702,-3.6184048279713,2.9642446736426e-4,0.033580467845395,Pver_g5639,Downregulated,PAR14_HUMANProtein mono-ADP-ribosyltransferase PARP14 OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=3,863,5,8.399999999999999e-70,50.82,15,P:GO:0000122; P:GO:0002376; P:GO:0009653; P:GO:0009966; P:GO:0048513; P:GO:0048518; P:GO:0051246; P:GO:0070212; P:GO:0140289; F:GO:0003714; F:GO:0003950; F:GO:0005515; F:GO:0070403; F:GO:1990404; C:GO:0005622,P:negative regulation of transcription by RNA polymerase II; P:immune system process; P:anatomical structure morphogenesis; P:regulation of signal transduction; P:animal organ development; P:positive regulation of biological process; P:regulation of protein metabolic process; P:protein poly-ADP-ribosylation; P:protein mono-ADP-ribosylation; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; F:protein binding; F:NAD+ binding; F:protein ADP-ribosylase activity; C:intracellular anatomical structure,EC:2.4.2.30,NAD(+) ADP-ribosyltransferase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,862,Coil (COILS); IPR002589 (SMART); IPR037197 (G3DSA:3.30.720.GENE3D); G3DSA:3.90.228.10 (GENE3D); IPR012317 (PFAM); IPR043472 (G3DSA:3.40.220.GENE3D); IPR002589 (PFAM); PTHR14453 (PANTHER); IPR034401 (PTHR14453:PANTHER); IPR012317 (PROSITE_PROFILES); IPR004170 (PROSITE_PROFILES); IPR002589 (PROSITE_PROFILES); cd01439 (CDD); SSF56399 (SUPERFAMILY); IPR037197 (SUPERFAMILY); IPR043472 (SUPERFAMILY),F:GO:0003950,F:NAD+ ADP-ribosyltransferase activity,XP_027052351.1,863,1,0,99.07,NA,NA,NA,NA,NA
2637.43759446333,0.252055561414671,0.0710049352621488,3.54983157838377,3.8547768118521e-4,0.0386886954428253,Pver_g17677,Upregulated,GCN1_MOUSEeIF-2-alpha kinase activator GCN1 OS=Mus musculus OX=10090 GN=Gcn1 PE=1 SV=1,2713,5,0,61.56,14,P:GO:0006417; P:GO:0009682; P:GO:0032270; P:GO:0036003; P:GO:0042327; P:GO:0062197; P:GO:1901701; P:GO:1990253; F:GO:0005515; F:GO:0008135; C:GO:0005634; C:GO:0005829; C:GO:0005840; C:GO:0005844,"P:regulation of translation; P:induced systemic resistance; P:positive regulation of cellular protein metabolic process; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; P:positive regulation of phosphorylation; P:cellular response to chemical stress; P:cellular response to oxygen-containing compound; P:cellular response to leucine starvation; F:protein binding; F:translation factor activity, RNA binding; C:nucleus; C:cytosol; C:ribosome; C:polysome",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2712,Coil (COILS); IPR034085 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); IPR011989 (G3DSA:1.25.10.GENE3D); PTHR23346 (PANTHER); IPR033173 (PTHR23346:PANTHER); IPR021133 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR021133 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR016024 (SUPERFAMILY),P:GO:0006417; P:GO:0033674; F:GO:0019887; F:GO:0019901; F:GO:0043022,P:regulation of translation; P:positive regulation of kinase activity; F:protein kinase regulator activity; F:protein kinase binding; F:ribosome binding,XP_027042965.1,2713,1,0,97.89,NA,NA,NA,NA,NA
402.94838542565,-0.3696307350423,0.102383124937231,-3.61027010329009,3.0587831131822e-4,0.033601766527112,Pver_g5006,Downregulated,SBDS_XENLARibosome maturation protein SBDS OS=Xenopus laevis OX=8355 GN=sbds PE=2 SV=1,252,5,2.3799999999999997e-133,87.97,15,P:GO:0001833; P:GO:0002244; P:GO:0006364; P:GO:0007052; P:GO:0030282; P:GO:0030595; P:GO:0042256; P:GO:0048539; F:GO:0008017; F:GO:0019843; F:GO:0043022; C:GO:0000922; C:GO:0005654; C:GO:0005730; C:GO:0005829,P:inner cell mass cell proliferation; P:hematopoietic progenitor cell differentiation; P:rRNA processing; P:mitotic spindle organization; P:bone mineralization; P:leukocyte chemotaxis; P:mature ribosome assembly; P:bone marrow development; F:microtubule binding; F:rRNA binding; F:ribosome binding; C:spindle pole; C:nucleoplasm; C:nucleolus; C:cytosol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,251,Coil (COILS); IPR019783 (PFAM); G3DSA:3.30.70.240 (GENE3D); IPR037188 (G3DSA:1.10.10.GENE3D); IPR036786 (G3DSA:3.30.1250.GENE3D); IPR018978 (PFAM); IPR002140 (TIGRFAM); IPR039100 (PANTHER); PTHR10927:SF1 (PANTHER); IPR018023 (PROSITE_PATTERNS); IPR036786 (SUPERFAMILY); IPR037188 (SUPERFAMILY),P:GO:0042254; P:GO:0042256,P:ribosome biogenesis; P:mature ribosome assembly,XP_027042175.1,252,1,2.5999999999999997e-135,100,NA,NA,NA,NA,NA
224.953492421512,2.407879161063,0.589135204464738,4.08714186966759,4.36720083357762e-5,0.0116467007373181,Pver_g20449,Upregulated,MICA_EMENIMicroperfuranone synthase OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=micA PE=3 SV=1,456,5,1.21e-10,52.21,3,P:GO:0044249; P:GO:0044281; P:GO:1901576,P:cellular biosynthetic process; P:small molecule metabolic process; P:organic substance biosynthetic process,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,455,IPR001031 (PFAM); IPR029058 (G3DSA:3.40.50.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR029058 (SUPERFAMILY); IPR029058 (SUPERFAMILY),P:GO:0009058,P:biosynthetic process,XP_027047435.1,456,1,2.4999999999999994e-152,66.35,NA,NA,NA,NA,NA
187.530743570755,-3.38528890615711,0.884748998328651,-3.82627040273812,1.3009937822657e-4,0.0213043437959091,Pver_g16517,Downregulated,HOXX_BRADUHydrogenase maturation factor HoxX OS=Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) OX=224911 GN=hoxX PE=4 SV=2,625,5,5.04e-94,45.92,2,P:GO:0044237; F:GO:0003824,P:cellular metabolic process; F:catalytic activity,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,624,IPR005793 (PFAM); G3DSA:3.90.226.10 (GENE3D); IPR001753 (PFAM); IPR002376 (PFAM); G3DSA:3.40.50.12230 (GENE3D); PTHR43388 (PANTHER); IPR018376 (PROSITE_PATTERNS); cd06558 (CDD); cd08650 (CDD); IPR029045 (SUPERFAMILY); IPR036477 (SUPERFAMILY); IPR011034 (SUPERFAMILY),P:GO:0009058; F:GO:0003824; F:GO:0016742,"P:biosynthetic process; F:catalytic activity; F:hydroxymethyl-, formyl- and related transferase activity",XP_027056597.1,625,1,0,97,NA,NA,NA,NA,NA
408.242857919391,1.23220462559042,0.257938279484917,4.77712973836625,1.77815055456992e-6,0.00150884157057779,Pver_g12511,Upregulated,ACHA3_CHICKNeuronal acetylcholine receptor subunit alpha-3 OS=Gallus gallus OX=9031 GN=CHRNA3 PE=1 SV=2,479,5,8.06e-98,56.33,25,P:GO:0006940; P:GO:0007171; P:GO:0007507; P:GO:0007626; P:GO:0010035; P:GO:0014056; P:GO:0035095; P:GO:0048814; P:GO:0060079; P:GO:0060084; P:GO:0095500; P:GO:2000300; F:GO:0005515; F:GO:0015464; F:GO:0022848; F:GO:0042166; F:GO:0044877; C:GO:0005892; C:GO:0014069; C:GO:0030425; C:GO:0043025; C:GO:0044853; C:GO:0098691; C:GO:0098981; C:GO:0099060,"P:regulation of smooth muscle contraction; P:activation of transmembrane receptor protein tyrosine kinase activity; P:heart development; P:locomotory behavior; P:response to inorganic substance; P:regulation of acetylcholine secretion, neurotransmission; P:behavioral response to nicotine; P:regulation of dendrite morphogenesis; P:excitatory postsynaptic potential; P:synaptic transmission involved in micturition; P:acetylcholine receptor signaling pathway; P:regulation of synaptic vesicle exocytosis; F:protein binding; F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; F:acetylcholine binding; F:protein-containing complex binding; C:acetylcholine-gated channel complex; C:postsynaptic density; C:dendrite; C:neuronal cell body; C:plasma membrane raft; C:dopaminergic synapse; C:cholinergic synapse; C:integral component of postsynaptic specialization membrane",EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,478,IPR006201 (PRINTS); IPR002394 (PRINTS); G3DSA:1.20.58.390 (GENE3D); IPR006029 (PFAM); IPR006201 (TIGRFAM); IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); PTHR18945:SF401 (PANTHER); IPR006201 (PANTHER); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036734 (SUPERFAMILY); IPR036719 (SUPERFAMILY),P:GO:0006811; P:GO:0034220; F:GO:0004888; F:GO:0005216; F:GO:0005230; F:GO:0022848; C:GO:0016021; C:GO:0045211,P:ion transport; P:ion transmembrane transport; F:transmembrane signaling receptor activity; F:ion channel activity; F:extracellular ligand-gated ion channel activity; F:acetylcholine-gated cation-selective channel activity; C:integral component of membrane; C:postsynaptic membrane,XP_027050388.1,479,1,1.6e-266,98.12,NA,NA,NA,NA,NA
1558.05739540037,0.66503466298001,0.170290202347612,3.90530197164533,9.41077961592658e-5,0.0185330897897075,Pver_g12512,Upregulated,ACHA3_CHICKNeuronal acetylcholine receptor subunit alpha-3 OS=Gallus gallus OX=9031 GN=CHRNA3 PE=1 SV=2,503,5,3.21e-98,55.95,14,P:GO:0007165; P:GO:0007399; P:GO:0014059; P:GO:0035095; P:GO:0051899; P:GO:0060084; P:GO:2000300; F:GO:0005515; F:GO:0015464; F:GO:0022848; C:GO:0005892; C:GO:0098691; C:GO:0099055; C:GO:0099056,P:signal transduction; P:nervous system development; P:regulation of dopamine secretion; P:behavioral response to nicotine; P:membrane depolarization; P:synaptic transmission involved in micturition; P:regulation of synaptic vesicle exocytosis; F:protein binding; F:acetylcholine receptor activity; F:acetylcholine-gated cation-selective channel activity; C:acetylcholine-gated channel complex; C:dopaminergic synapse; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,502,IPR002394 (PRINTS); IPR006201 (PRINTS); IPR006201 (TIGRFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR006029 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR006202 (PFAM); PTHR18945:SF860 (PANTHER); IPR006201 (PANTHER); IPR018000 (PROSITE_PATTERNS); cd19051 (CDD); cd18997 (CDD); IPR036734 (SUPERFAMILY); IPR036719 (SUPERFAMILY),P:GO:0006811; P:GO:0034220; F:GO:0004888; F:GO:0005216; F:GO:0005230; F:GO:0022848; C:GO:0016021; C:GO:0045211,P:ion transport; P:ion transmembrane transport; F:transmembrane signaling receptor activity; F:ion channel activity; F:extracellular ligand-gated ion channel activity; F:acetylcholine-gated cation-selective channel activity; C:integral component of membrane; C:postsynaptic membrane,XP_027050414.1,503,1,1.9e-291,99.2,NA,NA,NA,NA,NA
451.087975995678,0.903225191841882,0.25989731429287,3.4753156041623,5.1025265331982e-4,0.0447201715125558,Pver_g14201,Upregulated,CRTP1_DICDICrt homolog 1 OS=Dictyostelium discoideum OX=44689 GN=crtp1 PE=2 SV=1,414,1,1.23e-7,39.75,1,C:GO:0110165,C:cellular anatomical entity,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,413,IPR013936 (PFAM); PTHR31326:SF1 (PANTHER); IPR013936 (PANTHER); SSF103481 (SUPERFAMILY),NA,NA,XP_022791166.1,414,1,4.5999999999999995e-198,83.45,NA,NA,NA,NA,NA
5491.93505767088,1.14317591685203,0.286910780057031,3.98442999117982,6.76422946908622e-5,0.0157843294661127,Pver_g15639,Upregulated,FXDC2_MACFAFatty acid hydroxylase domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=FAXDC2 PE=2 SV=1,350,5,5.7199999999999994e-126,60.8,6,P:GO:0001934; P:GO:0016126; P:GO:0045654; F:GO:0000254; F:GO:0005515; C:GO:0005789,P:positive regulation of protein phosphorylation; P:sterol biosynthetic process; P:positive regulation of megakaryocyte differentiation; F:C-4 methylsterol oxidase activity; F:protein binding; C:endoplasmic reticulum membrane,EC:1.14.13; EC:1.14.18.9,"Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2); 4-alpha-methylsterol monooxygenase",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,349,IPR006694 (PFAM); mobidb-lite (MOBIDB_LITE); PTHR11863:SF26 (PANTHER); PTHR11863 (PANTHER),P:GO:0008610; F:GO:0005506; F:GO:0016491,P:lipid biosynthetic process; F:iron ion binding; F:oxidoreductase activity,XP_027039224.1,350,1,1.5e-202,97.41,NA,NA,NA,NA,NA
1058.21902883523,1.35323739787869,0.322351719430484,4.19801513784239,2.69264636324703e-5,0.00851971564560942,Pver_g15637,Upregulated,NA,440,NA,NA,NA,NA,NA,NA,NA,NA,A0A2B4R4K9_STYPITBC domain-containing protein kinase-like protein OS=Stylophora pistillata OX=50429 GN=Tbck PE=4 SV=1,440,2,0,83.95,3,P:GO:0016310; F:GO:0016301; C:GO:0016021,P:phosphorylation; F:kinase activity; C:integral component of membrane,EC:2.7,Transferring phosphorus-containing groups,439,mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,RMX49770.1,440,1,9.599999999999999e-178,90.34,1,C:GO:0016021,C:integral component of membrane,NA,NA
1553.71310362721,0.999877498233382,0.11990194125293,8.33912685470342,7.484109132619551e-17,2.32855582146236e-13,Pver_g255,Upregulated,ZIFL1_ARATHProtein ZINC INDUCED FACILITATOR-LIKE 1 OS=Arabidopsis thaliana OX=3702 GN=ZIFL1 PE=2 SV=1,479,5,5.95e-72,48.23,6,P:GO:0006810; P:GO:0009605; P:GO:0009628; P:GO:0065007; F:GO:0022857; C:GO:0005774,P:transport; P:response to external stimulus; P:response to abiotic stimulus; P:biological regulation; F:transmembrane transporter activity; C:vacuolar membrane,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,478,IPR011701 (PFAM); IPR036259 (G3DSA:1.20.1250.GENE3D); PTHR23504 (PANTHER); PTHR23504:SF15 (PANTHER); IPR020846 (PROSITE_PROFILES); cd17330 (CDD); IPR036259 (SUPERFAMILY),P:GO:0055085; F:GO:0022857,P:transmembrane transport; F:transmembrane transporter activity,XP_027057889.1,479,1,1.4999999999999999e-245,89.88,NA,NA,NA,NA,NA
220.177881935517,1.24063614601435,0.346161591470059,3.58397978454421,3.3839828790384e-4,0.0360983956490794,Pver_g8420,Upregulated,WECH_DROMEProtein wech OS=Drosophila melanogaster OX=7227 GN=wech PE=1 SV=2,799,5,2.38e-7,43.68,1,P:GO:0007275,P:multicellular organism development,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,798,IPR011042 (G3DSA:2.120.10.GENE3D); PTHR24104 (PANTHER); PTHR24104:SF8 (PANTHER); IPR013017 (PROSITE_PROFILES); SSF75011 (SUPERFAMILY); SSF101898 (SUPERFAMILY),NA,NA,PFX24581.1,799,1,4.9e-164,46.16,NA,NA,NA,NA,NA
105.022524577665,1.20674196136972,0.2927739162481,4.12175366178149,3.75999147877201e-5,0.010549592628446,Pver_g9487,Upregulated,KCNA2_HUMANPotassium voltage-gated channel subfamily A member 2 OS=Homo sapiens OX=9606 GN=KCNA2 PE=1 SV=2,596,5,6.05e-78,54.53,12,P:GO:0043269; P:GO:0050794; P:GO:0050877; P:GO:0071805; F:GO:0005249; F:GO:0005515; C:GO:0005887; C:GO:0030027; C:GO:0034705; C:GO:0042734; C:GO:0043025; C:GO:0043679,P:regulation of ion transport; P:regulation of cellular process; P:nervous system process; P:potassium ion transmembrane transport; F:voltage-gated potassium channel activity; F:protein binding; C:integral component of plasma membrane; C:lamellipodium; C:potassium channel complex; C:presynaptic membrane; C:neuronal cell body; C:axon terminus,EC:7,Translocases,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,595,PR00169 (PRINTS); IPR003972 (PRINTS); IPR027359 (G3DSA:1.20.120.GENE3D); IPR005821 (PFAM); G3DSA:1.10.287.70 (GENE3D); IPR003131 (PFAM); IPR011333 (G3DSA:3.30.710.GENE3D); PTHR11537:SF113 (PANTHER); PTHR11537:SF113 (PANTHER); IPR028325 (PANTHER); IPR028325 (PANTHER); SSF81324 (SUPERFAMILY); IPR011333 (SUPERFAMILY); IPR011333 (SUPERFAMILY),P:GO:0006811; P:GO:0006813; P:GO:0051260; P:GO:0055085; F:GO:0005216; F:GO:0005249; C:GO:0008076; C:GO:0016020,P:ion transport; P:potassium ion transport; P:protein homooligomerization; P:transmembrane transport; F:ion channel activity; F:voltage-gated potassium channel activity; C:voltage-gated potassium channel complex; C:membrane,XP_027053329.1,596,1,1.5999999999999997e-239,76.13,NA,NA,NA,NA,NA
82.1446335702707,-1.64240935956786,0.402461291808604,-4.08091260699162,4.4859220702713e-5,0.011794815944764,Pver_g18710,Downregulated,FBX11_MOUSEF-box only protein 11 OS=Mus musculus OX=10090 GN=Fbxo11 PE=1 SV=3,875,4,4.71e-6,46.28,26,P:GO:0002119; P:GO:0006464; P:GO:0006511; P:GO:0006915; P:GO:0007605; P:GO:0008078; P:GO:0008406; P:GO:0009792; P:GO:0016567; P:GO:0018996; P:GO:0035246; P:GO:0040034; P:GO:0042981; P:GO:0043065; F:GO:0004842; F:GO:0005515; F:GO:0008270; F:GO:0016274; F:GO:0046872; C:GO:0000151; C:GO:0005634; C:GO:0005654; C:GO:0005694; C:GO:0005730; C:GO:0005737; C:GO:0005829,"P:nematode larval development; P:cellular protein modification process; P:ubiquitin-dependent protein catabolic process; P:apoptotic process; P:sensory perception of sound; P:mesodermal cell migration; P:gonad development; P:embryo development ending in birth or egg hatching; P:protein ubiquitination; P:molting cycle, collagen and cuticulin-based cuticle; P:peptidyl-arginine N-methylation; P:regulation of development, heterochronic; P:regulation of apoptotic process; P:positive regulation of apoptotic process; F:ubiquitin-protein transferase activity; F:protein binding; F:zinc ion binding; F:protein-arginine N-methyltransferase activity; F:metal ion binding; C:ubiquitin ligase complex; C:nucleus; C:nucleoplasm; C:chromosome; C:nucleolus; C:cytoplasm; C:cytosol",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,874,Coil (COILS); IPR006626 (SMART); IPR012334 (G3DSA:2.160.20.GENE3D); G3DSA:6.10.140.2220 (GENE3D); IPR039448 (PFAM); IPR002893 (PFAM); PTHR22990:SF15 (PANTHER); PTHR22990 (PANTHER); IPR002893 (PROSITE_PROFILES); SSF144232 (SUPERFAMILY); IPR011050 (SUPERFAMILY),NA,NA,XP_022791600.1,875,1,0,58.68,NA,NA,NA,NA,NA
87.7693143982187,1.34511527134764,0.315364608565524,4.26527021363009,1.99660410929658e-5,0.00700682652969083,Pver_g591,Upregulated,TENX_HUMANTenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5,895,5,1.67e-28,36.16,6,P:GO:0006909; P:GO:0048731; P:GO:0050794; P:GO:0050896; C:GO:0016020; C:GO:0071944,P:phagocytosis; P:system development; P:regulation of cellular process; P:response to stimulus; C:membrane; C:cell periphery,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,894,IPR001774 (SMART); G3DSA:2.10.25.140 (GENE3D); G3DSA:2.10.25.140 (GENE3D); IPR001774 (PFAM); PTHR24044:SF454 (PANTHER); PTHR24044 (PANTHER); PTHR24044:SF454 (PANTHER); PTHR24044 (PANTHER); PTHR24044 (PANTHER); PTHR24044:SF454 (PANTHER); PTHR24044 (PANTHER); PTHR24044:SF454 (PANTHER); PTHR24044:SF454 (PANTHER); PTHR24044 (PANTHER); IPR001774 (PROSITE_PROFILES); IPR001774 (PROSITE_PROFILES); IPR001774 (PROSITE_PROFILES); IPR001774 (PROSITE_PROFILES); IPR001774 (PROSITE_PROFILES); IPR001774 (PROSITE_PROFILES),P:GO:0007154; C:GO:0016020,P:cell communication; C:membrane,XP_027035534.1,895,1,6.199999999999999e-232,98.66,NA,NA,NA,NA,NA
92.7853871414566,2.89319851689889,0.565861873835525,5.11290590632694,3.17240341144322e-7,4.2341703931316e-4,Pver_g6093,Upregulated,MFS12_MOUSEMajor facilitator superfamily domain-containing protein 12 OS=Mus musculus OX=10090 GN=Mfsd12 PE=1 SV=1,732,4,4.71e-22,50.22,5,P:GO:0048021; P:GO:0071702; C:GO:0005737; C:GO:0016020; C:GO:0043231,P:regulation of melanin biosynthetic process; P:organic substance transport; C:cytoplasm; C:membrane; C:intracellular membrane-bounded organelle,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,731,PF13347 (PFAM); IPR036259 (G3DSA:1.20.1250.GENE3D); IPR039672 (PANTHER); PTHR11328:SF28 (PANTHER); IPR036259 (SUPERFAMILY); IPR036259 (SUPERFAMILY),P:GO:0008643; F:GO:0015293; C:GO:0016021,P:carbohydrate transport; F:symporter activity; C:integral component of membrane,XP_027041995.1,732,1,0,76.68,NA,NA,NA,NA,NA
1014.7733151844,0.752605981325728,0.182857084617407,4.11581527125629,3.85813225794031e-5,0.0105917077928279,Pver_g9524,Upregulated,NMD3_MOUSE60S ribosomal export protein NMD3 OS=Mus musculus OX=10090 GN=Nmd3 PE=1 SV=1,510,5,0,74.51,9,P:GO:0000055; P:GO:0032092; P:GO:1902680; P:GO:1904751; F:GO:0030674; F:GO:0043023; C:GO:0005654; C:GO:0005730; C:GO:0005737,P:ribosomal large subunit export from nucleus; P:positive regulation of protein binding; P:positive regulation of RNA biosynthetic process; P:positive regulation of protein localization to nucleolus; F:protein-macromolecule adaptor activity; F:ribosomal large subunit binding; C:nucleoplasm; C:nucleolus; C:cytoplasm,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,509,IPR007064 (PFAM); mobidb-lite (MOBIDB_LITE); IPR039768 (PANTHER); PTHR12746:SF2 (PANTHER),F:GO:0043023,F:ribosomal large subunit binding,XP_027043143.1,510,1,4.4e-291,98.43,NA,NA,NA,NA,NA
1539.01679265357,-0.277146080630336,0.0807259092630968,-3.43317384914277,5.9655945248094e-4,0.0473684939218028,Pver_g6870,Downregulated,CNIH1_PONABProtein cornichon homolog 1 OS=Pongo abelii OX=9601 GN=CNIH1 PE=2 SV=1,142,5,3.9799999999999996e-57,78.43,12,P:GO:0006888; P:GO:0006955; P:GO:0007165; P:GO:0007310; P:GO:0007350; P:GO:0009952; P:GO:0046843; F:GO:0005515; C:GO:0005789; C:GO:0005794; C:GO:0012507; C:GO:0033116,P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:immune response; P:signal transduction; P:oocyte dorsal/ventral axis specification; P:blastoderm segmentation; P:anterior/posterior pattern specification; P:dorsal appendage formation; F:protein binding; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:ER to Golgi transport vesicle membrane; C:endoplasmic reticulum-Golgi intermediate compartment membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,141,IPR003377 (SMART); IPR003377 (PFAM); PTHR12290:SF10 (PANTHER); PTHR12290 (PANTHER),P:GO:0016192,P:vesicle-mediated transport,XP_027050309.1,142,1,9.6e-71,100,NA,NA,NA,NA,NA
291.13314832571,-0.803655349874109,0.219091007492504,-3.66813480421649,2.4432636256969e-4,0.0312403050441847,Pver_g23719,Downregulated,NA,411,NA,NA,NA,NA,NA,NA,NA,NA,A0A3M6TNU6_POCDAUncharacterized protein OS=Pocillopora damicornis OX=46731 GN=pdam_00006845 PE=4 SV=1,411,4,0,71.99,1,C:GO:0016021,C:integral component of membrane,NA,NA,410,mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE),NA,NA,XP_027047524.1,411,1,2.0999999999999997e-219,97.32,NA,NA,NA,NA,NA
1633.65866685114,0.741917871195854,0.18220809819168,4.0718161188169,4.6647999199399e-5,0.0120947895701997,Pver_g6370,Upregulated,MSRB3_PONABMethionine-R-sulfoxide reductase B3 OS=Pongo abelii OX=9601 GN=MSRB3 PE=2 SV=2,170,5,2.9099999999999995e-56,76.41,7,P:GO:0030091; F:GO:0005515; F:GO:0008270; F:GO:0033743; C:GO:0005739; C:GO:0005783; C:GO:0005829,P:protein repair; F:protein binding; F:zinc ion binding; F:peptide-methionine (R)-S-oxide reductase activity; C:mitochondrion; C:endoplasmic reticulum; C:cytosol,EC:1.8.4.12,Peptide-methionine (R)-S-oxide reductase,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,169,IPR002579 (PFAM); G3DSA:2.170.150.20 (GENE3D); IPR002579 (TIGRFAM); IPR028427 (PANTHER); IPR002579 (HAMAP); IPR002579 (PROSITE_PROFILES); IPR011057 (SUPERFAMILY),P:GO:0006979; P:GO:0030091; F:GO:0016671; F:GO:0033743,"P:response to oxidative stress; P:protein repair; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; F:peptide-methionine (R)-S-oxide reductase activity",XP_027060054.1,170,1,4.8e-93,99.41,NA,NA,NA,NA,NA
32.4562339349977,1.98997507440124,0.563276072537023,3.53285923443951,4.1109129479548e-4,0.0403027895435653,Pver_g4149,Upregulated,USOM5_ACRMIUncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,260,1,6.189999999999999e-48,77.97,1,C:GO:0005576,C:extracellular region,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,259,PTHR33834:SF4 (PANTHER); PTHR33834 (PANTHER),NA,NA,RMX35489.1,260,1,1.5e-141,96.91,NA,NA,NA,NA,NA
2417.40335155049,0.385212054668215,0.0910869757559469,4.2290574637183,2.34672405046347e-5,0.00770736156956022,Pver_g5236,Upregulated,KIF1A_RATKinesin-like protein KIF1A OS=Rattus norvegicus OX=10116 GN=Kif1a PE=1 SV=3,1450,5,0,64.26,28,P:GO:0008345; P:GO:0016188; P:GO:0016192; P:GO:0022027; P:GO:0032024; P:GO:0040012; P:GO:0045886; P:GO:0046847; P:GO:0048490; P:GO:0048814; P:GO:0060998; P:GO:0061001; P:GO:0098840; P:GO:1990048; P:GO:1990049; F:GO:0003777; F:GO:0008017; F:GO:0030742; F:GO:0042802; C:GO:0005829; C:GO:0005874; C:GO:0005875; C:GO:0008021; C:GO:0030424; C:GO:0030425; C:GO:0043025; C:GO:0098674; C:GO:0098794,P:larval locomotory behavior; P:synaptic vesicle maturation; P:vesicle-mediated transport; P:interkinetic nuclear migration; P:positive regulation of insulin secretion; P:regulation of locomotion; P:negative regulation of synaptic assembly at neuromuscular junction; P:filopodium assembly; P:anterograde synaptic vesicle transport; P:regulation of dendrite morphogenesis; P:regulation of dendritic spine development; P:regulation of dendritic spine morphogenesis; P:protein transport along microtubule; P:anterograde neuronal dense core vesicle transport; P:retrograde neuronal dense core vesicle transport; F:microtubule motor activity; F:microtubule binding; F:GTP-dependent protein binding; F:identical protein binding; C:cytosol; C:microtubule; C:microtubule associated complex; C:synaptic vesicle; C:axon; C:dendrite; C:neuronal cell body; C:extrinsic component of neuronal dense core vesicle membrane; C:postsynapse,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1449,Coil (COILS); IPR001752 (PRINTS); IPR001849 (SMART); IPR001752 (SMART); IPR022164 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR032405 (PFAM); IPR022140 (PFAM); IPR000253 (PFAM); IPR001752 (PFAM); G3DSA:6.10.250.2520 (GENE3D); G3DSA:2.60.200.20 (GENE3D); IPR036961 (G3DSA:3.40.850.GENE3D); mobidb-lite (MOBIDB_LITE); IPR027640 (PANTHER); PTHR24115:SF328 (PANTHER); PTHR24115:SF328 (PANTHER); IPR027640 (PANTHER); IPR019821 (PROSITE_PATTERNS); IPR001849 (PROSITE_PROFILES); IPR001752 (PROSITE_PROFILES); cd01365 (CDD); IPR000253 (CDD); SSF50729 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR008984 (SUPERFAMILY),P:GO:0007018; F:GO:0003777; F:GO:0003777; F:GO:0005515; F:GO:0005524; F:GO:0008017,P:microtubule-based movement; F:microtubule motor activity; F:microtubule motor activity; F:protein binding; F:ATP binding; F:microtubule binding,XP_027056523.1,1450,1,0,89.62,NA,NA,NA,NA,NA
857.870526121757,-0.226390451281254,0.0621833076559089,-3.6406949037511,2.7190318623318e-4,0.032591846256442,Pver_g12427,Downregulated,BAP18_MOUSEChromatin complexes subunit BAP18 OS=Mus musculus OX=10090 GN=Bap18 PE=1 SV=1,185,3,1.76e-16,65.49,4,F:GO:0042802; C:GO:0005829; C:GO:0016589; C:GO:0071339,F:identical protein binding; C:cytosol; C:NURF complex; C:MLL1 complex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,184,IPR001005 (SMART); IPR017930 (PFAM); G3DSA:1.10.10.60 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR037931 (PTHR21397:PANTHER); PTHR21397 (PANTHER); IPR001005 (CDD); IPR009057 (SUPERFAMILY),C:GO:0016589; C:GO:0071339,C:NURF complex; C:MLL1 complex,XP_027058285.1,185,1,1.1e-85,97.28,NA,NA,NA,NA,NA
5105.21886599516,-0.528909295638347,0.142763995631773,-3.70478069976794,2.1157369852422e-4,0.0278144915778183,Pver_g16743,Downregulated,HMX3_DANREHomeobox protein HMX3 OS=Danio rerio OX=7955 GN=hmx3 PE=2 SV=1,238,5,1.3199999999999999e-48,79.52,8,P:GO:0006357; P:GO:0007399; P:GO:0030154; P:GO:0042472; P:GO:0048916; F:GO:0000978; F:GO:0000981; C:GO:0005634,"P:regulation of transcription by RNA polymerase II; P:nervous system development; P:cell differentiation; P:inner ear morphogenesis; P:posterior lateral line development; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; C:nucleus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,237,IPR020479 (PRINTS); IPR001356 (SMART); G3DSA:1.10.10.60 (GENE3D); IPR001356 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); PTHR24340:SF81 (PANTHER); PTHR24340 (PANTHER); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY),P:GO:0006355; F:GO:0000981; F:GO:0003677,"P:regulation of transcription, DNA-templated; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding",XP_027058794.1,238,1,1.7999999999999998e-125,100,NA,NA,NA,NA,NA
2544.35312960478,-1.143585977081,0.0900811307933754,-12.6950668470638,6.29761554729805e-37,3.91879623456533e-33,Pver_g13944,Downregulated,CRY1_RATCryptochrome-1 OS=Rattus norvegicus OX=10116 GN=Cry1 PE=1 SV=1,1812,5,3.769999999999999e-161,68.07,25,P:GO:0000122; P:GO:0006975; P:GO:0014823; P:GO:0031398; P:GO:0032868; P:GO:0032922; P:GO:0042593; P:GO:0042754; P:GO:0043153; P:GO:0045721; P:GO:0045744; P:GO:2000001; P:GO:2000323; P:GO:2000850; F:GO:0000166; F:GO:0009881; F:GO:0016922; F:GO:0019900; F:GO:0019902; F:GO:0070888; C:GO:0005654; C:GO:0005739; C:GO:0005829; C:GO:0042622; C:GO:0097381,P:negative regulation of transcription by RNA polymerase II; P:DNA damage induced protein phosphorylation; P:response to activity; P:positive regulation of protein ubiquitination; P:response to insulin; P:circadian regulation of gene expression; P:glucose homeostasis; P:negative regulation of circadian rhythm; P:entrainment of circadian clock by photoperiod; P:negative regulation of gluconeogenesis; P:negative regulation of G protein-coupled receptor signaling pathway; P:regulation of DNA damage checkpoint; P:negative regulation of glucocorticoid receptor signaling pathway; P:negative regulation of glucocorticoid secretion; F:nucleotide binding; F:photoreceptor activity; F:nuclear receptor binding; F:kinase binding; F:phosphatase binding; F:E-box binding; C:nucleoplasm; C:mitochondrion; C:cytosol; C:photoreceptor outer segment membrane; C:photoreceptor disc membrane,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1811,Coil (COILS); G3DSA:1.25.40.80 (GENE3D); G3DSA:1.25.40.80 (GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); IPR005101 (PFAM); G3DSA:1.10.579.10 (GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); G3DSA:1.25.40.80 (GENE3D); IPR014729 (G3DSA:3.40.50.GENE3D); G3DSA:1.25.40.80 (GENE3D); G3DSA:1.10.579.10 (GENE3D); IPR006050 (PFAM); IPR002081 (PANTHER); IPR002081 (PANTHER); PTHR11455:SF30 (PANTHER); IPR002081 (PANTHER); IPR002081 (PANTHER); IPR002081 (PANTHER); PTHR11455:SF30 (PANTHER); PTHR11455:SF30 (PANTHER); PTHR11455:SF30 (PANTHER); IPR006050 (PROSITE_PROFILES); IPR006050 (PROSITE_PROFILES); IPR006050 (PROSITE_PROFILES); IPR006050 (PROSITE_PROFILES); IPR036134 (SUPERFAMILY); IPR036134 (SUPERFAMILY); IPR036155 (SUPERFAMILY); IPR036155 (SUPERFAMILY); IPR036134 (SUPERFAMILY); IPR036134 (SUPERFAMILY); IPR036155 (SUPERFAMILY); IPR036155 (SUPERFAMILY),NA,NA,RMX55555.1,1812,1,0,89.2,1,P:GO:0018298,P:protein-chromophore linkage,NA,NA
